BG 10-Q Quarterly Report Sept. 30, 2022 | Alphaminr
ALPHAMINR

BG 10-Q Quarter ended Sept. 30, 2022

Balance Sheet
Cash Flow
Income Statement
Debt
BUNGELTD
10-Qs and 10-Ks
10-Q
 		Quarter ended Sept. 30, 2023
10-Q
 		Quarter ended June 30, 2023
10-Q
 		Quarter ended March 31, 2023
10-K
 		Fiscal year ended Dec. 31, 2022
10-Q
 		Quarter ended Sept. 30, 2022
10-Q
 		Quarter ended June 30, 2022
10-Q
 		Quarter ended March 31, 2022
10-K
 		Fiscal year ended Dec. 31, 2021
10-Q
 		Quarter ended Sept. 30, 2021
10-Q
 		Quarter ended June 30, 2021
10-Q
 		Quarter ended March 31, 2021
10-K
 		Fiscal year ended Dec. 31, 2020
10-Q
 		Quarter ended Sept. 30, 2020
10-Q
 		Quarter ended June 30, 2020
10-Q
 		Quarter ended March 31, 2020
10-K
 		Fiscal year ended Dec. 31, 2019
10-Q
 		Quarter ended Sept. 30, 2019
10-Q
 		Quarter ended June 30, 2019
10-Q
 		Quarter ended March 31, 2019
10-K
 		Fiscal year ended Dec. 31, 2018
10-Q
 		Quarter ended Sept. 30, 2018
10-Q
 		Quarter ended June 30, 2018
10-Q
 		Quarter ended March 31, 2018
10-K
 		Fiscal year ended Dec. 31, 2017
10-Q
 		Quarter ended Sept. 30, 2017
10-Q
 		Quarter ended June 30, 2017
10-Q
 		Quarter ended March 31, 2017
10-K
 		Fiscal year ended Dec. 31, 2016
10-Q
 		Quarter ended Sept. 30, 2016
10-Q
 		Quarter ended June 30, 2016
10-Q
 		Quarter ended March 31, 2016
10-K
 		Fiscal year ended Dec. 31, 2015
10-Q
 		Quarter ended Sept. 30, 2015
10-Q
 		Quarter ended June 30, 2015
10-Q
 		Quarter ended March 31, 2015
10-K
 		Fiscal year ended Dec. 31, 2014
10-Q
 		Quarter ended Sept. 30, 2014
10-Q
 		Quarter ended June 30, 2014
10-Q
 		Quarter ended March 31, 2014
10-K
 		Fiscal year ended Dec. 31, 2013
10-Q
 		Quarter ended Sept. 30, 2013
10-Q
 		Quarter ended June 30, 2013
10-Q
 		Quarter ended March 31, 2013
10-K
 		Fiscal year ended Dec. 31, 2012
10-Q
 		Quarter ended Sept. 30, 2012
10-Q
 		Quarter ended June 30, 2012
10-Q
 		Quarter ended March 31, 2012
10-K
 		Fiscal year ended Dec. 31, 2011
10-Q
 		Quarter ended Sept. 30, 2011
10-Q
 		Quarter ended June 30, 2011
10-Q
 		Quarter ended March 31, 2011
10-K
 		Fiscal year ended Dec. 31, 2010
10-Q
 		Quarter ended Sept. 30, 2010
10-Q
 		Quarter ended June 30, 2010
10-Q
 		Quarter ended March 31, 2010
10-K
 		Fiscal year ended Dec. 31, 2009
PROXIES
DEF 14A
 		Filed on March 31, 2023
DEF 14A
 		Filed on March 31, 2022
DEF 14A
 		Filed on March 23, 2021
DEF 14A
 		Filed on April 8, 2020
DEF 14A
 		Filed on April 10, 2019
DEF 14A
 		Filed on April 12, 2018
DEF 14A
 		Filed on April 13, 2017
DEF 14A
 		Filed on April 15, 2016
DEF 14A
 		Filed on April 10, 2015
DEF 14A
 		Filed on April 11, 2014
DEF 14A
 		Filed on April 12, 2013
DEF 14A
 		Filed on April 10, 2012
DEF 14A
 		Filed on April 18, 2011
DEF 14A
 		Filed on April 16, 2010
bg-20220930
0001144519 false 12/31 2022 Q3 0001144519 2022-01-01 2022-09-30 0001144519 2022-10-21 xbrli:shares 0001144519 2022-07-01 2022-09-30 iso4217:USD 0001144519 2021-07-01 2021-09-30 0001144519 2021-01-01 2021-09-30 iso4217:USD xbrli:shares 0001144519 2022-09-30 0001144519 2021-12-31 0001144519 2020-12-31 0001144519 2021-09-30 0001144519 bg:RedeemableNoncontrollingInterestMember 2022-06-30 0001144519 bg:ConvertiblePreferenceSharesMember 2022-06-30 0001144519 bg:CommonStockOutstandingMember 2022-06-30 0001144519 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001144519 us-gaap:RetainedEarningsMember 2022-06-30 0001144519 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001144519 us-gaap:TreasuryStockMember 2022-06-30 0001144519 us-gaap:NoncontrollingInterestMember 2022-06-30 0001144519 2022-06-30 0001144519 bg:RedeemableNoncontrollingInterestMember 2022-07-01 2022-09-30 0001144519 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001144519 us-gaap:NoncontrollingInterestMember 2022-07-01 2022-09-30 0001144519 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0001144519 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001144519 bg:CommonStockOutstandingMember 2022-07-01 2022-09-30 0001144519 us-gaap:TreasuryStockMember 2022-07-01 2022-09-30 0001144519 bg:RedeemableNoncontrollingInterestMember 2022-09-30 0001144519 bg:ConvertiblePreferenceSharesMember 2022-09-30 0001144519 bg:CommonStockOutstandingMember 2022-09-30 0001144519 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001144519 us-gaap:RetainedEarningsMember 2022-09-30 0001144519 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001144519 us-gaap:TreasuryStockMember 2022-09-30 0001144519 us-gaap:NoncontrollingInterestMember 2022-09-30 0001144519 bg:RedeemableNoncontrollingInterestMember 2021-06-30 0001144519 bg:ConvertiblePreferenceSharesMember 2021-06-30 0001144519 bg:CommonStockOutstandingMember 2021-06-30 0001144519 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001144519 us-gaap:RetainedEarningsMember 2021-06-30 0001144519 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001144519 us-gaap:TreasuryStockMember 2021-06-30 0001144519 us-gaap:NoncontrollingInterestMember 2021-06-30 0001144519 2021-06-30 0001144519 bg:RedeemableNoncontrollingInterestMember 2021-07-01 2021-09-30 0001144519 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001144519 us-gaap:NoncontrollingInterestMember 2021-07-01 2021-09-30 0001144519 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001144519 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001144519 bg:CommonStockOutstandingMember 2021-07-01 2021-09-30 0001144519 us-gaap:TreasuryStockMember 2021-07-01 2021-09-30 0001144519 bg:RedeemableNoncontrollingInterestMember 2021-09-30 0001144519 bg:ConvertiblePreferenceSharesMember 2021-09-30 0001144519 bg:CommonStockOutstandingMember 2021-09-30 0001144519 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001144519 us-gaap:RetainedEarningsMember 2021-09-30 0001144519 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001144519 us-gaap:TreasuryStockMember 2021-09-30 0001144519 us-gaap:NoncontrollingInterestMember 2021-09-30 0001144519 bg:RedeemableNoncontrollingInterestMember 2021-12-31 0001144519 bg:ConvertiblePreferenceSharesMember 2021-12-31 0001144519 bg:CommonStockOutstandingMember 2021-12-31 0001144519 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001144519 us-gaap:RetainedEarningsMember 2021-12-31 0001144519 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001144519 us-gaap:TreasuryStockMember 2021-12-31 0001144519 us-gaap:NoncontrollingInterestMember 2021-12-31 0001144519 bg:RedeemableNoncontrollingInterestMember 2022-01-01 2022-09-30 0001144519 us-gaap:RetainedEarningsMember 2022-01-01 2022-09-30 0001144519 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-09-30 0001144519 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-09-30 0001144519 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0001144519 bg:CommonStockOutstandingMember 2022-01-01 2022-09-30 0001144519 us-gaap:TreasuryStockMember 2022-01-01 2022-09-30 0001144519 bg:ConvertiblePreferenceSharesMember 2022-01-01 2022-09-30 0001144519 bg:RedeemableNoncontrollingInterestMember 2020-12-31 0001144519 bg:ConvertiblePreferenceSharesMember 2020-12-31 0001144519 bg:CommonStockOutstandingMember 2020-12-31 0001144519 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001144519 us-gaap:RetainedEarningsMember 2020-12-31 0001144519 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001144519 us-gaap:TreasuryStockMember 2020-12-31 0001144519 us-gaap:NoncontrollingInterestMember 2020-12-31 0001144519 bg:RedeemableNoncontrollingInterestMember 2021-01-01 2021-09-30 0001144519 us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0001144519 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-09-30 0001144519 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-09-30 0001144519 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0001144519 bg:CommonStockOutstandingMember 2021-01-01 2021-09-30 0001144519 us-gaap:TreasuryStockMember 2021-01-01 2021-09-30 0001144519 bg:CoverCressIncMember bg:BayerAGMember 2022-08-01 xbrli:pure 0001144519 bg:CoverCressIncMember 2022-07-01 2022-09-30 0001144519 bg:CoverCressIncMember 2022-09-30 0001144519 bg:BungeChevronAgRenewablesLLCMember 2022-05-01 bg:soybeanProcessingFacility 0001144519 bg:BungeChevronAgRenewablesLLCMember 2022-05-01 2022-05-01 0001144519 country:UA bg:InternationalConflictsMember 2022-09-30 bg:oilSeedCrushingFacility bg:employee 0001144519 country:UA bg:InternationalConflictsMember 2022-01-01 2022-09-30 0001144519 us-gaap:LiabilitiesTotalMember country:UA bg:InternationalConflictsMember us-gaap:GeographicConcentrationRiskMember 2022-01-01 2022-09-30 0001144519 country:UA bg:InternationalConflictsMember 2022-07-01 2022-09-30 0001144519 country:UA bg:InternationalConflictsMember us-gaap:OtherCurrentAssetsMember 2022-09-30 0001144519 bg:NonUkrainianOffShoreMember bg:GovernmentAndCorporateDebtSecuritiesNonUSMember bg:InternationalConflictsMember us-gaap:OtherCurrentAssetsMember 2022-09-30 0001144519 bg:GovernmentAndCorporateDebtSecuritiesNonUSMember country:UA bg:InternationalConflictsMember us-gaap:OtherNonoperatingIncomeExpenseMember 2022-07-01 2022-09-30 0001144519 bg:GovernmentAndCorporateDebtSecuritiesNonUSMember country:UA bg:InternationalConflictsMember us-gaap:OtherNonoperatingIncomeExpenseMember 2022-01-01 2022-09-30 0001144519 country:UA bg:InternationalConflictsMember bg:GovernmentAndCorporateDebtSecuritiesNonUSSecuritiesHeldMember us-gaap:OtherCurrentAssetsMember 2022-01-01 2022-09-30 0001144519 country:UA bg:InternationalConflictsMember us-gaap:OtherNoncurrentAssetsMember 2022-09-30 0001144519 country:RU bg:InternationalConflictsMember 2022-01-01 2022-09-30 iso4217:RUB 0001144519 bg:RussiaOilseedProcessingMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember srt:MaximumMember 2022-01-01 2022-09-30 0001144519 bg:RussiaOilseedProcessingMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember srt:MaximumMember 2022-07-01 2022-09-30 0001144519 bg:AgribusinessMember 2022-09-30 0001144519 bg:RefinedAndSpecialtyOilsMember 2022-09-30 0001144519 us-gaap:CorporateAndOtherMember 2022-09-30 0001144519 bg:RussiaOilseedProcessingMember us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember 2022-09-30 0001144519 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember bg:MexicoWheatMillingMember 2021-01-01 2021-12-31 0001144519 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember bg:MexicoWheatMillingMember 2022-01-01 2022-09-30 0001144519 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember bg:MexicoWheatMillingMember 2022-09-30 0001144519 bg:MexicoWheatMillingMember 2022-09-30 0001144519 bg:TimeDepositsAndLettersOfCreditsMember 2022-09-30 0001144519 bg:TimeDepositsAndLettersOfCreditsMember 2021-12-31 0001144519 us-gaap:LondonInterbankOfferedRateLIBORMember 2022-01-01 2022-09-30 0001144519 us-gaap:TradeAccountsReceivableMember 2021-12-31 0001144519 us-gaap:OtherNoncurrentAssetsMember 2021-12-31 0001144519 us-gaap:TradeAccountsReceivableMember 2022-01-01 2022-09-30 0001144519 us-gaap:OtherNoncurrentAssetsMember 2022-01-01 2022-09-30 0001144519 us-gaap:TradeAccountsReceivableMember 2022-09-30 0001144519 us-gaap:OtherNoncurrentAssetsMember 2022-09-30 0001144519 us-gaap:TradeAccountsReceivableMember 2020-12-31 0001144519 us-gaap:OtherNoncurrentAssetsMember 2020-12-31 0001144519 us-gaap:TradeAccountsReceivableMember 2021-01-01 2021-09-30 0001144519 us-gaap:OtherNoncurrentAssetsMember 2021-01-01 2021-09-30 0001144519 us-gaap:TradeAccountsReceivableMember 2021-09-30 0001144519 us-gaap:OtherNoncurrentAssetsMember 2021-09-30 0001144519 bg:BungeSecuritizationBVMember 2022-03-31 2022-03-31 0001144519 bg:BungeSecuritizationBVMember 2022-03-30 0001144519 bg:BungeSecuritizationBVMember 2022-03-31 0001144519 bg:BungeSecuritizationBVMember 2022-09-30 0001144519 bg:BungeSecuritizationBVMember 2021-12-31 0001144519 bg:BungeSecuritizationBVMember 2022-01-01 2022-09-30 0001144519 bg:BungeSecuritizationBVMember 2021-01-01 2021-09-30 0001144519 bg:AgribusinessMember 2021-12-31 0001144519 bg:RefinedAndSpecialtyOilsMember 2021-12-31 0001144519 bg:MillingProductsMember 2022-09-30 0001144519 bg:MillingProductsMember 2021-12-31 0001144519 bg:CorporateAndReconcilingItemsMember 2022-09-30 0001144519 bg:CorporateAndReconcilingItemsMember 2021-12-31 0001144519 bg:AgribusinessMember bg:MerchandisingActivitiesMember 2022-09-30 0001144519 bg:AgribusinessMember bg:MerchandisingActivitiesMember 2021-12-31 0001144519 us-gaap:ForeignGovernmentDebtSecuritiesMember 2022-09-30 0001144519 us-gaap:ForeignGovernmentDebtSecuritiesMember 2021-12-31 0001144519 us-gaap:CorporateDebtSecuritiesMember 2022-09-30 0001144519 us-gaap:CorporateDebtSecuritiesMember 2021-12-31 0001144519 us-gaap:EquitySecuritiesMember 2022-09-30 0001144519 us-gaap:EquitySecuritiesMember 2021-12-31 0001144519 bg:OtherSecuritiesMember 2022-09-30 0001144519 bg:OtherSecuritiesMember 2021-12-31 0001144519 bg:NotesAndLoansReceivableMember 2022-01-01 2022-09-30 0001144519 bg:NotesAndLoansReceivableMember 2021-01-01 2021-12-31 0001144519 bg:NotesAndLoansReceivableMember bg:LegalCollectionProcessMember 2022-09-30 0001144519 bg:NotesAndLoansReceivableMember bg:LegalCollectionProcessMember 2021-12-31 0001144519 bg:NotesAndLoansReceivableMember bg:RenegotiatedAmountMember 2022-09-30 0001144519 bg:NotesAndLoansReceivableMember bg:RenegotiatedAmountMember 2021-12-31 0001144519 bg:NotesAndLoansReceivableMember bg:OtherLongTermReceivablesMember 2022-09-30 0001144519 bg:NotesAndLoansReceivableMember bg:OtherLongTermReceivablesMember 2021-12-31 0001144519 bg:NotesAndLoansReceivableMember 2022-09-30 0001144519 bg:NotesAndLoansReceivableMember 2021-12-31 0001144519 bg:NotesAndLoansReceivableMember 2020-12-31 0001144519 bg:NotesAndLoansReceivableMember 2021-01-01 2021-09-30 0001144519 bg:NotesAndLoansReceivableMember 2021-09-30 0001144519 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2022-09-30 0001144519 bg:SinagroProdutosAgropecuriosSAMember 2022-06-10 2022-06-10 iso4217:BRL 0001144519 bg:SinagroProdutosAgropecuriosSAMember 2022-09-30 0001144519 bg:SinagroProdutosAgropecuriosSAMember 2022-06-10 0001144519 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-09-30 0001144519 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001144519 us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001144519 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001144519 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001144519 us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001144519 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-09-30 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-09-30 0001144519 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-09-30 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-09-30 0001144519 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0001144519 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-12-31 0001144519 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2022-09-30 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2022-09-30 0001144519 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2022-09-30 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2022-09-30 0001144519 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2021-12-31 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2021-12-31 0001144519 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2021-12-31 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2021-12-31 0001144519 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember us-gaap:CommodityContractMember 2022-09-30 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember us-gaap:FairValueInputsLevel2Member us-gaap:CommodityContractMember 2022-09-30 0001144519 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember us-gaap:CommodityContractMember 2022-09-30 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember us-gaap:CommodityContractMember 2022-09-30 0001144519 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember us-gaap:CommodityContractMember 2021-12-31 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember us-gaap:FairValueInputsLevel2Member us-gaap:CommodityContractMember 2021-12-31 0001144519 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember us-gaap:CommodityContractMember 2021-12-31 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember us-gaap:CommodityContractMember 2021-12-31 0001144519 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember bg:OceanFreightDerivativesMember us-gaap:NondesignatedMember 2022-09-30 0001144519 us-gaap:FairValueMeasurementsRecurringMember bg:OceanFreightDerivativesMember us-gaap:NondesignatedMember us-gaap:FairValueInputsLevel2Member 2022-09-30 0001144519 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember bg:OceanFreightDerivativesMember us-gaap:NondesignatedMember 2022-09-30 0001144519 us-gaap:FairValueMeasurementsRecurringMember bg:OceanFreightDerivativesMember us-gaap:NondesignatedMember 2022-09-30 0001144519 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember bg:OceanFreightDerivativesMember us-gaap:NondesignatedMember 2021-12-31 0001144519 us-gaap:FairValueMeasurementsRecurringMember bg:OceanFreightDerivativesMember us-gaap:NondesignatedMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001144519 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember bg:OceanFreightDerivativesMember us-gaap:NondesignatedMember 2021-12-31 0001144519 us-gaap:FairValueMeasurementsRecurringMember bg:OceanFreightDerivativesMember us-gaap:NondesignatedMember 2021-12-31 0001144519 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember bg:EnergyDerivativesMember 2022-09-30 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember us-gaap:FairValueInputsLevel2Member bg:EnergyDerivativesMember 2022-09-30 0001144519 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember bg:EnergyDerivativesMember 2022-09-30 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember bg:EnergyDerivativesMember 2022-09-30 0001144519 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember bg:EnergyDerivativesMember 2021-12-31 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember us-gaap:FairValueInputsLevel2Member bg:EnergyDerivativesMember 2021-12-31 0001144519 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember bg:EnergyDerivativesMember 2021-12-31 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember bg:EnergyDerivativesMember 2021-12-31 0001144519 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember bg:CreditDerivativesMember 2022-09-30 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember us-gaap:FairValueInputsLevel2Member bg:CreditDerivativesMember 2022-09-30 0001144519 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember bg:CreditDerivativesMember 2022-09-30 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember bg:CreditDerivativesMember 2022-09-30 0001144519 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember bg:CreditDerivativesMember 2021-12-31 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember us-gaap:FairValueInputsLevel2Member bg:CreditDerivativesMember 2021-12-31 0001144519 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember bg:CreditDerivativesMember 2021-12-31 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember bg:CreditDerivativesMember 2021-12-31 0001144519 us-gaap:FairValueInputsLevel1Member bg:EquityDerivativesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2022-09-30 0001144519 bg:EquityDerivativesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember us-gaap:FairValueInputsLevel2Member 2022-09-30 0001144519 bg:EquityDerivativesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2022-09-30 0001144519 bg:EquityDerivativesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2022-09-30 0001144519 us-gaap:FairValueInputsLevel1Member bg:EquityDerivativesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2021-12-31 0001144519 bg:EquityDerivativesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001144519 bg:EquityDerivativesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2021-12-31 0001144519 bg:EquityDerivativesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2021-12-31 0001144519 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2022-09-30 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember us-gaap:FairValueInputsLevel2Member 2022-09-30 0001144519 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2022-09-30 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2022-09-30 0001144519 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2021-12-31 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001144519 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2021-12-31 0001144519 us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2021-12-31 0001144519 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember 2022-09-30 0001144519 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember 2021-12-31 0001144519 bg:ReadilyMarketableInventoriesMember 2022-06-30 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember 2022-06-30 0001144519 bg:TradeAccountsPayableMember 2022-06-30 0001144519 us-gaap:OtherCurrentAssetsMember 2022-06-30 0001144519 us-gaap:CostOfSalesMember bg:ReadilyMarketableInventoriesMember 2022-07-01 2022-09-30 0001144519 us-gaap:CostOfSalesMember bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember 2022-07-01 2022-09-30 0001144519 us-gaap:CostOfSalesMember bg:TradeAccountsPayableMember 2022-07-01 2022-09-30 0001144519 us-gaap:CostOfSalesMember us-gaap:OtherCurrentAssetsMember 2022-07-01 2022-09-30 0001144519 us-gaap:CostOfSalesMember 2022-07-01 2022-09-30 0001144519 bg:ReadilyMarketableInventoriesMember us-gaap:ForeignCurrencyGainLossMember 2022-07-01 2022-09-30 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember us-gaap:ForeignCurrencyGainLossMember 2022-07-01 2022-09-30 0001144519 bg:TradeAccountsPayableMember us-gaap:ForeignCurrencyGainLossMember 2022-07-01 2022-09-30 0001144519 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignCurrencyGainLossMember 2022-07-01 2022-09-30 0001144519 us-gaap:ForeignCurrencyGainLossMember 2022-07-01 2022-09-30 0001144519 bg:ReadilyMarketableInventoriesMember us-gaap:OtherNonoperatingIncomeExpenseMember 2022-07-01 2022-09-30 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember us-gaap:OtherNonoperatingIncomeExpenseMember 2022-07-01 2022-09-30 0001144519 bg:TradeAccountsPayableMember us-gaap:OtherNonoperatingIncomeExpenseMember 2022-07-01 2022-09-30 0001144519 us-gaap:OtherCurrentAssetsMember us-gaap:OtherNonoperatingIncomeExpenseMember 2022-07-01 2022-09-30 0001144519 us-gaap:OtherNonoperatingIncomeExpenseMember 2022-07-01 2022-09-30 0001144519 bg:ReadilyMarketableInventoriesMember 2022-07-01 2022-09-30 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember 2022-07-01 2022-09-30 0001144519 bg:TradeAccountsPayableMember 2022-07-01 2022-09-30 0001144519 us-gaap:OtherCurrentAssetsMember 2022-07-01 2022-09-30 0001144519 bg:ReadilyMarketableInventoriesMember 2022-09-30 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember 2022-09-30 0001144519 bg:TradeAccountsPayableMember 2022-09-30 0001144519 us-gaap:OtherCurrentAssetsMember 2022-09-30 0001144519 bg:ReadilyMarketableInventoriesMember 2021-06-30 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember 2021-06-30 0001144519 bg:TradeAccountsPayableMember 2021-06-30 0001144519 bg:ReadilyMarketableInventoriesMember 2021-07-01 2021-09-30 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember 2021-07-01 2021-09-30 0001144519 bg:TradeAccountsPayableMember 2021-07-01 2021-09-30 0001144519 bg:ReadilyMarketableInventoriesMember 2021-09-30 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember 2021-09-30 0001144519 bg:TradeAccountsPayableMember 2021-09-30 0001144519 bg:ReadilyMarketableInventoriesMember 2021-12-31 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember 2021-12-31 0001144519 bg:TradeAccountsPayableMember 2021-12-31 0001144519 us-gaap:OtherCurrentAssetsMember 2021-12-31 0001144519 us-gaap:CostOfSalesMember bg:ReadilyMarketableInventoriesMember 2022-01-01 2022-09-30 0001144519 us-gaap:CostOfSalesMember bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember 2022-01-01 2022-09-30 0001144519 us-gaap:CostOfSalesMember bg:TradeAccountsPayableMember 2022-01-01 2022-09-30 0001144519 us-gaap:CostOfSalesMember us-gaap:OtherCurrentAssetsMember 2022-01-01 2022-09-30 0001144519 us-gaap:CostOfSalesMember 2022-01-01 2022-09-30 0001144519 bg:ReadilyMarketableInventoriesMember us-gaap:ForeignCurrencyGainLossMember 2022-01-01 2022-09-30 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember us-gaap:ForeignCurrencyGainLossMember 2022-01-01 2022-09-30 0001144519 bg:TradeAccountsPayableMember us-gaap:ForeignCurrencyGainLossMember 2022-01-01 2022-09-30 0001144519 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignCurrencyGainLossMember 2022-01-01 2022-09-30 0001144519 us-gaap:ForeignCurrencyGainLossMember 2022-01-01 2022-09-30 0001144519 bg:ReadilyMarketableInventoriesMember us-gaap:OtherNonoperatingIncomeExpenseMember 2022-01-01 2022-09-30 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember us-gaap:OtherNonoperatingIncomeExpenseMember 2022-01-01 2022-09-30 0001144519 bg:TradeAccountsPayableMember us-gaap:OtherNonoperatingIncomeExpenseMember 2022-01-01 2022-09-30 0001144519 us-gaap:OtherCurrentAssetsMember us-gaap:OtherNonoperatingIncomeExpenseMember 2022-01-01 2022-09-30 0001144519 us-gaap:OtherNonoperatingIncomeExpenseMember 2022-01-01 2022-09-30 0001144519 bg:ReadilyMarketableInventoriesMember 2022-01-01 2022-09-30 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember 2022-01-01 2022-09-30 0001144519 bg:TradeAccountsPayableMember 2022-01-01 2022-09-30 0001144519 us-gaap:OtherCurrentAssetsMember 2022-01-01 2022-09-30 0001144519 bg:ReadilyMarketableInventoriesMember 2020-12-31 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember 2020-12-31 0001144519 bg:TradeAccountsPayableMember 2020-12-31 0001144519 bg:ReadilyMarketableInventoriesMember 2021-01-01 2021-09-30 0001144519 bg:DerivativeFinancialInstrumentsAssetsLiabilitiesNetMember 2021-01-01 2021-09-30 0001144519 bg:TradeAccountsPayableMember 2021-01-01 2021-09-30 0001144519 us-gaap:CashFlowHedgingMember us-gaap:ForeignExchangeContractMember 2022-01-01 2022-09-30 0001144519 us-gaap:FairValueHedgingMember us-gaap:InterestRateContractMember 2022-09-30 0001144519 us-gaap:FairValueHedgingMember us-gaap:InterestRateContractMember 2021-12-31 0001144519 us-gaap:FairValueHedgingMember us-gaap:InterestRateContractMember 2022-01-01 2022-09-30 0001144519 us-gaap:FairValueHedgingMember us-gaap:InterestRateContractMember 2021-01-01 2021-12-31 0001144519 us-gaap:FairValueHedgingMember us-gaap:ForeignExchangeContractMember 2022-09-30 0001144519 us-gaap:FairValueHedgingMember us-gaap:ForeignExchangeContractMember 2021-12-31 0001144519 us-gaap:CashFlowHedgingMember us-gaap:ForeignExchangeContractMember us-gaap:ForwardContractsMember 2022-09-30 0001144519 us-gaap:CashFlowHedgingMember us-gaap:ForeignExchangeContractMember us-gaap:ForwardContractsMember 2021-12-31 0001144519 us-gaap:CashFlowHedgingMember us-gaap:OptionMember us-gaap:ForeignExchangeContractMember 2022-09-30 0001144519 us-gaap:CashFlowHedgingMember us-gaap:OptionMember us-gaap:ForeignExchangeContractMember 2021-12-31 0001144519 us-gaap:NetInvestmentHedgingMember us-gaap:ForeignExchangeContractMember 2022-09-30 0001144519 us-gaap:NetInvestmentHedgingMember us-gaap:ForeignExchangeContractMember 2021-12-31 0001144519 us-gaap:SwapMember us-gaap:LongMember us-gaap:InterestRateContractMember 2022-09-30 0001144519 us-gaap:SwapMember us-gaap:InterestRateContractMember us-gaap:ShortMember 2022-09-30 0001144519 us-gaap:SwapMember us-gaap:LongMember us-gaap:InterestRateContractMember 2021-12-31 0001144519 us-gaap:SwapMember us-gaap:InterestRateContractMember us-gaap:ShortMember 2021-12-31 0001144519 us-gaap:LongMember us-gaap:InterestRateContractMember us-gaap:FutureMember 2022-09-30 0001144519 us-gaap:InterestRateContractMember us-gaap:ShortMember us-gaap:FutureMember 2022-09-30 0001144519 us-gaap:LongMember us-gaap:InterestRateContractMember us-gaap:FutureMember 2021-12-31 0001144519 us-gaap:InterestRateContractMember us-gaap:ShortMember us-gaap:FutureMember 2021-12-31 0001144519 us-gaap:LongMember us-gaap:ForeignExchangeContractMember us-gaap:ForwardContractsMember 2022-09-30 0001144519 us-gaap:ShortMember us-gaap:ForeignExchangeContractMember us-gaap:ForwardContractsMember 2022-09-30 0001144519 us-gaap:LongMember us-gaap:ForeignExchangeContractMember us-gaap:ForwardContractsMember 2021-12-31 0001144519 us-gaap:ShortMember us-gaap:ForeignExchangeContractMember us-gaap:ForwardContractsMember 2021-12-31 0001144519 us-gaap:SwapMember us-gaap:LongMember us-gaap:ForeignExchangeContractMember 2022-09-30 0001144519 us-gaap:SwapMember us-gaap:ShortMember us-gaap:ForeignExchangeContractMember 2022-09-30 0001144519 us-gaap:SwapMember us-gaap:LongMember us-gaap:ForeignExchangeContractMember 2021-12-31 0001144519 us-gaap:SwapMember us-gaap:ShortMember us-gaap:ForeignExchangeContractMember 2021-12-31 0001144519 us-gaap:LongMember us-gaap:ForeignExchangeContractMember us-gaap:FutureMember 2022-09-30 0001144519 us-gaap:ShortMember us-gaap:ForeignExchangeContractMember us-gaap:FutureMember 2022-09-30 0001144519 us-gaap:LongMember us-gaap:ForeignExchangeContractMember us-gaap:FutureMember 2021-12-31 0001144519 us-gaap:ShortMember us-gaap:ForeignExchangeContractMember us-gaap:FutureMember 2021-12-31 0001144519 us-gaap:LongMember us-gaap:OptionMember us-gaap:ForeignExchangeContractMember 2022-09-30 0001144519 us-gaap:ShortMember us-gaap:OptionMember us-gaap:ForeignExchangeContractMember 2022-09-30 0001144519 us-gaap:LongMember us-gaap:OptionMember us-gaap:ForeignExchangeContractMember 2021-12-31 0001144519 us-gaap:ShortMember us-gaap:OptionMember us-gaap:ForeignExchangeContractMember 2021-12-31 0001144519 us-gaap:LongMember us-gaap:CommodityContractMember us-gaap:ForwardContractsMember 2022-01-01 2022-09-30 utr:t 0001144519 us-gaap:CommodityContractMember us-gaap:ShortMember us-gaap:ForwardContractsMember 2022-01-01 2022-09-30 0001144519 us-gaap:LongMember us-gaap:CommodityContractMember us-gaap:ForwardContractsMember 2021-01-01 2021-12-31 0001144519 us-gaap:CommodityContractMember us-gaap:ShortMember us-gaap:ForwardContractsMember 2021-01-01 2021-12-31 0001144519 us-gaap:SwapMember us-gaap:LongMember us-gaap:CommodityContractMember 2022-01-01 2022-09-30 0001144519 us-gaap:SwapMember us-gaap:CommodityContractMember us-gaap:ShortMember 2022-01-01 2022-09-30 0001144519 us-gaap:SwapMember us-gaap:LongMember us-gaap:CommodityContractMember 2021-01-01 2021-12-31 0001144519 us-gaap:SwapMember us-gaap:CommodityContractMember us-gaap:ShortMember 2021-01-01 2021-12-31 0001144519 us-gaap:LongMember us-gaap:CommodityContractMember us-gaap:FutureMember 2022-01-01 2022-09-30 0001144519 us-gaap:CommodityContractMember us-gaap:ShortMember us-gaap:FutureMember 2022-01-01 2022-09-30 0001144519 us-gaap:LongMember us-gaap:CommodityContractMember us-gaap:FutureMember 2021-01-01 2021-12-31 0001144519 us-gaap:CommodityContractMember us-gaap:ShortMember us-gaap:FutureMember 2021-01-01 2021-12-31 0001144519 us-gaap:LongMember us-gaap:CommodityContractMember us-gaap:OptionMember 2022-01-01 2022-09-30 0001144519 us-gaap:CommodityContractMember us-gaap:ShortMember us-gaap:OptionMember 2022-01-01 2022-09-30 0001144519 us-gaap:LongMember us-gaap:CommodityContractMember us-gaap:OptionMember 2021-01-01 2021-12-31 0001144519 us-gaap:CommodityContractMember us-gaap:ShortMember us-gaap:OptionMember 2021-01-01 2021-12-31 0001144519 bg:OceanFreightDerivativesMember us-gaap:ForeignExchangeForwardMember us-gaap:LongMember 2022-01-01 2022-09-30 bg:day 0001144519 bg:OceanFreightDerivativesMember us-gaap:ForeignExchangeForwardMember us-gaap:ShortMember 2022-01-01 2022-09-30 0001144519 bg:OceanFreightDerivativesMember us-gaap:ForeignExchangeForwardMember us-gaap:LongMember 2021-01-01 2021-12-31 0001144519 bg:OceanFreightDerivativesMember us-gaap:ForeignExchangeForwardMember us-gaap:ShortMember 2021-01-01 2021-12-31 0001144519 bg:OceanFreightDerivativesMember us-gaap:LongMember us-gaap:OptionMember 2022-01-01 2022-09-30 0001144519 bg:OceanFreightDerivativesMember us-gaap:ShortMember us-gaap:OptionMember 2022-01-01 2022-09-30 0001144519 bg:OceanFreightDerivativesMember us-gaap:LongMember us-gaap:OptionMember 2021-01-01 2021-12-31 0001144519 bg:OceanFreightDerivativesMember us-gaap:ShortMember us-gaap:OptionMember 2021-01-01 2021-12-31 0001144519 us-gaap:SwapMember bg:NaturalGasDerivativesMember us-gaap:LongMember 2022-01-01 2022-09-30 utr:MMBTU 0001144519 us-gaap:SwapMember bg:NaturalGasDerivativesMember us-gaap:ShortMember 2022-01-01 2022-09-30 0001144519 us-gaap:SwapMember bg:NaturalGasDerivativesMember us-gaap:LongMember 2021-01-01 2021-12-31 0001144519 us-gaap:SwapMember bg:NaturalGasDerivativesMember us-gaap:ShortMember 2021-01-01 2021-12-31 0001144519 bg:NaturalGasDerivativesMember us-gaap:LongMember us-gaap:FutureMember 2022-01-01 2022-09-30 0001144519 bg:NaturalGasDerivativesMember us-gaap:ShortMember us-gaap:FutureMember 2022-01-01 2022-09-30 0001144519 bg:NaturalGasDerivativesMember us-gaap:LongMember us-gaap:FutureMember 2021-01-01 2021-12-31 0001144519 bg:NaturalGasDerivativesMember us-gaap:ShortMember us-gaap:FutureMember 2021-01-01 2021-12-31 0001144519 us-gaap:SwapMember us-gaap:LongMember bg:EnergyDerivativesExcludingNaturalGasMember 2022-01-01 2022-09-30 0001144519 us-gaap:SwapMember bg:EnergyDerivativesExcludingNaturalGasMember us-gaap:ShortMember 2022-01-01 2022-09-30 0001144519 us-gaap:SwapMember us-gaap:LongMember bg:EnergyDerivativesExcludingNaturalGasMember 2021-01-01 2021-12-31 0001144519 us-gaap:SwapMember bg:EnergyDerivativesExcludingNaturalGasMember us-gaap:ShortMember 2021-01-01 2021-12-31 0001144519 bg:ElectricityDerivativesMember us-gaap:SwapMember us-gaap:LongMember 2022-01-01 2022-09-30 utr:MWh 0001144519 bg:ElectricityDerivativesMember us-gaap:SwapMember us-gaap:ShortMember 2022-01-01 2022-09-30 0001144519 bg:ElectricityDerivativesMember us-gaap:SwapMember us-gaap:LongMember 2021-01-01 2021-12-31 0001144519 bg:ElectricityDerivativesMember us-gaap:SwapMember us-gaap:ShortMember 2021-01-01 2021-12-31 0001144519 bg:EnergyDerivativesCarbonDioxideMember us-gaap:LongMember us-gaap:FutureMember 2022-01-01 2022-09-30 0001144519 bg:EnergyDerivativesCarbonDioxideMember us-gaap:ShortMember us-gaap:FutureMember 2022-01-01 2022-09-30 0001144519 bg:EnergyDerivativesCarbonDioxideMember us-gaap:LongMember us-gaap:FutureMember 2021-01-01 2021-12-31 0001144519 bg:EnergyDerivativesCarbonDioxideMember us-gaap:ShortMember us-gaap:FutureMember 2021-01-01 2021-12-31 0001144519 bg:OtherDerivativesMember us-gaap:LongMember bg:SwapsandFuturesMember 2022-09-30 0001144519 bg:OtherDerivativesMember us-gaap:ShortMember bg:SwapsandFuturesMember 2022-09-30 0001144519 bg:OtherDerivativesMember us-gaap:LongMember bg:SwapsandFuturesMember 2021-12-31 0001144519 bg:OtherDerivativesMember us-gaap:ShortMember bg:SwapsandFuturesMember 2021-12-31 0001144519 us-gaap:SalesMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2022-07-01 2022-09-30 0001144519 us-gaap:SalesMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2021-07-01 2021-09-30 0001144519 us-gaap:CostOfSalesMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2022-07-01 2022-09-30 0001144519 us-gaap:CostOfSalesMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2021-07-01 2021-09-30 0001144519 us-gaap:CostOfSalesMember us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2022-07-01 2022-09-30 0001144519 us-gaap:CostOfSalesMember us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2021-07-01 2021-09-30 0001144519 us-gaap:CostOfSalesMember us-gaap:NondesignatedMember us-gaap:CommodityContractMember 2022-07-01 2022-09-30 0001144519 us-gaap:CostOfSalesMember us-gaap:NondesignatedMember us-gaap:CommodityContractMember 2021-07-01 2021-09-30 0001144519 us-gaap:CostOfSalesMember bg:OtherDerivativesMember us-gaap:NondesignatedMember 2022-07-01 2022-09-30 0001144519 us-gaap:CostOfSalesMember bg:OtherDerivativesMember us-gaap:NondesignatedMember 2021-07-01 2021-09-30 0001144519 us-gaap:CostOfSalesMember 2021-07-01 2021-09-30 0001144519 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:ForeignExchangeContractMember 2022-07-01 2022-09-30 0001144519 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:ForeignExchangeContractMember 2021-07-01 2021-09-30 0001144519 us-gaap:InterestExpenseMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-07-01 2022-09-30 0001144519 us-gaap:InterestExpenseMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-07-01 2021-09-30 0001144519 us-gaap:ForeignCurrencyGainLossMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2022-07-01 2022-09-30 0001144519 us-gaap:ForeignCurrencyGainLossMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2021-07-01 2021-09-30 0001144519 us-gaap:NondesignatedMember us-gaap:ForeignCurrencyGainLossMember us-gaap:ForeignExchangeContractMember 2022-07-01 2022-09-30 0001144519 us-gaap:NondesignatedMember us-gaap:ForeignCurrencyGainLossMember us-gaap:ForeignExchangeContractMember 2021-07-01 2021-09-30 0001144519 us-gaap:ForeignCurrencyGainLossMember 2021-07-01 2021-09-30 0001144519 us-gaap:NondesignatedMember bg:OtherIncomeExpenseMember us-gaap:InterestRateContractMember 2022-07-01 2022-09-30 0001144519 us-gaap:NondesignatedMember bg:OtherIncomeExpenseMember us-gaap:InterestRateContractMember 2021-07-01 2021-09-30 0001144519 us-gaap:FairValueHedgingMember us-gaap:ForeignExchangeContractMember 2022-07-01 2022-09-30 0001144519 us-gaap:FairValueHedgingMember us-gaap:ForeignExchangeContractMember 2021-07-01 2021-09-30 0001144519 us-gaap:CashFlowHedgingMember us-gaap:ForeignExchangeContractMember 2022-07-01 2022-09-30 0001144519 us-gaap:CashFlowHedgingMember us-gaap:ForeignExchangeContractMember 2021-07-01 2021-09-30 0001144519 us-gaap:NetInvestmentHedgingMember 2022-07-01 2022-09-30 0001144519 us-gaap:NetInvestmentHedgingMember 2021-07-01 2021-09-30 0001144519 us-gaap:SalesMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2022-01-01 2022-09-30 0001144519 us-gaap:SalesMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2021-01-01 2021-09-30 0001144519 us-gaap:CostOfSalesMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2022-01-01 2022-09-30 0001144519 us-gaap:CostOfSalesMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2021-01-01 2021-09-30 0001144519 us-gaap:CostOfSalesMember us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2022-01-01 2022-09-30 0001144519 us-gaap:CostOfSalesMember us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2021-01-01 2021-09-30 0001144519 us-gaap:CostOfSalesMember us-gaap:NondesignatedMember us-gaap:CommodityContractMember 2022-01-01 2022-09-30 0001144519 us-gaap:CostOfSalesMember us-gaap:NondesignatedMember us-gaap:CommodityContractMember 2021-01-01 2021-09-30 0001144519 us-gaap:CostOfSalesMember bg:OtherDerivativesMember us-gaap:NondesignatedMember 2022-01-01 2022-09-30 0001144519 us-gaap:CostOfSalesMember bg:OtherDerivativesMember us-gaap:NondesignatedMember 2021-01-01 2021-09-30 0001144519 us-gaap:CostOfSalesMember 2021-01-01 2021-09-30 0001144519 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:ForeignExchangeContractMember 2022-01-01 2022-09-30 0001144519 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:ForeignExchangeContractMember 2021-01-01 2021-09-30 0001144519 us-gaap:InterestExpenseMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-09-30 0001144519 us-gaap:InterestExpenseMember us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-01-01 2021-09-30 0001144519 us-gaap:InterestExpenseMember us-gaap:NondesignatedMember us-gaap:InterestRateContractMember 2022-01-01 2022-09-30 0001144519 us-gaap:InterestExpenseMember us-gaap:NondesignatedMember us-gaap:InterestRateContractMember 2021-01-01 2021-09-30 0001144519 us-gaap:InterestExpenseMember 2022-01-01 2022-09-30 0001144519 us-gaap:InterestExpenseMember 2021-01-01 2021-09-30 0001144519 us-gaap:ForeignCurrencyGainLossMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2022-01-01 2022-09-30 0001144519 us-gaap:ForeignCurrencyGainLossMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2021-01-01 2021-09-30 0001144519 us-gaap:NondesignatedMember us-gaap:ForeignCurrencyGainLossMember us-gaap:ForeignExchangeContractMember 2022-01-01 2022-09-30 0001144519 us-gaap:NondesignatedMember us-gaap:ForeignCurrencyGainLossMember us-gaap:ForeignExchangeContractMember 2021-01-01 2021-09-30 0001144519 us-gaap:ForeignCurrencyGainLossMember 2021-01-01 2021-09-30 0001144519 us-gaap:NondesignatedMember bg:OtherIncomeExpenseMember us-gaap:InterestRateContractMember 2022-01-01 2022-09-30 0001144519 us-gaap:NondesignatedMember bg:OtherIncomeExpenseMember us-gaap:InterestRateContractMember 2021-01-01 2021-09-30 0001144519 us-gaap:FairValueHedgingMember us-gaap:ForeignExchangeContractMember 2022-01-01 2022-09-30 0001144519 us-gaap:FairValueHedgingMember us-gaap:ForeignExchangeContractMember 2021-01-01 2021-09-30 0001144519 us-gaap:CashFlowHedgingMember us-gaap:ForeignExchangeContractMember 2021-01-01 2021-09-30 0001144519 us-gaap:NetInvestmentHedgingMember 2022-01-01 2022-09-30 0001144519 us-gaap:NetInvestmentHedgingMember 2021-01-01 2021-09-30 0001144519 srt:MaximumMember us-gaap:CommercialPaperMember 2022-09-30 0001144519 us-gaap:CommercialPaperMember 2022-09-30 0001144519 us-gaap:CommercialPaperMember 2021-12-31 0001144519 bg:LiquidityFacilityMember 2022-09-30 0001144519 bg:LiquidityFacilityMember 2021-12-31 0001144519 bg:RevolvingCreditFacilityMaturingJuly2022Member us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2022-09-30 0001144519 bg:RevolvingCreditFacilityMaturingJuly2023Member us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2022-07-15 0001144519 bg:RevolvingCreditFacilityMaturingJuly2023Member us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2022-07-15 2022-07-15 0001144519 bg:RevolvingCreditFacilityMaturingJuly2022Member us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2021-07-16 0001144519 bg:RevolvingCreditFacilityMaturingJuly2022Member us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2021-07-16 2021-07-16 0001144519 us-gaap:RevolvingCreditFacilityMember bg:RevolvingCreditFacilityMaturingJuly2026Member us-gaap:LineOfCreditMember 2021-12-31 0001144519 us-gaap:RevolvingCreditFacilityMember bg:RevolvingCreditFacilityMaturingJuly2026Member us-gaap:LineOfCreditMember 2022-09-30 0001144519 us-gaap:RevolvingCreditFacilityMember bg:RevolvingCreditFacilityMaturingJuly2026Member us-gaap:LineOfCreditMember 2021-07-16 0001144519 us-gaap:RevolvingCreditFacilityMember bg:RevolvingCreditFacilityMaturingJuly2026Member us-gaap:LineOfCreditMember 2021-07-16 2021-07-16 0001144519 bg:RevolvingCreditFacilityMaturingOctober2026Member us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2021-12-31 0001144519 bg:RevolvingCreditFacilityMaturingOctober2026Member us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2022-09-30 0001144519 bg:RevolvingCreditFacilityMaturingOctober2026Member us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2021-10-29 0001144519 us-gaap:RevolvingCreditFacilityMember bg:RevolvingCreditFacilityMaturingDecember2024Member us-gaap:LineOfCreditMember 2021-12-31 0001144519 us-gaap:RevolvingCreditFacilityMember bg:RevolvingCreditFacilityMaturingDecember2024Member us-gaap:LineOfCreditMember 2022-09-30 0001144519 us-gaap:RevolvingCreditFacilityMember bg:RevolvingCreditFacilityMaturingDecember2024Member us-gaap:LineOfCreditMember 2021-12-16 0001144519 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember bg:RevolvingCreditFacilityMaturingDecember2024Member us-gaap:LondonInterbankOfferedRateLIBORMember us-gaap:LineOfCreditMember 2021-12-16 2021-12-16 0001144519 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember bg:RevolvingCreditFacilityMaturingDecember2024Member us-gaap:LondonInterbankOfferedRateLIBORMember us-gaap:LineOfCreditMember 2021-12-16 2021-12-16 0001144519 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember bg:RevolvingCreditFacilityMaturingDecember2024Member us-gaap:LineOfCreditMember 2021-12-16 2021-12-16 0001144519 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember bg:RevolvingCreditFacilityMaturingDecember2024Member us-gaap:LineOfCreditMember 2021-12-16 2021-12-16 0001144519 us-gaap:LineOfCreditMember 2022-09-30 0001144519 bg:DelayedDrawTermLoanMember 2022-09-30 0001144519 us-gaap:LineOfCreditMember 2021-12-31 0001144519 bg:DelayedDrawTermLoanMember 2021-12-31 0001144519 bg:BilateralCreditLinesMember 2022-09-30 0001144519 bg:BilateralCreditLinesMember 2021-12-31 0001144519 bg:LocalBankLineOfCreditMember 2022-09-30 0001144519 bg:LocalBankLineOfCreditMember 2021-12-31 0001144519 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-09-30 0001144519 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-09-30 0001144519 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0001144519 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-12-31 0001144519 bg:SeniorNotes4.35PercentDue2024Member 2022-03-10 0001144519 bg:SeniorNotes4.35PercentDue2024Member 2022-01-01 2022-09-30 0001144519 bg:SeniorNotes300PercentDue2022Member 2022-08-23 0001144519 bg:SeniorNotes300PercentDue2022Member 2022-07-01 2022-09-30 0001144519 bg:SeniorNotes300PercentDue2022Member 2022-01-01 2022-09-30 0001144519 bg:A750MillionDelayedDrawTermLoanMember bg:DelayedDrawTermLoanMember 2022-07-26 0001144519 bg:DelayedDrawTermLoanMember 2022-08-05 0001144519 bg:DelayedDrawTermLoanMember 2021-10-29 0001144519 srt:MaximumMember srt:AffiliatedEntityMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember 2022-07-01 2022-09-30 0001144519 srt:MaximumMember srt:AffiliatedEntityMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember 2021-01-01 2021-09-30 0001144519 srt:MaximumMember srt:AffiliatedEntityMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember 2021-07-01 2021-09-30 0001144519 srt:MaximumMember srt:AffiliatedEntityMember us-gaap:SupplierConcentrationRiskMember us-gaap:CostOfGoodsTotalMember 2022-01-01 2022-09-30 0001144519 srt:MaximumMember srt:AffiliatedEntityMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001144519 srt:MaximumMember srt:AffiliatedEntityMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2021-09-30 0001144519 srt:MaximumMember srt:AffiliatedEntityMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-09-30 0001144519 srt:MaximumMember srt:AffiliatedEntityMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2022-09-30 0001144519 srt:MaximumMember srt:AffiliatedEntityMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001144519 srt:MaximumMember srt:AffiliatedEntityMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001144519 srt:MaximumMember srt:AffiliatedEntityMember us-gaap:SupplierConcentrationRiskMember bg:TradeAccountsPayableBenchmarkMember 2021-01-01 2021-12-31 0001144519 srt:MaximumMember srt:AffiliatedEntityMember us-gaap:SupplierConcentrationRiskMember bg:TradeAccountsPayableBenchmarkMember 2022-01-01 2022-09-30 0001144519 bg:NonIncomeTaxClaimsMember 2022-09-30 0001144519 bg:NonIncomeTaxClaimsMember 2021-12-31 0001144519 bg:LaborClaimsMember 2022-09-30 0001144519 bg:LaborClaimsMember 2021-12-31 0001144519 bg:CivilAndOtherClaimsMember 2022-09-30 0001144519 bg:CivilAndOtherClaimsMember 2021-12-31 0001144519 country:BR bg:TaxReturnExamination1990ToPresentMember bg:ICMSTaxLiabilityMember 2022-01-01 2022-09-30 0001144519 country:BR bg:TaxReturnExamination1990ToPresentMember bg:ICMSTaxLiabilityMember 2021-01-01 2021-12-31 0001144519 country:BR bg:TaxReturnExamination2004To2016Member bg:PisCofinsLiabilityMember 2022-01-01 2022-09-30 0001144519 country:BR bg:TaxReturnExamination2004To2016Member bg:PisCofinsLiabilityMember 2021-01-01 2021-12-31 0001144519 bg:UnconsolidatedAffiliatesFinancingGuaranteesMember 2022-09-30 0001144519 bg:ResidualValueGuaranteeMember 2022-09-30 0001144519 us-gaap:GuaranteeTypeOtherMember 2022-09-30 0001144519 us-gaap:PensionPlansDefinedBenefitMember us-gaap:OtherNonoperatingIncomeExpenseMember 2022-01-01 2022-09-30 0001144519 us-gaap:PensionPlansDefinedBenefitMember 2022-01-01 2022-09-30 0001144519 us-gaap:NoncontrollingInterestMember us-gaap:PensionPlansDefinedBenefitMember us-gaap:OtherNonoperatingIncomeExpenseMember 2022-01-01 2022-09-30 0001144519 bg:IOILodersCroklaanMember 2022-09-30 0001144519 bg:IOILodersCroklaanMember bg:IOILodersCroklaanMember 2022-09-30 0001144519 bg:IOILodersCroklaanMember bg:IOILodersCroklaanMember 2022-08-05 0001144519 bg:IOILodersCroklaanMember bg:IOILodersCroklaanMember 2022-08-05 2022-08-05 0001144519 srt:MinimumMember bg:IOILodersCroklaanMember bg:IOILodersCroklaanMember 2022-08-04 0001144519 bg:IOILodersCroklaanMember srt:MaximumMember bg:IOILodersCroklaanMember 2022-08-05 0001144519 bg:ConvertiblePerpetualPreferenceSharesMember 2022-03-23 2022-03-23 0001144519 bg:ConvertiblePerpetualPreferenceSharesMember 2022-03-23 0001144519 2022-03-23 0001144519 bg:ConvertiblePerpetualPreferenceSharesMember 2021-12-31 0001144519 bg:ConvertiblePerpetualPreferenceSharesMember 2022-02-16 0001144519 bg:ConvertiblePreferenceSharesMember 2022-03-22 0001144519 bg:ConvertiblePreferenceSharesMember 2022-03-23 0001144519 us-gaap:ConvertiblePreferredStockMember 2022-01-01 2022-03-31 0001144519 us-gaap:CommonStockMember 2022-03-31 0001144519 2022-02-23 2022-02-23 0001144519 bg:ConvertiblePreferenceSharesMember 2022-02-23 2022-02-23 0001144519 bg:CommonStockIssuedAndOutstandingMemberMember 2021-10-31 0001144519 bg:CommonStockOutstandingMember 2022-07-01 2022-09-30 0001144519 bg:CommonStockOutstandingMember 2022-01-01 2022-09-30 0001144519 bg:CommonStockOutstandingMember 2022-09-30 0001144519 bg:CommonStockOutstandingMember 2021-01-01 2021-09-30 0001144519 bg:CommonStockOutstandingMember 2021-07-01 2021-09-30 0001144519 2022-08-11 2022-08-11 0001144519 us-gaap:AccumulatedTranslationAdjustmentMember 2022-06-30 0001144519 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-06-30 0001144519 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-06-30 0001144519 us-gaap:AccumulatedTranslationAdjustmentMember 2022-07-01 2022-09-30 0001144519 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-07-01 2022-09-30 0001144519 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-07-01 2022-09-30 0001144519 us-gaap:AccumulatedTranslationAdjustmentMember 2022-09-30 0001144519 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-09-30 0001144519 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-09-30 0001144519 us-gaap:AccumulatedTranslationAdjustmentMember 2021-06-30 0001144519 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-06-30 0001144519 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-06-30 0001144519 us-gaap:AccumulatedTranslationAdjustmentMember 2021-07-01 2021-09-30 0001144519 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-07-01 2021-09-30 0001144519 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-07-01 2021-09-30 0001144519 us-gaap:AccumulatedTranslationAdjustmentMember 2021-09-30 0001144519 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-09-30 0001144519 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-09-30 0001144519 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0001144519 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-12-31 0001144519 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-12-31 0001144519 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-09-30 0001144519 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-01-01 2022-09-30 0001144519 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-01-01 2022-09-30 0001144519 us-gaap:ParentMember us-gaap:PensionPlansDefinedBenefitMember 2022-01-01 2022-09-30 0001144519 us-gaap:NoncontrollingInterestMember us-gaap:PensionPlansDefinedBenefitMember 2022-01-01 2022-09-30 0001144519 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0001144519 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-12-31 0001144519 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0001144519 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-09-30 0001144519 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-01 2021-09-30 0001144519 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-09-30 0001144519 bg:StockOptionsAndContingentlyIssuableRestrictedStockUnitsMember 2022-07-01 2022-09-30 0001144519 bg:StockOptionsAndContingentlyIssuableRestrictedStockUnitsMember 2021-07-01 2021-09-30 0001144519 bg:StockOptionsAndContingentlyIssuableRestrictedStockUnitsMember 2022-01-01 2022-09-30 0001144519 bg:StockOptionsAndContingentlyIssuableRestrictedStockUnitsMember 2021-01-01 2021-09-30 bg:segment 0001144519 bg:SugarAndBioenergyMember bg:BPBungeBioenergiaMember 2022-09-30 0001144519 bg:AgribusinessMember us-gaap:OperatingSegmentsMember 2022-07-01 2022-09-30 0001144519 us-gaap:OperatingSegmentsMember bg:RefinedAndSpecialtyOilsMember 2022-07-01 2022-09-30 0001144519 bg:MillingProductsMember us-gaap:OperatingSegmentsMember 2022-07-01 2022-09-30 0001144519 bg:SugarAndBioenergyMember us-gaap:OperatingSegmentsMember 2022-07-01 2022-09-30 0001144519 bg:CorporateAndReconcilingItemsMember 2022-07-01 2022-09-30 0001144519 us-gaap:IntersegmentEliminationMember bg:AgribusinessMember 2022-07-01 2022-09-30 0001144519 us-gaap:IntersegmentEliminationMember bg:RefinedAndSpecialtyOilsMember 2022-07-01 2022-09-30 0001144519 us-gaap:IntersegmentEliminationMember bg:MillingProductsMember 2022-07-01 2022-09-30 0001144519 us-gaap:IntersegmentEliminationMember bg:SugarAndBioenergyMember 2022-07-01 2022-09-30 0001144519 us-gaap:IntersegmentEliminationMember 2022-07-01 2022-09-30 0001144519 bg:AgribusinessMember us-gaap:OperatingSegmentsMember 2022-09-30 0001144519 us-gaap:OperatingSegmentsMember bg:RefinedAndSpecialtyOilsMember 2022-09-30 0001144519 bg:MillingProductsMember us-gaap:OperatingSegmentsMember 2022-09-30 0001144519 bg:SugarAndBioenergyMember us-gaap:OperatingSegmentsMember 2022-09-30 0001144519 us-gaap:IntersegmentEliminationMember 2022-09-30 0001144519 bg:AgribusinessMember us-gaap:OperatingSegmentsMember 2021-07-01 2021-09-30 0001144519 us-gaap:OperatingSegmentsMember bg:RefinedAndSpecialtyOilsMember 2021-07-01 2021-09-30 0001144519 bg:MillingProductsMember us-gaap:OperatingSegmentsMember 2021-07-01 2021-09-30 0001144519 bg:SugarAndBioenergyMember us-gaap:OperatingSegmentsMember 2021-07-01 2021-09-30 0001144519 bg:CorporateAndReconcilingItemsMember 2021-07-01 2021-09-30 0001144519 us-gaap:IntersegmentEliminationMember bg:AgribusinessMember 2021-07-01 2021-09-30 0001144519 us-gaap:IntersegmentEliminationMember bg:RefinedAndSpecialtyOilsMember 2021-07-01 2021-09-30 0001144519 us-gaap:IntersegmentEliminationMember bg:MillingProductsMember 2021-07-01 2021-09-30 0001144519 us-gaap:IntersegmentEliminationMember bg:SugarAndBioenergyMember 2021-07-01 2021-09-30 0001144519 us-gaap:IntersegmentEliminationMember 2021-07-01 2021-09-30 0001144519 bg:AgribusinessMember us-gaap:OperatingSegmentsMember 2021-09-30 0001144519 us-gaap:OperatingSegmentsMember bg:RefinedAndSpecialtyOilsMember 2021-09-30 0001144519 bg:MillingProductsMember us-gaap:OperatingSegmentsMember 2021-09-30 0001144519 bg:SugarAndBioenergyMember us-gaap:OperatingSegmentsMember 2021-09-30 0001144519 bg:CorporateAndReconcilingItemsMember 2021-09-30 0001144519 us-gaap:IntersegmentEliminationMember 2021-09-30 0001144519 bg:AgribusinessMember us-gaap:OperatingSegmentsMember 2022-01-01 2022-09-30 0001144519 us-gaap:OperatingSegmentsMember bg:RefinedAndSpecialtyOilsMember 2022-01-01 2022-09-30 0001144519 bg:MillingProductsMember us-gaap:OperatingSegmentsMember 2022-01-01 2022-09-30 0001144519 bg:SugarAndBioenergyMember us-gaap:OperatingSegmentsMember 2022-01-01 2022-09-30 0001144519 bg:CorporateAndReconcilingItemsMember 2022-01-01 2022-09-30 0001144519 us-gaap:IntersegmentEliminationMember bg:AgribusinessMember 2022-01-01 2022-09-30 0001144519 us-gaap:IntersegmentEliminationMember bg:RefinedAndSpecialtyOilsMember 2022-01-01 2022-09-30 0001144519 us-gaap:IntersegmentEliminationMember bg:MillingProductsMember 2022-01-01 2022-09-30 0001144519 us-gaap:IntersegmentEliminationMember bg:SugarAndBioenergyMember 2022-01-01 2022-09-30 0001144519 us-gaap:IntersegmentEliminationMember 2022-01-01 2022-09-30 0001144519 bg:AgribusinessMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-09-30 0001144519 us-gaap:OperatingSegmentsMember bg:RefinedAndSpecialtyOilsMember 2021-01-01 2021-09-30 0001144519 bg:MillingProductsMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-09-30 0001144519 bg:SugarAndBioenergyMember us-gaap:OperatingSegmentsMember 2021-01-01 2021-09-30 0001144519 bg:CorporateAndReconcilingItemsMember 2021-01-01 2021-09-30 0001144519 us-gaap:IntersegmentEliminationMember bg:AgribusinessMember 2021-01-01 2021-09-30 0001144519 us-gaap:IntersegmentEliminationMember bg:RefinedAndSpecialtyOilsMember 2021-01-01 2021-09-30 0001144519 us-gaap:IntersegmentEliminationMember bg:MillingProductsMember 2021-01-01 2021-09-30 0001144519 us-gaap:IntersegmentEliminationMember bg:SugarAndBioenergyMember 2021-01-01 2021-09-30 0001144519 us-gaap:IntersegmentEliminationMember 2021-01-01 2021-09-30
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2022
OR
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from        to
Commission File Number 001-16625
BUNGE LIMITED
(Exact name of registrant as specified in its charter)
Bermuda 98-0231912
(State or other jurisdiction of incorporation or
organization) 		(I.R.S. Employer Identification No.)
1391 Timberlake Manor Parkway
Chesterfield
Missouri 63017
(Address of principal executive offices) (Zip Code)
( 314 ) 292-2000
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Shares, $0.01 par value per share BG New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ý No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ý Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.  Yes ☐ No ý
As of October 21, 2022, the number of common shares outstanding of the registrant was:
Common shares, par value $.01 per share: 149,800,163

Table of Contents
BUNGE LIMITED
TABLE OF CONTENTS
Page
Item 1.
Item 2.
Item 3.
Item 4.
Item 1.
Item 1A.
Item 2.
Item 3.
Item 4.
Item 5.
Item 6.
2
Table of Contents
PART I — FINANCIAL INFORMATION
ITEM 1.    FINANCIAL STATEMENTS

BUNGE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)
(Unaudited)
(U.S. dollars in millions, except per share data)
Three Months Ended
September 30, 		Nine Months Ended
September 30,
2022 2021 2022 2021
Net sales $ 16,759 $ 14,117 $ 50,572 $ 42,469
Cost of goods sold ( 15,871 ) ( 13,255 ) ( 47,708 ) ( 39,795 )
Gross profit 888 862 2,864 2,674
Selling, general and administrative expenses ( 337 ) ( 327 ) ( 979 ) ( 896 )
Interest income 30 19 50 34
Interest expense ( 103 ) ( 57 ) ( 306 ) ( 184 )
Foreign exchange (losses) gains ( 52 ) ( 36 ) ( 150 ) ( 11 )
Other income (expense) – net 40 220 ( 13 ) 519
Income (loss) from affiliates 30 60 95 133
Income (loss) before income tax 496 741 1,561 2,269
Income tax (expense) benefit ( 113 ) ( 92 ) ( 257 ) ( 334 )
Net income (loss) 383 649 1,304 1,935
Net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests ( 3 ) 4 ( 30 ) ( 88 )
Net income (loss) attributable to Bunge 380 653 1,274 1,847
Convertible preference share dividends — ( 8 ) — ( 25 )
Net income (loss) available to Bunge common shareholders $ 380 $ 645 $ 1,274 $ 1,822
Earnings per common share—basic (Note 20)
Net income (loss) attributable to Bunge common shareholders - basic $ 2.52 $ 4.56 $ 8.59 $ 12.91
Earnings per common share—diluted (Note 20)
Net income (loss) attributable to Bunge common shareholders - diluted $ 2.49 $ 4.28 $ 8.30 $ 12.12
The accompanying notes are an integral part of these condensed consolidated financial statements.
3
Table of Contents
BUNGE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited)
(U.S. dollars in millions)
Three Months Ended
September 30, 		Nine Months Ended
September 30,
2022 2021 2022 2021
Net income (loss) $ 383 $ 649 $ 1,304 $ 1,935
Other comprehensive income (loss):
Foreign exchange translation adjustment ( 344 ) ( 230 ) ( 244 ) ( 159 )
Unrealized gains (losses) on designated hedges, net of tax (expense) benefit of zero and $( 2 ) in 2022 and $ 1 and $( 2 ) in 2021
32 43 ( 38 ) ( 51 )
Pension adjustment, net of tax (expense) benefit of zero and zero in 2022 and $ 2 and zero in 2021
— 2 — —
Reclassification of net (gains) losses to net income, net of tax expense (benefit) of zero and $ 12 in 2022 and zero and zero in 2021
141 ( 1 ) 107 ( 3 )
Total other comprehensive income (loss) ( 171 ) ( 186 ) ( 175 ) ( 213 )
Total comprehensive income (loss) 212 463 1,129 1,722
Comprehensive (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests 8 15 20 ( 65 )
Comprehensive income (loss) from acquisition of redeemable noncontrolling interest ( 15 ) — ( 15 ) —
Total comprehensive income (loss) attributable to Bunge
$ 205 $ 478 $ 1,134 $ 1,657
The accompanying notes are an integral part of these condensed consolidated financial statements.

4
Table of Contents
BUNGE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(U.S. dollars in millions, except share data)
September 30,
2022 		December 31,
2021
ASSETS
Current assets:
Cash and cash equivalents $ 956 $ 902
Trade accounts receivable (less allowances of $ 94 and $ 85 ) (Note 5)
2,336 2,112
Inventories (Note 6) 8,112 8,431
Assets held for sale (Note 3) 58 264
Other current assets (Note 7) 5,733 4,751
Total current assets 17,195 16,460
Property, plant and equipment, net 3,408 3,499
Operating lease assets 1,091 912
Goodwill 445 484
Other intangible assets, net 350 431
Investments in affiliates 981 764
Deferred income taxes 638 550
Other non-current assets (Note 8) 684 719
Total assets $ 24,792 $ 23,819
LIABILITIES AND EQUITY
Current liabilities:
Short-term debt (Note 14) $ 1,327 $ 673
Current portion of long-term debt (Note 14) 773 504
Trade accounts payable (includes $ 906 and $ 568 carried at fair value)
4,455 4,250
Current operating lease obligations 436 350
Liabilities held for sale (Note 3) 13 122
Other current liabilities (Note 11) 3,563 3,425
Total current liabilities 10,567 9,324
Long-term debt (Note 14) 2,997 4,787
Deferred income taxes 335 338
Non-current operating lease obligations 602 506
Other non-current liabilities (Note 17) 918 658
Redeemable noncontrolling interest (Note 18)
2 381
Equity (Note 19):
Convertible perpetual preference shares, par value $ .01 ; authorized – 21,000,000 shares, issued and outstanding: 2022 - zero shares, 2021 - 6,899,683 shares (liquidation preference $ 100 per share)
— 690
Common shares, par value $ .01 ; authorized – 400,000,000 shares; issued and outstanding: 2022 – 149,796,910 shares, 2021 – 141,057,414 shares
1 1
Additional paid-in capital 6,655 5,590
Retained earnings 9,980 8,979
Accumulated other comprehensive income (loss) (Note 19) ( 6,611 ) ( 6,471 )
Treasury shares, at cost; 2022 - 18,835,812 shares, 2021 - 16,726,697 shares
( 1,320 ) ( 1,120 )
Total Bunge shareholders’ equity 8,705 7,669
Noncontrolling interests 666 156
Total equity 9,371 7,825
Total liabilities, redeemable noncontrolling interest and equity $ 24,792 $ 23,819
The accompanying notes are an integral part of these condensed consolidated financial statements.
5
Table of Contents
BUNGE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(U.S. dollars in millions)
Nine Months Ended
September 30,
2022 2021
OPERATING ACTIVITIES
Net income (loss) $ 1,304 $ 1,935
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities:
Impairment charges 86 —
Foreign exchange (gain) loss on net debt ( 96 ) 7
Bad debt expense 23 4
Depreciation, depletion and amortization 305 317
Share-based compensation expense 47 46
Deferred income tax expense (benefit) ( 92 ) ( 263 )
(Gain) loss on sale of investments and property, plant and equipment ( 7 ) ( 416 )
Other, net ( 8 ) ( 105 )
Changes in operating assets and liabilities, excluding the effects of acquisitions and dispositions:
Trade accounts receivable ( 359 ) ( 785 )
Inventories ( 229 ) ( 771 )
Trade accounts payable and accrued liabilities 259 1,268
Advances on sales ( 81 ) ( 129 )
Net unrealized (gains) losses on derivative contracts ( 456 ) 559
Margin deposits ( 55 ) 280
Recoverable and income taxes, net ( 201 ) 254
Marketable securities 341 ( 95 )
Beneficial interest in securitized trade receivables ( 5,288 ) ( 3,621 )
Other, net ( 524 ) ( 127 )
Cash provided by (used for) operating activities ( 5,031 ) ( 1,642 )
INVESTING ACTIVITIES
Payments made for capital expenditures ( 353 ) ( 239 )
Proceeds from investments 217 171
Payments for investments ( 225 ) ( 217 )
Settlements of net investment hedges ( 153 ) ( 29 )
Proceeds from beneficial interest in securitized trade receivables 5,176 3,432
Payments for beneficial interest in securitized trade receivables — ( 177 )
Proceeds from disposals of businesses and property, plant and equipment 496 646
Proceeds from sale of investments in affiliates — 11
Payments for investments in affiliates ( 55 ) ( 46 )
Other, net 10 10
Cash provided by (used for) investing activities 5,113 3,562
FINANCING ACTIVITIES
Proceeds from short-term debt 28,232 24,157
Repayments of short-term debt ( 27,398 ) ( 25,798 )
Proceeds from long-term debt 48 998
Repayments of long-term debt ( 1,029 ) —
Proceeds from the exercise of options for common shares 30 72
Repurchases of common shares ( 200 ) ( 100 )
Dividends paid to common and preference shareholders ( 256 ) ( 240 )
Dividends paid to noncontrolling interest — ( 75 )
Sale of noncontrolling interest 521 —
Acquisition of redeemable noncontrolling interest and noncontrolling interest ( 102 ) ( 147 )
Other, net 52 ( 33 )
Cash provided by (used for) financing activities ( 102 ) ( 1,166 )
Effect of exchange rate changes on cash and cash equivalents, restricted cash, and cash held for sale 112 ( 79 )
Net increase (decrease) in cash and cash equivalents, restricted cash, and cash held for sale 92 675
Cash and cash equivalents, restricted cash, and cash held for sale - beginning of period 905 381
Cash and cash equivalents, restricted cash, and cash held for sale - end of period $ 997 $ 1,056
The accompanying notes are an integral part of these condensed consolidated financial statements.
6
Table of Contents
BUNGE LIMITED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY AND REDEEMABLE NONCONTROLLING INTERESTS
(Unaudited)
(U.S. dollars in millions, except share data)

Convertible
Preference Shares 		Common Shares
Redeemable
Non-
Controlling
Interests 		Shares Amount Shares Amount Additional
Paid-in
Capital 		Retained
Earnings 		Accumulated
Other
Comprehensive
Income (Loss) 		Treasury
Shares 		Non-
Controlling
Interests 		Total
Equity
Balance, July 1, 2022 $ 351 — $ — 151,885,454 $ 1 $ 6,595 $ 9,692 $ ( 6,436 ) $ ( 1,120 ) $ 457 $ 9,189
Net income (loss) 7 — — — — — 380 — — ( 4 ) 376
Other comprehensive income (loss) 11 — — — — — — ( 160 ) — ( 22 ) ( 182 )
Dividends on common shares, $ 0.625 per share
— — — — — — ( 92 ) — — — ( 92 )
Acquisition of redeemable noncontrolling interest (Note 18) ( 367 ) — — — — 45 — ( 15 ) — 235 265
Share-based compensation expense — — — — — 15 — — — — 15
Repurchase of common shares — — — ( 2,109,115 ) — — — — ( 200 ) — ( 200 )
Issuance of common shares, including stock dividends — — — 20,571 — — — — — — —
Balance, September 30, 2022 $ 2 — $ — 149,796,910 $ 1 $ 6,655 $ 9,980 $ ( 6,611 ) $ ( 1,320 ) $ 666 $ 9,371

Convertible
Preference Shares 		Common Shares
Redeemable
Non-
Controlling
Interests 		Shares Amount Shares Amount Additional
Paid-in
Capital 		Retained
Earnings 		Accumulated
Other
Comprehensive
Income (Loss) 		Treasury
Shares 		Non-
Controlling
Interests 		Total
Equity
Balance, July 1, 2021 $ 483 6,899,683 $ 690 141,714,847 $ 1 $ 5,512 $ 8,259 $ ( 6,258 ) $ ( 1,020 ) $ 147 $ 7,331
Net income (loss) 2 — — — — — 653 — — ( 6 ) 647
Other comprehensive income (loss) ( 11 ) — — — — — — ( 178 ) — — ( 178 )
Dividends on common shares, $ 0.525 per share
— — — — — — ( 74 ) — — — ( 74 )
Dividends on preference shares, $ 1.21875 per share
— — — — — — ( 8 ) — — — ( 8 )
Dividends to noncontrolling interests on subsidiary common stock ( 71 ) — — — — — — — — ( 2 ) ( 2 )
Capital contribution (return) from (to) noncontrolling interest — — — — — — — — — ( 3 ) ( 3 )
Share-based compensation expense — — — — — 17 — — — — 17
Repurchase of common shares — — — ( 1,298,384 ) — — — — ( 100 ) — ( 100 )
Issuance of common shares, including stock dividends — — — 21,775 — 1 — — — — 1
Balance, September 30, 2021 $ 403 6,899,683 $ 690 140,438,238 $ 1 $ 5,530 $ 8,830 $ ( 6,436 ) $ ( 1,120 ) $ 136 $ 7,631
7
Table of Contents
Convertible
Preference Shares 		Common Shares
Redeemable
Non-
Controlling
Interests 		Shares Amount Shares Amount Additional
Paid-in
Capital 		Retained
Earnings 		Accumulated
Other
Comprehensive
Income (Loss) 		Treasury
Shares 		Non-
Controlling
Interests 		Total
Equity
Balance, January 1, 2022 $ 381 6,899,683 $ 690 141,057,414 $ 1 $ 5,590 $ 8,979 $ ( 6,471 ) $ ( 1,120 ) $ 156 $ 7,825
Net income (loss) 13 — — — — — 1,274 — — 17 1,291
Other comprehensive income (loss) ( 25 ) — — — — — — ( 125 ) — ( 25 ) ( 150 )
Dividends on common shares, $ 1.775 per share
— — — — — — ( 268 ) — — — ( 268 )
Dividends to noncontrolling interests on subsidiary common stock — — — — — — — — — ( 4 ) ( 4 )
Sale of noncontrolling interest — — — — — 234 — — — 287 521
Acquisition of redeemable noncontrolling interest (Note 18) ( 367 ) — — — — 45 — ( 15 ) — 235 265
Share-based compensation expense — — — — — 47 — — — — 47
Repurchase of common shares — — — ( 2,109,115 ) — — — — ( 200 ) — ( 200 )
Conversion of preference shares to common shares — ( 6,899,683 ) ( 690 ) 8,863,331 — 690 — — — — —
Issuance of common shares, including stock dividends — — — 1,985,280 — 49 ( 5 ) — — — 44
Balance, September 30, 2022 $ 2 — $ — 149,796,910 $ 1 $ 6,655 $ 9,980 $ ( 6,611 ) $ ( 1,320 ) $ 666 $ 9,371

Convertible
Preference Shares 		Common Shares
Redeemable
Non-
Controlling
Interests 		Shares Amount Shares Amount Additional
Paid-in
Capital 		Retained
Earnings 		Accumulated
Other
Comprehensive
Income (Loss) 		Treasury
Shares 		Non-
Controlling
Interests 		Total
Equity
Balance, January 1, 2021 $ 415 6,899,683 $ 690 139,790,238 $ 1 $ 5,408 $ 7,236 $ ( 6,246 ) $ ( 1,020 ) $ 136 $ 6,205
Net income (loss) 81 — — — — — 1,847 — — 7 1,854
Other comprehensive income (loss) ( 23 ) — — — — — — ( 190 ) — — ( 190 )
Dividends on common shares, $ 1.550 per share
— — — — — — ( 221 ) — — — ( 221 )
Dividends on preference shares, $ 3.65625 per share
— — — — — — ( 25 ) — — — ( 25 )
Dividends to noncontrolling interests on subsidiary common stock ( 71 ) — — — — — — — — ( 4 ) ( 4 )
Capital contribution (return) from (to) noncontrolling interest — — — — — — — — — ( 3 ) ( 3 )
Acquisition of noncontrolling interest — — — — — — ( 3 ) — — — ( 3 )
Disposition of noncontrolling interest in a subsidiary 1 — — — — — — — — — —
Share-based compensation expense — — — — — 46 — — — — 46
Repurchase of common shares — — — ( 1,298,384 ) — — — — ( 100 ) — ( 100 )
Issuance of common shares, including stock dividends — — — 1,946,384 — 76 ( 4 ) — — — 72
Balance, September 30, 2021 $ 403 6,899,683 $ 690 140,438,238 $ 1 $ 5,530 $ 8,830 $ ( 6,436 ) $ ( 1,120 ) $ 136 $ 7,631
The accompanying notes are an integral part of these condensed consolidated financial statements.
8
Table of Contents
BUNGE LIMITED AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. BASIS OF PRESENTATION, PRINCIPLES OF CONSOLIDATION, AND SIGNIFICANT ACCOUNTING POLICIES
The accompanying unaudited condensed consolidated financial statements include the accounts of Bunge Limited ("Bunge" or the "Company"), its subsidiaries and variable interest entities ("VIEs") in which Bunge is considered to be the primary beneficiary, and as a result, include the assets, liabilities, revenues and expenses of all entities over which Bunge has a controlling financial interest. The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X under the Securities Exchange Act of 1934, as amended ("Exchange Act"). Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to Securities and Exchange Commission ("SEC") rules. In the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation have been included. The condensed consolidated balance sheet at December 31, 2021 has been derived from Bunge’s audited consolidated financial statements at that date. Operating results for the nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022. The financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2021, forming part of Bunge’s 2021 Annual Report on Form 10-K filed with the SEC on February 24, 2022.
On September 4, 2022, Argentina’s government published Emergency Decree 576/2022, Programa de Incremento Exportador (the "Export Program"), aimed at boosting farmer selling, and in turn soybean exports. The Export Program introduced a new preferential U.S. dollar to Argentinian peso foreign exchange rate, available exclusively during the period between September 5 and September 30, 2022, payable to Argentinian farmers on qualifying Argentinian peso denominated sales of soybeans. Purchasers of the qualifying soybeans, including Bunge, received the same preferential rate on U.S. dollar funds placed onshore in Argentina and converted to Argentinian peso to fund soybean purchases.
Bunge is both a receiver of the preferential exchange rate for cash converted to Argentinian peso, as well as a payer of the same preferential rate on purchases of soybeans from farmers and related export duties. Transactions and monetary balances related to the Export Program were accounted for at the preferential rate. The net impact of the Export Program on Bunge's condensed consolidated statements of income was not material.
On August 1, 2022, Bayer AG (FRA: BAYN) acquired a 65 % controlling interest in CoverCress Inc. ("CCI"), a Bunge Ventures portfolio company that has developed a novel low carbon-intensity winter oilseed crop called CoverCress™, by purchasing all equity interests in CCI other than those held by Bunge Ventures and Chevron USA, Inc., a subsidiary of Chevron Corporation ("Chevron", NYSE: CVX).
As a result of the transaction, during the three months ended September 30, 2022, the Company recorded an $ 18 million unrealized gain on its remaining 21.93 % ownership interest in CCI within Other income (expense) – net of the Company’s condensed consolidated statements of income. Additionally, the Company reclassified its $ 44 million investment in CCI as of September 30, 2022 from Long-term Investments, within Other Non-current Assets, to Investments in affiliates in the condensed consolidated balance sheet. Both Bunge's investment in CCI and the above mentioned related unrealized gain are recorded within Corporate and Other activities.
On May 1, 2022, Bunge completed a transaction with Chevron to create a joint venture, Bunge Chevron Ag Renewables LLC (the "Joint Venture"), leveraging Bunge’s expertise in oilseed processing and farmer relationships, and Chevron’s expertise in fuels manufacturing and marketing, to help meet the demand for renewable fuels and to develop lower carbon intensity feedstocks. Bunge has a 50 % ownership interest in the Joint Venture. Bunge contributed certain property, plant, and equipment related to two of its soybean processing facilities to the Joint Venture, with a fair value totaling approximately $ 521 million, and Chevron contributed an approximately equal value of cash and working capital. Bunge has also committed to undertake certain capital improvements on the soybean processing facilities contributed to the Joint Venture, up to an estimated $ 80 million, at which point Chevron will contribute an additional equivalent amount in cash. Under the terms of the Joint Venture's agreements, Bunge will operate the Joint Venture’s facilities, and Chevron will have purchase rights for oil produced by the Joint Venture for use as a renewable feedstock to manufacture low lifecycle carbon intensity transportation fuels. See Note 9 - Variable Interest Entities for further accounting considerations related to this transaction.

9
Table of Contents
Bunge has operations in Turkey, which until March 31, 2022, used the official exchange rate published by the Turkish government to translate the Company's commercial transactions and for financial statement re-measurement purposes. Over the last several years, Turkey has experienced negative economic trends, as evidenced by multiple periods of increasing inflation rates, depreciation of the Turkish lira , and increasing borrowing rates, which have required the Turkish government to take mitigating actions. During the first quarter of 2022, Turkey became a highly inflationary economy as defined under U.S. GAAP. In accordance with ASC 830, Foreign Currency Matters , the financial statements of foreign entities in highly inflationary economies are required to be remeasured as if the functional currency were the reporting currency, commencing in the period subsequent to such economies becoming highly inflationary. As a result, effective April 1, 2022, the financial statements of Bunge's Turkish subsidiary have been remeasured using the reporting currency, the U.S. dollar, rather than the Turkish lira . This change has not had a material impact on Bunge's condensed consolidated financial statements.
Cash, Cash Equivalents, Restricted Cash, and Cash held for sale
Restricted cash and cash held for sale is included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the condensed consolidated statement of cash flows. The following table provides a reconciliation of cash and cash equivalents, restricted cash, and cash held for sale, reported within the condensed consolidated balance sheets, which sum to the total of the same such amounts shown in the condensed consolidated statement of cash flows.
(US$ in millions) September 30, 2022 September 30, 2021
Cash and cash equivalents $ 956 $ 1,033
Restricted cash included in Other current assets 5 23
Cash and cash equivalents in Assets held for sale 36 —
Total $ 997 $ 1,056
Cash paid for taxes, which primarily comprises inco me taxes and value added taxes, net of refunds, was $ 383 million and $ 309 million for the nine months ended September 30, 2022 and 2021, respectively. Cash paid for interest expense was $ 315 million and $ 231 million for the nine months ended September 30, 2022 and 2021, respectively.

Recently Adopted Accounting Pronouncements

On January 1, 2022, the Company adopted Accounting Standards Update ("ASU") 2021-10, Government Assistance (Topic 832) - Disclosures by Business Entities About Government Assistance , which requires annual disclosures for transactions with a government authority that are accounted for by applying a grant or contribution accounting model by analogy. The guidance is effective for annual periods beginning after December 15, 2021. This guidance will be applied prospectively to all transactions within the scope of the standard that are reflected in financial statements at the date of initial application and new transactions that are entered into after the date of initial application. As this standard requires annual disclosure only, the Company continues to identify its transactions that are subject to this guidance and evaluate the impact of this standard on its condensed consolidated financial statements.

On January 1, 2022, the Company adopted ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40), which simplifies the accounting for convertible instruments and contracts in an entity’s own equity. The guidance also addresses how convertible instruments are accounted for in the diluted earnings per share calculation and requires enhanced disclosures about the terms of convertible instruments and contracts in an entity’s own equity. This guidance will be applied prospectively to modifications or exchanges occurring on or after the effective date of the amendments. The adoption of this guidance did not have a material impact on Bunge's condensed consolidated financial statements.

10
Table of Contents
In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting , with subsequent updates through ASU 2021-01, which collectively provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting, to ease the financial reporting burden related to the expected market transition from the London Interbank Offered Rate ("LIBOR") and other interbank offered rates to alternative reference rates. The guidance was effective upon issuance, and per the guidance, the Company is applying it prospectively to all eligible contract modifications through December 31, 2022. In March 2021, the United Kingdom's Financial Conduct Authority ("FCA"), responsible for regulating LIBOR, announced that most LIBOR settings would be discontinued after December 31, 2021, except for certain USD LIBOR settings, which will continue through June 30, 2023. In September 2021, the FCA further announced that it will require the LIBOR benchmark administrator to publish sterling and Japanese yen LIBOR settings under a synthetic methodology based on term risk-free rates for the duration of 2022. These synthetic LIBOR settings will be available only for use in legacy contracts and are not for use in new business.
Bunge has utilized the relief provided by Topic 848 to ensure financial reporting results reflect the intended continuation of such contracts and arrangements during the period of the market-wide transition to alternative reference rates. The expedients allow an eligible modified contract to be accounted for and presented as a continuation of the existing contract.
The Company has identified its LIBOR-based contracts that have been, or will be, impacted by the cessation of LIBOR. The Company continues to actively work with counterparties to incorporate fallback language in negotiated contracts, in addition to incorporating non-LIBOR reference rate and fallback language, when applicable, in new contracts. The modification of contracts is ongoing; however, as of September 30, 2022, the adoption of this guidance has not had a material impact on Bunge's condensed consolidated financial statements.
11
Table of Contents
2. UKRAINE-RUSSIA WAR
On February 24, 2022, Russia initiated a military invasion of Ukraine (the "war"). Ukraine forms part of a key international grain originating region and is also the world’s largest supplier of sunflower seed and sunflower oil; commodities that cannot be completely replaced from other origin s. The scope, intensity, duration and outcome of the ongoing war is uncertain, and any continuation or escalation of the war may have a material adverse effect on Bunge, including its Ukrainian and Russian operations. Further details concerning the impact of the war and its corresponding accounting considerations relating to Bunge's Ukrainian and Russian operations are provided below.
Ukraine
Bunge's Ukrainian operations comprise two oilseed crushing facilities, located in Mykolaiv and Dnipropetrovsk, a grain export terminal in the Mykolaiv commercial seaport, numerous grain elevators, and an office in Kiev. The Company also operates a corn milling facility in Ukraine via a joint venture. Bunge currently maintains control over all of its material operations and facilities in Ukraine.
As of the date of this report, no material damage has been noted at any of Bunge's Ukrainian facilities, including its Mykolaiv port facility, which sustained minor shelling damage earlier in the year. However, due to safety concerns, it is not always possible to conduct onsite physical inspections of all of the Company's Ukrainian facilities.
Immediately after the start of the invasion, Bunge temporarily idled its Ukrainian operations. However, Bunge has subsequently restarted certain commercial and operational activities in Ukraine, including oilseed crushing activities at its Dnipropetrovsk facility, as well as certain exports from Ukraine, including via the Black Sea from three Ukrainian ports (Pivdennyi/Yuzhnvi, Odesa, and Chornomorsk; the "POC corridor”), under an agreement between Ukraine and Russia, brokered by the United Nations and Turkey. Although operations in Ukraine have steadily increased during recent months, they remain limited and are subject to Bunge's ability to perform activities safely. Furthermore, Bunge's ability to continue these activities indefinitely is unknown.

The Company’s Ukrainian operations employ over 1,000 employees. While, as of the date of this report, some of the Company’s Ukrainian employees have been forced to relocate to other countries or elsewhere within Ukraine, our workforce remains largely intact. The safety of Bunge's employees is its top priority. The Company is actively providing support and resources to employees and their families who have been impacted by these events, and Bunge employees in neighboring countries have mobilized to provide accommodation, food, clothing, toys and other supplies for displaced colleagues and their families. Bunge is also committed to supporting humanitarian efforts in Ukraine and has provided approximately $ 3 million in food products and monetary assistance to multiple relief organizations helping the people of Ukraine.

In accordance with industry standards, Bunge has insured against many types of risks, including against certain of the losses that we have or may experience in the future. However, the Company's level of insurance may not cover all losses the Company could incur.
The condensed consolidated balance sheet and related discussion below provides information on the Company’s major classes of assets and liabilities in Ukraine. As of September 30, 2022, total assets and total liabilities associated with Bunge’s Ukrainian subsidiaries each comprise approximately 1 % of Bunge’s consolidated Total assets and Total liabilities, respectively.
Due to the nature of the war and its rapidly shifting areas of active combat, it is currently not possible to obtain all information necessary to determine all financial statement impacts. As such, the various financial statement impacts and related disclosures presented in these interim financial statements represent management’s best estimates considering available facts and circumstances as of the date of this report.
The functional currency of Bunge’s Ukrainian subsidiaries is the U.S. dollar and the foreign exchange rates used to convert assets and liabilities denominated in Ukrainian hryvnia represent the official exchange rates published by the National Bank of Ukraine. Following the onset of the war, the Ukrainian government imposed restrictions on companies’ abilities to repatriate or otherwise remit cash from their Ukrainian-based operations to locations outside Ukraine. However, these restrictions are not expected to persist indefinitely and the Ukrainian government has eased certain restrictions surrounding the payment of international purchase invoices during the three months ended September 30, 2022. The restrictions have not adversely impacted the Company's Ukrainian operations. Bunge is able to readily purchase U.S. dollars and other non-Ukrainian currencies onshore in Ukraine to pay for imports of goods and allowed services, where needed. Bunge is also able to sell foreign currency onshore in Ukraine. Bunge continues to exercise control of and consolidates its Ukrainian subsidiaries.



12
Table of Contents
The condensed consolidated balance sheet related to the Company’s Ukrainian operations as of September 30, 2022 consists of the following:
(US$ in millions) September 30,
2022
Current assets:
Cash and cash equivalents $ 1
Trade accounts receivable (less allowances of zero )
4
Inventories 39
Other current assets 56
Total current assets 100
Property, plant and equipment, net 136
Other non-current assets 57
Total assets $ 293
Current liabilities:
Trade accounts payable and accrued liabilities $ 12
Short-term debt 161
Other current liabilities 3
Total current liabilities 176
Non-current liabilities 4
Total liabilities $ 180

Inventories— Bunge’s Ukrainian inventories generally comprise agricultural commodity inventories, primarily sunflower seeds, sunflower meal, sunflower oil, corn, and wheat. Due to their commodity characteristics, widely available markets, and international pricing mechanisms, such inventories are generally carried at fair value. Following the creation of the POC corridor during the three months ended September 30, 2022, Bunge is able to market and make available for immediate delivery certain of its Ukrainian inventories at internationally-quoted prices. These inventories were carried at fair value as of September 30, 2022. Where the Company's inventories do not qualify to be recorded at fair value, primarily due to their physical location being close to active combat zones or in difficult to access locations with high costs of recovery, they are recorded at the lower of cost or net realizable value, by product category. In such instances, a thorough onsite physical inspection of the inventories is not currently possible due to safety concerns. As such, significant judgments have been made in estimating the net realizable value of the Company’s Ukrainian inventories.
As of September 30, 2022, the Company evaluated the recoverability of its inventories inside Ukraine considering the latest information available to management regarding: the current status of the war; expectations regarding continued escalation of conflict and the likelihood and timing of a potential peaceful resolution to the war; the physical location and condition of Bunge's inventories, including expectations regarding the timing of spoilage and the rate at which inventories can be transported from their current location to markets in other parts of Ukraine or exported to adjacent markets. As a result of this analysis, during the three and nine months ended September 30, 2022, the Company recorded reserves of zero and $ 71 million, respectively, related to inventories physically located in occupied territories in Ukraine, or in difficult to access locations with high costs of recovery.

The Company also recorded zero and $ 6 million in corresponding allowances for recoverable tax assets generated on the purchase of such inventories during the three and nine months ended September 30, 2022, respectively.

Other current assets— Comprises $ 28 million of marketable securities and other short-term investments, $ 22 million of recoverable taxes, net, and $ 6 million of various other items, as follows:
• Marketable securities and other short-term investments— Primarily comprise Ukrainian (“on-shore”) government debt securities, denominated in Ukrainian hryvnia . Bunge classifies these securities as “trading securities”, carried at fair value in the Company’s condensed consolidated balance sheet, with changes in fair value recorded in the Company’s condensed consolidated statements of income in the period in which they occur.

13
Table of Contents
In addition to the marketable securities and other short-term investments belonging to Bunge’s Ukrainian subsidiaries, as shown in the above balance sheet, certain of the Company’s non-Ukrainian subsidiaries hold certain U.S. dollar denominated, non-Ukrainian (“off-shore”) corporate debt securities of issuers with significant exposure to Ukraine. The values of these off-shore securities are directly impacted by the ongoing war. Such items, again reported within Other current assets as marketable securities and other short-term investments, totaled $ 8 million as of September 30, 2022.
As a result of the war, trading in the Ukrainian and Ukrainian-exposed debt securities has largely ceased. As such, at September 30, 2022, the prices of such securities were determined using pricing models with inputs based on similar securities adjusted to reflect management’s best estimate of the specific characteristics of the securities held by the Company. Such inputs represent a significant component of the fair value of the securities held by the Company, resulting in the securities being classified as Level 3 in the Company’s table of assets and liabilities accounted for at fair value on a recurring basis in Note 12 - Fair Value Measurements .
During the three and nine months ended September 30, 2022, the Company recorded a combined $ 7 million and $ 76 million loss, respectively, on its “on-shore” and “off-shore” portfolios, within Other income (expense) – net, in the condensed consolidated statement of income, of which $ 45 million relates to securities still held at September 30, 2022.
• Recoverable taxes, net— Comprise value-added taxes paid upon the acquisition of property, plant and equipment, raw materials, taxable services, and other transactional taxes, recoverable in cash from the Ukrainian government. Bunge has continued to receive refunds of recoverable taxes from the Ukrainian government since the start of the war, including as recently as early October, 2022. Therefore, as of September 30, 2022, and during the three and nine months then ended, Bunge has not recorded any change in allowances for recoverable taxes in Ukraine except for those associated with the Company's write-off of inventories, described above.
• Other— Primarily comprise prepaid expenses and advance payments against contracts for future deliveries of specified quantities of agricultural commodities.
Property, plant, and equipment, net— As described above, since the onset of the war, Bunge’s Mykolaiv port facility has sustained immaterial damage. Accordingly, the Company has recorded impairment provisions of zero and $ 2 million in relation to such damage, within Cost of goods sold, during the three and nine months ended September 30, 2022, respectively. The expense was recorded in the Agribusiness segment.
In light of the war, as of September 30, 2022, Bunge evaluated the recoverability of its Ukrainian property, plant and equipment using an income method based on forecasts of expected future cash flows attributable to the respective assets under a range of possible outcomes, including those with reduced or no future cash flows, and concluded that the Company's Ukrainian property, plant and equipment was recoverable. The recoverability tests depend on a number of significant estimates and assumptions, including the likelihood and timing of a potential peaceful resolution to the war, the likelihood and timing of resuming Bunge's remaining Ukrainian operations, expectations around the size of future harvests in Ukraine and the availability and costs of raw materials commodities and inputs, and market demand levels for products. The Company believes these estimates and assumptions are reasonable, and the reported amounts are not highly sensitive to any individual assumption underlying the recoverability tests. However, future changes in the judgments, assumptions, and estimates used in these recoverability tests could result in different conclusions regarding the recoverability of the Company's Ukrainian property, plant and equipment and may result in the need for the Company to record non-cash impairment charges of its Ukrainian property, plant and equipment at such time.
Other non-current assets— Comprises $ 34 million of deferred tax assets, $ 12 million of operating lease right-of-use assets associated with Bunge’s facilities, $ 5 million of recoverable taxes, net, expected to be realized in periods greater than twelve months from the balance sheet date, and $ 6 million of various other items.
Trade accounts payable and accrued liabilities— Comprise amounts owed by the Company’s Ukrainian subsidiaries for goods delivered to or services consumed by such subsidiaries in the ordinary course of business.
Short-term debt— Bunge's short-term debt represents Ukrainian hryvnia denominated debt, primarily used to fund working capital requirements, issued by Ukrainian branches of non-Ukraine-based financial institutions.
14
Table of Contents
Russia
In response to Russia's invasion of Ukraine, the United States, other North Atlantic Treaty Organization ("NATO") member states, as well as non-member states, have announced targeted economic sanctions on Russia, certain Russian citizens and Russian enterprises. The continuation or escalation of the war may trigger additional economic and other sanctions. The scope or extent of potential additional sanctions, and the related impact on Bunge is unknown, as of the date of this report.
Bunge currently maintains control over its Russian subsidiary and related operations and continues to monitor developments regarding the legal and operational environments in Russia together with their related impacts on the Company’s operations. During the three and nine months ended September 30, 2022, the Company's Russian subsidiaries have not experienced any material financial statement impacts as a result of the war.
On September 16, 2022, Bunge signed an agreement to sell its remaining Russian operations, primarily comprising an oilseed crushing and refining facility in Voronezh, southwest Russia, to Karen Vanetsyan. Please refer to Note 3 - Acquisitions and Dispositions for further details regarding the transaction.
The functional currency of Bunge’s Russian subsidiaries is the Russian ruble (RUB) and the foreign exchange rates used to convert assets and liabilities denominated in Russian rubles represent the official exchange rates published by the Central Bank of the Russian Federation. Since the onset of the war, the Russian government has imposed restrictions on companies’ abilities to repatriate or otherwise remit cash from their Russian-based operations to various locations outside of Russia, including limiting capital repayments to non-Russian entities to RUB 10 million ($ 0.2 million) per month. However, Bunge currently remains able to readily purchase U.S. dollars and other non-Russian currencies onshore in Russia in order to make international payments for commercial contracts.
15
Table of Contents
3. ACQUISITIONS AND DISPOSITIONS
Assets held for sale and Liabilities held for sale
Russian Oilseed Processing and Refining Operations Disposition
On September 16, 2022, Bunge signed an agreement to sell its remaining Russian operations, primarily comprising an oilseed crushing and refining facility in Voronezh, southwest Russia, to Karen Vanetsyan (the "Buyer"), in exchange for a cash price approximately equal to the book value of the disposal group's net assets. Additionally, cumulative translation adjustment losses, among other items related to the disposal group, resulted in a corresponding impairment loss on sale of $ 84 million, recognized in Cost of goods sold during the three and nine months ended September 30, 2022. In connection with the transaction, Bunge has agreed to indemnify the Buyer against certain legal claims involving Bunge's Russian subsidiary. Management believes the likelihood of any loss related to the claims underlying the expected indemnity is remote. Completion of the sale is subject to customary closing conditions, including regulatory approvals.
The following table presents the disposal group's major classes of assets and liabilities included in Assets held for sale and Liabilities held for sale, respectively, on the condensed consolidated balance sheet as of September 30, 2022. Intercompany balances between the disposal group and other Bunge consolidated entities have been omitted. Assets held for sale comprise $ 15 million, $ 37 million, and $ 6 million, reported under the Agribusiness segment, Refined and Specialty Oils segment, and Corporate and Other, respectively. Liabilities held for sale comprise $ 4 million and $ 9 million, reported under the Agribusiness segment and Refined and Specialty Oils segment, respectively.
(US$ in millions) September 30,
2022
Cash and cash equivalents $ 36
Trade accounts receivable (less allowances of zero )
21
Inventories 17
Other current assets 12
Property, plant and equipment, net 30
Goodwill & Other intangible assets, net 10
Other non-current assets 16
Impairment reserve ( 84 )
Assets held for sale $ 58
Trade accounts payable and accrued liabilities $ 6
Other current liabilities 7
Total liabilities held for sale $ 13
Mexico Wheat Milling Disposition
On October 12, 2021, Bunge entered into an agreement to sell substantially all of its wheat milling business in Mexico in exchange for cash proceeds approximately equal to the book value of Property, plant and equipment, net, plus an additional sum in consideration for the value of net working capital to be transferred on closing. Additionally, cumulative translation adjustments, among other items related to the disposal group, resulted in a corresponding impairment loss on sale of $ 170 million, recognized in Cost of goods sold for the year ended December 31, 2021. The Company also incurred a $ 30 million tax expense in connection with the disposal. On September 14, 2022, the transaction closed in accordance with the terms of the agreement.






16
Table of Contents
The following table presents the book values of the major classes of assets and liabilities that were included in the disposal group, reported under the Milling segment:
(US$ in millions)
Trade accounts receivable $ 73
Inventories 187
Other current assets 7
Property, plant and equipment, net 164
Operating lease assets 2
Goodwill & Other intangible assets, net 86
Impairment reserve ( 170 )
Total assets $ 349
Trade accounts payable $ 13
Current operating lease obligations 1
Other current liabilities 5
Total liabilities $ 19

4. TRADE STRUCTURED FINANCE PROGRAM
The Company engages in various trade structured finance activities to leverage the value of its global trade flows. These activities include programs under which the Company generally obtains U.S. dollar-denominated letters of credit ("LCs") from financial institutions, each based on an underlying commodity trade flow, and time deposits denominated in either the local currency of the financial institutions' counterparties or in U.S. dollars, as well as foreign exchange forward contracts, in which trade related payables are set-off against receivables, all of which are subject to legally enforceable set-off agreements.
As of September 30, 2022 and December 31, 2021, time deposits and LCs of $ 6,123 million and $ 6,543 million, respectively, were presented net on the condensed consolidated balance sheets as the criteria of ASC 210-20, Offsetting , had been met. The net losses and gains related to such activities are included as an adjustment to Cost of goods sold in the accompanying condensed consolidated statements of income. At September 30, 2022 and December 31, 2021, time deposits, including those presented on a net basis, carried weighted-average interest rates of 2.84 % and 1.08 %, respectively. During the nine months ended September 30, 2022 and 2021, total net proceeds from issuances of LCs were $ 5,045 million and $ 5,379 million, respectively. These cash inflows were offset by the related cash outflows resulting from placement of the time deposits and repayment of the LCs. All cash flows related to the programs are included in operating activities in the condensed consolidated statements of cash flows.
As part of the trade structured finance activities, LCs may be sold to financial institutions on a discounted basis. Bunge does not service derecognized LCs. The terms of the sale may require the Company to continue to make periodic interest payments to financial institutions based on changes in Secured Overnight Financing Rate ("SOFR"), or LIBOR for trades prior to January 1, 2022, for a period of up to 365 days. Bunge’s payment obligation to financial institutions as part of the trade structured finance activities, reported in Other current liabilities, including any unrealized gain or loss on changes in SOFR, or LIBOR for trades prior to January 1, 2022, is not significant as of September 30, 2022 or December 31, 2021. The notional amounts of LCs subject to continuing variable interest payments that have been derecognized from the Company's condensed consolidated balance sheets as of September 30, 2022 and December 31, 2021 are included in Note 13 - Derivative Instruments And Hedging Activities . The net gain or loss included in Cost of goods sold resulting from the fair valuation of such variable interest rate obligations is not significant for the three and nine month periods ended September 30, 2022 and 2021.

17
Table of Contents
5. TRADE ACCOUNTS RECEIVABLE AND TRADE RECEIVABLES SECURITIZATION PROGRAM
Trade Accounts Receivable
Changes to the allowance for lifetime expected credit losses related to trade accounts receivable were as follows:
Nine Months Ended September 30, 2022
Rollforward of the Allowance for Credit Losses (US$ in millions) Short-term
Long-term (1)
Total
Allowance as of January 1, 2022 $ 85 $ 47 $ 132
Current period provisions 49 1 50
Recoveries ( 27 ) ( 1 ) ( 28 )
Write-offs charged against the allowance ( 11 ) ( 3 ) ( 14 )
Foreign exchange translation differences ( 2 ) 1 ( 1 )
Allowance as of September 30, 2022
$ 94 $ 45 $ 139

(1) Long-term portion of the allowance for credit losses included in Other non-current assets.

Nine Months Ended September 30, 2021
Rollforward of the Allowance for Credit Losses (US$ in millions) Short-term
Long-term (1)
Total
Allowance as of January 1, 2021 $ 93 $ 51 $ 144
Current period provisions 25 — 25
Recoveries ( 20 ) ( 1 ) ( 21 )
Write-offs charged against the allowance ( 3 ) — ( 3 )
Foreign exchange translation differences ( 2 ) ( 2 ) ( 4 )
Allowance as of September 30, 2021
$ 93 $ 48 $ 141
(1) Long-term portion of the allowance for credit losses included in Other non-current assets.

Trade Receivables Securitization Program
Bunge and certain of its subsidiaries participate in a trade receivables securitization program (the "Program") with a financial institution, as administrative agent, and certain commercial paper conduit purchasers and committed purchasers. On March 31, 2022, Bunge and certain of its subsidiaries renewed and amended the Program. As a result, the aggregate size of the facility that provides funding against receivables sold into the Program increased by $ 175 million from $ 925 million to $ 1.1 billion. Bunge may also, from time to time with the consent of the administrative agent, request one or more of the existing committed purchasers or new committed purchasers to increase the total commitments by an amount not to exceed $ 250 million pursuant to an accordion provision. The Program will terminate on May 17, 2031; however, each committed purchaser's commitment to purchase trade receivables under the Program will terminate on May 17, 2025, unless extended for an additional period in accordance with the terms of the receivables transfer agreement. The Program was further amended to add sustainability provisions, pursuant to which the applicable margin will be increased or decreased based on Bunge's performance in comparison with certain sustainability targets, including, but not limited to, recently established science-based targets that define Bunge's climate goals within its operations and a commitment to a deforestation-free supply chain in 2025.
(US$ in millions) September 30,
2022 		December 31,
2021
Receivables sold that were derecognized from Bunge's condensed consolidated balance sheet $ 1,712 $ 1,426
Deferred purchase price included in Other current assets (1)
$ 607 $ 496
(1) Bunge's risk of loss following the sale of the trade receivables is limited to the deferred purchase price ("DPP"), included in Other current assets in the condensed consolidated balance sheets (see Note 7 - Other Current Assets ). The DPP will be repaid in cash as receivables are collected, generally within 30 days of collection. Provisions for
18
Table of Contents
delinquencies and credit losses on trade receivables sold under the Program were $ 5 million and $ 5 million at September 30, 2022 and December 31, 2021, respectively.

The table below summarizes the cash flows and discounts of Bunge’s trade receivables associated with the Program. Servicing fees under the Program were not significant in any period.
Nine Months Ended
September 30,
(US$ in millions) 2022 2021
Gross receivables sold $ 13,182 $ 10,658
Proceeds received in cash related to transfers of receivables $ 12,455 $ 10,015
Cash collections from customers on receivables previously sold $ 13,035 $ 10,061
Discounts related to gross receivables sold included in Selling, general and administrative expense $ 12 $ 6

Non-cash activity for the Program in the reporting period is represented by the difference between gross receivables sold and cash collections from customers on receivables previously sold.

6. INVENTORIES
Inventories by segment are presented below. Readily marketable inventories ("RMI") are agricultural commodity inventories, such as soybeans, soybean meal, soybean oil, palm oil, corn, and wheat carried at fair value because of their commodity characteristics, widely available markets, and international pricing mechanisms. The Company engages in trading and distribution, or merchandising activities, and part of RMI can be attributable to such activities and is not held for processing. All other inventories are carried at lower of cost or net realizable value.
(US$ in millions) September 30,
2022 		December 31,
2021
Agribusiness (1)
$ 6,552 $ 6,800
Refined and Specialty Oils (2)
1,318 1,310
Milling (3)
238 319
Corporate and Other 4 2
Total $ 8,112 $ 8,431
(1) Includes RMI of $ 6,144 million and $ 6,490 million at September 30, 2022, and December 31, 2021, respectively.  Of these amounts, $ 4,834 million and $ 4,857 million can be attributable to merchandising activities at September 30, 2022, and December 31, 2021, respectively.
(2) Includes RMI of $ 296 million and $ 257 million at September 30, 2022, and December 31, 2021, respectively.
(3) Includes RMI of $ 3 million and $ 122 million at September 30, 2022, and December 31, 2021, respectively.
19
Table of Contents

7. OTHER CURRENT ASSETS
Other current assets consist of the following:
(US$ in millions) September 30,
2022 		December 31,
2021
Unrealized gains on derivative contracts, at fair value $ 2,484 $ 1,630
Prepaid commodity purchase contracts (1)
254 186
Secured advances to suppliers, net (2)
305 375
Recoverable taxes, net 394 347
Margin deposits 596 569
Deferred purchase price receivable (3)
607 496
Marketable securities and other short-term investments (4)
90 520
Income taxes receivable 122 47
Prepaid expenses 548 380
Restricted cash 5 3
Other 328 198
Total $ 5,733 $ 4,751
(1) Prepaid commodity purchase contracts represent advance payments against contracts for future deliveries of specified quantities of agricultural commodities.
(2) The Company provides cash advances to suppliers, primarily Brazilian soybean farmers, to finance a portion of the suppliers’ production costs. The Company does not bear any of the costs or operational risks associated with the related growing activities. The advances are largely collateralized by future crops and physical assets of the suppliers, carry a local market interest rate, and settle when the farmers' crops are harvested and sold. The secured advances to farmers are reported net of allowances of $ 6 million at September 30, 2022, and $ 3 million at December 31, 2021.
Interest earned on secured advances to suppliers of $ 4 million and $ 5 million for the three months ended September 30, 2022, and 2021, respectively, and $ 16 million and $ 18 million for the nine months ended September 30, 2022, and 2021, respectively, is included in Net sales in the condensed consolidated statements of income.
(3) Deferred purchase price receivable represents additional credit support for the investment conduits in the Company’s trade receivables securitization program (see Note 5 - Trade Accounts Receivable and Trade Receivable Securitization Program ).
(4) Marketable securities and other short-term investments - The Company invests in foreign government securities, corporate debt securities, deposits, equity securities, and other securities. The following is a summary of amounts recorded in the Company's condensed consolidated balance sheets as marketable securities and other short-term investments.
(US$ in millions) September 30,
2022 		December 31,
2021
Foreign government securities $ 39 $ 261
Corporate debt securities 10 158
Equity securities 26 60
Other 15 41
Total $ 90 $ 520
As of September 30, 2022, and December 31, 2021, $ 73 million and $ 479 million, respectively, of marketable securities and other short-term investments were recorded at fair value. All other investments were recorded at cost, and due to the short-term nature of these investments, their carrying values approximated their fair values. For the three months ended September 30, 2022, and 2021, unrealized losses of $ 9 million and unrealized gains of $ 42 million, respectively, have been recognized in Other income (expense) - net for investments held at September 30, 2022, and 2021. For the nine months ended September 30, 2022 and 2021, unrealized losses of $ 123 million and
20
Table of Contents
unrealized gains of $ 60 million, respectively, have been recognized in Other income (expense) - net for investments held at September 30, 2022, and 2021.

8. OTHER NON-CURRENT ASSETS
Other non-current assets consist of the following:
(US$ in millions) September 30,
2022 		December 31,
2021
Recoverable taxes, net (1)
$ 50 $ 66
Judicial deposits (1)
109 89
Other long-term receivables, net 6 11
Income taxes receivable
143 139
Long-term investments (2)
218 196
Affiliate loans receivable 10 16
Long-term receivables from farmers in Brazil, net (1)
30 33
Unrealized gains on derivative contracts, at fair value 5 49
Other 113 120
Total $ 684 $ 719
(1) A significant portion of these non-current assets arise from the Company’s Brazilian operations and their realization could take several years.
(2) As of September 30, 2022, and December 31, 2021, $ 9 million a nd $ 12 million, respectively, of long-term investments are recorded at fair value.
Recoverable taxes, net - Recoverable taxes include value-added taxes paid upon the acquisition of property, plant and equipment, raw materials and taxable services, and other transactional taxes which can be recovered in cash or as compensation against income taxes, or other taxes Bunge may owe, primarily in Brazil and Europe. Recoverable taxes are reported net of allow ances of $ 14 million and $ 18 million at September 30, 2022, and December 31, 2021, respectively.
Judicial deposits - Judicial deposits are funds the Company has placed on deposit with the courts in Brazil. These funds are held in judicial escrow relating to certain legal proceedings pending resolution and bear interest at the Selic rate, which is the benchmark rate of the Brazilian central bank.
Income taxes receivable - Income taxes receivable include overpayments of current income taxes plus accrued interest. These income tax prepayments are expected to be primarily used for the settlement of future income tax obligations. Income taxes receivable in Brazil bear interest at the Selic rate.
Long-term investments - Long-term investments primarily comprise Bunge's noncontrolling equity investments in growth stage agribusiness and food companies held by Bunge Ventures.
Affiliate loans receivable - Affiliate loans receivable are primarily interest-bearing receivables from unconsolidated affiliates with remaining maturities of greater than one year .
Long-term receivables from farmers in Brazil, net - The Company provides financing to farmers in Brazil, primarily through secured advances against farmer commitments to deliver agricultural commodities (primarily soybeans) upon harvest of the then-current year’s crop, and through credit sales of fertilizer to farmers. Certain such long-term receivables from farmers are originally recorded in Other current assets as prepaid commodity contracts or secured advances to suppliers (see Note 7 - Other Current Assets ) or Other non-current assets according to their maturity. Advances initially recorded in Other current assets are reclassified to Other non-current assets if collection issues arise and amounts become past due with resolution of such matters expected to take more than one year.
21
Table of Contents
The average recorded investment in long-term receivables from farmers in Brazil for the nine months ended September 30, 2022, and the year ended December 31, 2021, was $ 98 million and $ 92 million, respectively. The table below summarizes the Company’s recorded investment in long-term receivables from farmers in Brazil and the related allowance amounts.
September 30, 2022 December 31, 2021
(US$ in millions) Recorded
Investment 		Allowance Recorded
Investment 		Allowance
For which an allowance has been provided:
Legal collection process (1)
$ 38 $ 32 $ 42 $ 35
Renegotiated amounts 2 2 3 1
For which no allowance has been provided:
Legal collection process (1)
20 — 20 —
Renegotiated amounts (2)
4 — 2 —
Other long-term receivables (3)
— — 2 —
Total $ 64 $ 34 $ 69 $ 36
(1) All amounts in legal collection processes are considered past due upon initiation of legal action.
(2) These renegotiated amounts are current on repayment terms.
(3) New advances expected to be realized through farmer commitments to deliver agricultural commodities in crop periods greater than twelve months from the balance sheet date. Such advances are reclassified from Other non-current assets to Other current assets in later periods depending on the expected date of their realization.
The table below summarizes the activity in the allowance for doubtful accounts related to long-term receivables from farmers in Brazil.
Nine Months Ended
September 30,
(US$ in millions) 2022 2021
Allowance as of January 1 $ 36 $ 63
Bad debt provisions 2 2
Recoveries ( 6 ) ( 4 )
Write-offs ( 1 ) ( 4 )
Transfers 1 ( 1 )
Foreign exchange translation 2 ( 2 )
Allowance as of September 30 $ 34 $ 54

9. VARIABLE INTEREST ENTITIES
Consolidated Variable Interest Entities
As indicated in Note 1 - Basis of Presentation, Principles of Consolidation, And Significant Accounting Policies, on May 1, 2022, Bunge completed a transaction with Chevron Corporation ("Chevron") to create a joint venture, Bunge Chevron Ag Renewables LLC (the "Joint Venture"), leveraging Bunge’s expertise in oilseed processing and farmer relationships, and Chevron’s expertise in fuels manufacturing and marketing, to help meet the demand for renewable fuels and to develop lower carbon intensity feedstocks.
The Joint Venture is a variable interest entity ("VIE") in which Bunge is considered to be the primary beneficiary because it is responsible for the day-to-day operating decisions of the Joint Venture as well as the marketing of the principal products, primarily soybean meal and oil produced and sold by the Joint Venture, among other factors.
The Joint Venture's assets can only be used to settle the Joint Venture’s own obligations and the Joint Venture’s creditors have no recourse to Bunge’s assets beyond Bunge’s maximum exposure to loss associated with the Joint Venture at any given time. The following table presents the values of the assets and liabilities associated with the Joint Venture, which are
22
Table of Contents
included in Bunge’s condensed consolidated balance sheet as of September 30, 2022. All amounts exclude intercompany balances, which have been eliminated upon consolidation.
For all other VIEs in which Bunge is considered the primary beneficiary, the entities meet the definition of a business, and the VIE's assets can be used other than for the settlement of the VIE’s obligations. As such these VIEs have been excluded from the below table:
(US$ in millions) September 30,
2022
Current assets:
Cash and cash equivalents $ 509
Trade accounts receivable 5
Inventories 74
Other current assets 131
Total current assets 719
Property, plant and equipment, net 61
Total assets $ 780
Current liabilities:
Trade accounts payable and accrued liabilities $ 49
Other current liabilities 129
Total current liabilities 178
Total liabilities $ 178
Non-Consolidated Variable Interest Entities
On June 10, 2022, Bunge completed its acquisition of a 33 % interest in Sinagro Produtos Agropecuários S.A. ("Sinagro"), a Brazilian distributor of agricultural inputs and originator of grains, in exchange for Brazilian real (R$) 280 million (approximately $ 53 million). As of September 30, 2022, the Company's maximum exposure to loss related to this unconsolidated VIE is limited to the investment balance of approximately $ 49 million. However, as part of the acquisition cost, Bunge has committed to provide certain future guarantees of Sinagro’s approximately R$ 329 million (approximately $ 61 million) third-party indebtedness in proportion to Bunge’s 33 % equity holding, representing a maximum expected future guarantee of approximately R$ 110 million (approximately $ 20 million).

For additional information on VIEs for which Bunge has determined it is not the primary beneficiary, along with the Company's related maximum exposure to losses associated with such investments, please refer to Note 11 - Investments in Affiliates , included in the Company's 2021 Annual Report on Form 10-K.

10. INCOME TAXES
Income tax expense is provided on an interim basis based on management’s estimate of the annual effective income tax rate and includes the tax effects of certain discrete items, such as changes in tax laws or tax rates or other unusual or non-recurring tax adjustments in the interim period in which they occur. In addition, results from jurisdictions projecting a loss for the year where no tax benefit can be recognized are treated discretely in the interim period in which they occur. The effective tax rate is highly dependent on the geographic distribution of the Company’s worldwide earnings or losses and tax regulations in each jurisdiction. Management regularly monitors the assumptions used in estimating its annual effective tax rate, including the realizability of deferred tax assets, and adjusts estimates accordingly. Volatility in earnings within a taxing jurisdiction could result in a determination that additional valuation allowance adjustments may be warranted.
Income tax expense for the three and nine months ended September 30, 2022, was $ 113 million and $ 257 million, respectively. Income tax expense for the three and nine months ended September 30, 2021, was $ 92 million and $ 334 million, respectively. The effective tax rate for the three months ended September 30, 2022, was higher than the U.S. statutory rate of 21% primarily due to unfavorable tax impact on North American and expected European dispositions and the effective tax rate for the nine months ended September 30, 2022, was lower than the U.S. statutory rate of 21%, primarily due to favorable earnings mix, incentives in South America, and the release of valuation allowances in Europe and Asia. The effective tax rate for the three and nine months ended September 30, 2021, was lower than the U.S. statutory rate of 21% primarily due to favorable earnings mix and incentives in South and North America.
23
Table of Contents
As a global enterprise, the Company files income tax returns that are subject to periodic examination and challenge by federal, state, and foreign tax authorities. In many jurisdictions, income tax examinations, including settlement negotiations or litigation, may take several years to finalize. The Company is currently under examination or litigation in various locations throughout the world. While it is difficult to predict the outcome or timing of resolution of any particular matter, management believes that the condensed consolidated financial statements reflect the largest amount of tax benefit that is more likely than not to be realized.

11. OTHER CURRENT LIABILITIES
Other current liabilities consist of the following:
(US$ in millions) September 30,
2022 		December 31,
2021
Unrealized losses on derivative contracts, at fair value $ 2,041 $ 1,713
Accrued liabilities 686 689
Advances on sales (1)
339 437
Income tax payable 54 168
Other 443 418
Total $ 3,563 $ 3,425
(1) The Company records advances on sales when cash payments are received in advance of the Company’s performance and recognizes revenue once the related performance obligation is completed. Advances on sales are impacted by the seasonality of Bunge's business, including the timing of harvests in the northern and southern hemispheres, and amounts at each balance sheet date will generally be recognized in earnings within twelve months or less.


12. FAIR VALUE MEASUREMENTS
Bunge's various financial instruments include certain components of working capital such as trade accounts receivable and trade accounts payable. Additionally, Bunge uses short- and long-term debt to fund operating requirements. Trade accounts receivable, trade accounts payable, and short-term debt are stated at their carrying value, which is a reasonable estimate of fair value. See Note 4 - Trade Structured Finance Program for trade structured finance program, Note 8- Other Non-Current Assets for long-term receivables from farmers in Brazil, net and other long-term investments, and Note 14- Debt for long-term debt. Bunge's financial instruments also include derivative instruments and marketable securities, which are stated at fair value.
The fair value standard describes three levels within its hierarchy that may be used to measure fair value.
Level Description Financial Instrument (Assets / Liabilities)
Level 1 Quoted prices (unadjusted) in active markets for identical assets or liabilities. Exchange traded derivative contracts.

Marketable securities in active markets.
Level 2 Observable inputs, including adjusted Level 1 quotes, quoted prices for similar assets or liabilities, quoted prices in markets that are less active than traded exchanges and other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Exchange traded derivative contracts (less liquid markets).

Readily marketable inventories.

Over-the-counter ("OTC") commodity purchase and sales contracts.

OTC derivatives whose value is determined using pricing models with inputs that are generally based on exchange traded prices, adjusted for location specific inputs that are primarily observable in the market or can be derived principally from or corroborated by observable market data.

Marketable securities in less active markets.
Level 3 Unobservable inputs that are supported by little or no market activity and that are a significant component of the fair value of the assets or liabilities. Assets and liabilities whose value is determined using proprietary pricing models, discounted cash flow methodologies or similar techniques.

Assets and liabilities for which the determination of fair value requires significant management judgment or estimation.
24
Table of Contents
In many cases, a valuation technique used to measure fair value includes inputs from multiple levels of the fair value hierarchy. The lowest level of input that is a significant component of the fair value measurement determines the placement of the entire fair value measurement in the hierarchy. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the classification of fair value assets and liabilities within the fair value hierarchy levels.
For a further definition of fair value and the associated fair value levels, refer to Note 15 - Fair Value Measurements, included in the Company's 2021 Annual Report on Form 10-K.
The following table sets forth, by level, the Company’s assets and liabilities that were accounted for at fair value on a recurring basis.
Fair Value Measurements at Reporting Date
September 30, 2022 December 31, 2021
(US$ in millions) Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total
Assets:
Readily marketable inventories (Note 6) $ — $ 5,583 $ 860 $ 6,443 $ — $ 6,664 $ 205 $ 6,869
Trade accounts receivable (1)
— 5 — 5 — 1 — 1
Unrealized gain on derivative contracts (2) :
Interest rate — 2 — 2 — 49 — 49
Foreign exchange 1 843 — 844 — 340 — 340
Commodities 212 1,106 103 1,421 63 1,055 34 1,152
Freight 121 — — 121 79 5 — 84
Energy 86 10 — 96 44 4 — 48
Credit — 5 — 5 — 6 — 6
Equity — — — — 1 — — 1
Other (3)
37 179 36 252 91 406 — 497
Total assets $ 457 $ 7,733 $ 999 $ 9,189 $ 278 $ 8,530 $ 239 $ 9,047
Liabilities:
Trade accounts payable (1)
$ — $ 564 $ 342 $ 906 $ — $ 545 $ 23 $ 568
Unrealized loss on derivative contracts (4) :
Interest rate — 362 — 362 — 47 — 47
Foreign exchange 1 837 — 838 — 309 — 309
Commodities 190 770 43 1,003 98 1,051 65 1,214
Freight 74 — — 74 162 — — 162
Energy 111 2 — 113 29 1 — 30
Credit — 2 — 2 — 1 — 1
Total liabilities $ 376 $ 2,537 $ 385 $ 3,298 $ 289 $ 1,954 $ 88 $ 2,331
(1) These receivables and payables are hybrid financial instruments for which Bunge has elected the fair value option as they are derived from purchases and sales of agricultural commodity products in the normal course of business.
(2) Unrealized gains on derivative contracts are generally included in Other current assets. There were $ 5 million and $ 49 million included in Other non-current assets at September 30, 2022, and December 31, 2021, respectively. There were no unrealized gains on derivative contracts included in Assets held for sale at September 30, 2022, and $ 2 million included in Assets held for sale at December 31, 2021.
(3) Other includes the fair values of marketable securities and investments in Other current assets and Other non-current assets.
(4) Unrealized losses on derivative contracts are generally included in Other current liabilities. There were $ 351 million and $ 49 million included in Other non-current liabilities at September 30, 2022, and December 31, 2021, respectively. There were no unrealized losses on derivative contracts included in Liabilities held for sale at September 30, 2022, and $ 1 million was included in Liabilities held for sale at December 31, 2021.
Readily marketable inventories —RMI reported at fair value are valued based on commodity futures exchange quotations, broker or dealer quotations, or market transactions in either listed or OTC markets with appropriate adjustments for
25
Table of Contents
differences in local markets where the Company's inventories are located. In such cases, the inventory is classified within Level 2. Certain inventories may utilize significant unobservable data related to local market adjustments to determine fair value. In such cases, the inventory is classified as Level 3.
If the Company used different methods or factors to determine fair values, amounts reported as unrealized gains and losses on derivative contracts and RMI at fair value in the condensed consolidated balance sheets and condensed consolidated statements of income could differ. Additionally, if market conditions change subsequent to the reporting date, amounts reported in future periods as unrealized gains and losses on derivative contracts and RMI at fair value in the condensed consolidated balance sheets and condensed consolidated statements of income could differ.
Derivatives —The majority of exchange traded futures and options contracts and exchange cleared contracts are valued based on unadjusted quoted prices in active markets and are classified within Level 1. The majority of the Company’s exchange traded agricultural commodity futures are cash-settled on a daily basis and, therefore, are not included in these tables. The Company's forward commodity purchase and sales contracts are classified as derivatives along with other OTC derivative instruments, primarily relating to freight, energy, foreign exchange and interest rates, and are classified within Level 2 or Level 3 as described below. The Company estimates fair values based on exchange quoted prices, adjusted as appropriate for differences in local markets. These differences are generally valued using inputs from broker or dealer quotations, or market transactions in either the listed or OTC markets. In such cases, these derivative contracts are classified within Level 2.
OTC derivative contracts include swaps, options, and structured transactions that are generally fair valued using quantitative models that require the use of multiple market inputs including quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets which are not highly active, other observable inputs relevant to the asset or liability, and market inputs corroborated by correlation or other means. These valuation models include inputs such as interest rates, prices, and indices, to generate continuous yield or pricing curves and volatility factors. Where observable inputs are available for substantially the full term of the asset or liability, the instrument is categorized in Level 2. Certain OTC derivatives trade in less active markets with less availability of pricing information and certain structured transactions can require internally developed model inputs that might not be observable in or corroborated by the market.

Marketable securities and investments —comprise government treasury securities, corporate debt securities and other investments. Bunge analyzes how the prices are derived and determines whether the prices are liquid or less liquid tradable prices. Marketable securities and investments with liquid prices are valued using prices from publicly available sources and classified as Level 1. Marketable securities and investments with less-liquid prices are valued using third-party quotes or pricing models and classified as Level 2 or Level 3 as described below.
Level 3 Measurements
The following relates to Level 3 measurements. An instrument may transfer into or out of Level 3 due to inputs becoming either observable or unobservable.
Level 3 Measurements —Transfers in and/or out of Level 3 represent existing assets or liabilities that were either previously categorized as a higher level for which the inputs to the model became unobservable or assets and liabilities that were previously classified as Level 3 for which the lowest significant input became observable during the period. Bunge's policy regarding the timing of transfers between levels is to record the transfers at the beginning of the reporting period.
Level 3 Readily marketable inventories and trade accounts payable —The significant unobservable inputs resulting in Level 3 classification for RMI, physically settled forward purchase and sales contracts, and trade accounts payable, relate to certain management estimations regarding costs of transportation and other local market or location-related adjustments, primarily freight related adjustments in the interior of Brazil and the lack of market corroborated information in Canada. In both situations, the Company uses proprietary information such as purchase and sales contracts and contracted prices to value freight, premiums and discounts in its contracts. Movements in the prices of these unobservable inputs alone would not have a material effect on the Company's financial statements as these contracts do not typically exceed one future crop cycle.
Level 3 Derivatives —Level 3 derivative instruments utilize both market observable and unobservable inputs within the fair value measurements. These inputs include commodity prices, price volatility, interest rates, volumes, and locations.
Level 3 Others —primarily relates to marketable securities and investments valued using third-party quotes or pricing models with inputs based on similar securities adjusted to reflect management’s best estimate of the specific characteristics of the securities held by the Company. Such inputs represent a significant component of the fair value of the securities held by the Company, resulting in the securities being classified as Level 3.
The tables below present reconciliations for assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three and nine months ended September 30, 2022, and 2021. These
26
Table of Contents
instruments were valued using pricing models that management believes reflect the assumptions that would be used by a marketplace participant.
Three Months Ended September 30, 2022
(US$ in millions) Readily
Marketable
Inventories 		Derivatives,
Net 		Trade
Accounts
Payable
Other (2)
Total
Balance, July 1, 2022 $ 941 $ 10 $ ( 271 ) $ 66 $ 746
Total gains and losses (realized/unrealized) included in cost of goods sold (1)
251 60 3 — 314
Total gains and losses (realized/unrealized) included in Foreign exchange (losses) gains — — — ( 7 ) ( 7 )
Total gains and losses (realized/unrealized) included in Other income (expense) - net — — — ( 7 ) ( 7 )
Purchases 732 — ( 63 ) — 669
Sales ( 1,584 ) — — — ( 1,584 )
Issuances — — — — —
Settlements — — 69 ( 16 ) 53
Transfers into Level 3 727 ( 3 ) ( 88 ) — 636
Transfers out of Level 3 ( 182 ) ( 7 ) — — ( 189 )
Translation adjustment ( 25 ) — 8 — ( 17 )
Balance, September 30, 2022 $ 860 $ 60 $ ( 342 ) $ 36 $ 614
(1) Readily marketable inventories, derivatives, net, and trade accounts payable, include gains/(losses) of $ 313 million, $ 62 million and $ 3 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at September 30, 2022.
(2) Comprises the fair values of marketable securities and investments in Other current assets. Included within Other income (expense) - net of the condensed consolidated statements of income are $ 7 million in mark-to-market losses related to securities still held at September 30, 2022.
Three Months Ended September 30, 2021
(US$ in millions) Readily
Marketable
Inventories 		Derivatives,
Net 		Trade
Accounts Payable 		Total
Balance, July 1, 2021 $ 492 $ ( 20 ) $ ( 92 ) $ 380
Total gains and losses (realized/unrealized) included in cost of goods sold (1)
87 10 7 104
Purchases 596 — ( 13 ) 583
Sales ( 1,011 ) — — ( 1,011 )
Issuances — — — —
Settlements — — 36 36
Transfers into Level 3 349 8 ( 24 ) 333
Transfers out of Level 3 ( 211 ) ( 2 ) 35 ( 178 )
Balance, September 30, 2021 $ 302 $ ( 4 ) $ ( 51 ) $ 247
(1) Readily marketable inventories, derivatives, net, and trade accounts payable, includes gains/(losses) of $ 84 million, $ 15 million and $ 7 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at September 30, 2021.

27
Table of Contents
Nine Months Ended September 30, 2022
(US$ in millions) Readily
Marketable
Inventories 		Derivatives,
Net 		Trade
Accounts
Payable
Other (2)
Total
Balance, January 1, 2022 $ 205 $ ( 31 ) $ ( 23 ) $ — $ 151
Total gains and losses (realized/unrealized) included in cost of goods sold (1)
421 87 36 — 544
Total gains and losses (realized/unrealized) included in Foreign exchange (losses) gains — — — ( 7 ) ( 7 )
Total gains and losses (realized/unrealized) included in Other income (expense) - net — — — ( 76 ) ( 76 )
Purchases 2,834 — ( 509 ) — 2,325
Sales ( 4,271 ) — — — ( 4,271 )
Issuances — — — — —
Settlements — — 394 ( 101 ) 293
Transfers into Level 3 2,142 25 ( 434 ) 218 1,951
Transfers out of Level 3 ( 360 ) ( 21 ) 146 — ( 235 )
Translation adjustment ( 111 ) — 48 2 ( 61 )
Balance, September 30, 2022 $ 860 $ 60 $ ( 342 ) $ 36 $ 614
(1) Readily marketable inventories, derivatives, net and trade accounts payable, includes gains/(losses) of $ 480 million, $ 89 million and $ 30 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at September 30, 2022.
(2) Comprises the fair values of marketable securities and investments in Other current assets. Included within Other income (expense) - net of the condensed consolidated statements of income are $ 45 million in mark-to-market losses related to securities still held at September 30, 2022.

Nine Months Ended September 30, 2021
(US$ in millions) Readily
Marketable
Inventories 		Derivatives,
Net 		Trade
Accounts Payable 		Total
Balance, January 1, 2021 $ 208 $ ( 8 ) $ ( 9 ) $ 191
Total gains and losses (realized/unrealized) included in cost of goods sold (1)
356 30 15 401
Purchases 1,670 3 ( 238 ) 1,435
Sales ( 2,866 ) — — ( 2,866 )
Issuances — ( 2 ) — ( 2 )
Settlements — ( 49 ) 209 160
Transfers into Level 3 1,248 ( 17 ) ( 212 ) 1,019
Transfers out of Level 3 ( 314 ) 39 184 ( 91 )
Balance, September 30, 2021 $ 302 $ ( 4 ) $ ( 51 ) $ 247
(1) Readily marketable inventories, derivatives, net and trade accounts payable, includes gains/(losses) of $ 347 million, $( 19 ) million and $ 15 million, respectively, that are attributable to the change in unrealized gains/(losses) relating to Level 3 assets and liabilities still held at September 30, 2021.

13. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
The Company uses derivative instruments to manage several market risks, such as interest rate, foreign currency, and commodity risk. Some of those hedges the Company enters into qualify for hedge accounting in the financial statements (Hedge
28
Table of Contents
Accounting Derivatives) and some, while intended as economic hedges, do not qualify or are not designated for hedge accounting (Economic Hedge Derivatives). As these derivatives impact the financial statements in different ways, they are discussed separately below.
Hedge Accounting Derivatives - The Company uses derivatives in qualifying hedge accounting relationships to manage certain of its interest rate, foreign currency, and commodity risks. In executing these hedge strategies, the Company primarily relies on the shortcut and critical terms match methods in designing its hedge accounting strategy, which results in little to no net earnings impact for these hedge relationships. The Company monitors these relationships on a quarterly basis and performs a quantitative analysis to validate the assertion that the hedges are highly effective if there are changes to the hedged item or hedging derivative.
Fair value hedges - These derivatives are used to hedge the effect of interest rate and currency exchange rate changes on certain long-term debt. Under fair value hedge accounting, the derivative is measured at fair value and the carrying value of hedged debt is adjusted for the change in value related to the exposure being hedged, with both adjustments offset to earnings. In other words, the earnings effect of a change in the fair value of the derivative will be substantially offset by the earnings effect of the change in the carrying value of the hedged debt. The net impact of fair value hedge accounting for interest rate swaps is recognized in Interest expense. For cross currency swaps the changes in currency risk on the derivative are recognized in Foreign exchange gains (losses), and the changes in interest rate risk are recognized in Interest expense. Changes in basis risk are held in Accumulated other comprehensive income (loss) until realized through the coupon.
Cash flow hedges of currency risk - The Company manages currency risk on certain forecasted sales, purchases and selling, general and administrative expenses with currency forwards. The change in the value of the forward is held in Accumulated other comprehensive income (loss) until the transaction affects earnings, at which time the change in value of the currency forward is reclassified to Net sales, Cost of goods sold, or Selling, general and administrative expenses. These hedges mature at various times through July 2023. Of the amount currently in Accumulated other comprehensive income (loss), $ 4 million of deferred losses is expected to be reclassified to earnings in the next twelve months.
Net investment hedges - The Company hedges the currency risk of certain of its foreign subsidiaries with currency forwards for which the currency risk is remeasured through Accumulated other comprehensive income (loss). For currency forwards, the forward method is used. The change in the value of the forward is classified in Accumulated other comprehensive income (loss) until the transaction affects earnings by way of either sale or substantial liquidation of the foreign subsidiary.
The table below provides information about the balance sheet values of hedged items and the notional amount of derivatives used in hedging strategies. The notional amount of the derivative is the number of units of the underlying (for example, the notional principal amount of the debt in an interest rate swap). The notional amount is used to compute interest or other payment streams to be made under the contract and is a measure of the Company’s level of activity. The Company discloses derivative notional amounts on a gross basis.
(US$ in millions) September 30,
2022 		December 31, 2021 Unit of
Measure
Hedging instrument type:
Fair value hedges of interest rate risk
Interest rate swap $ 3,680 $ 4,006 $ Notional
Cumulative adjustment to long-term debt from application of hedge accounting $ ( 359 ) $ — $ Notional
Carrying value of hedged debt $ 3,303 $ 3,990 $ Notional
Fair value hedges of currency risk
Cross currency swap $ 213 $ 267 $ Notional
Carrying value of hedged debt $ 213 $ 267 $ Notional
Cash flow hedges of currency risk
Foreign currency forward $ 318 $ 148 $ Notional
Foreign currency option $ 60 $ 60 $ Notional
Net investment hedges
Foreign currency forward $ 932 $ 1,020 $ Notional
29
Table of Contents
Economic Hedge Derivatives - In addition to using derivatives in qualifying hedge relationships, the Company enters into derivatives to economically hedge its exposure to a variety of market risks it incurs in the normal course of operations.
Interest rate derivatives are used to hedge exposures to the Company's financial instrument portfolios and debt issuances. The impact of changes in fair value of these instruments is primarily presented in Interest expense.
Currency derivatives are used to hedge the balance sheet and commercial exposures that arise from the Company's global operations. The impact of changes in fair value of these instruments is presented in Cost of goods sold when hedging commercial exposures and Foreign exchange gains (losses) when hedging monetary exposures.
Agricultural commodity derivatives are used primarily to manage the Company's inventory and forward purchase and sales contracts. Contracts to purchase agricultural commodities generally relate to current or future crop years for delivery periods quoted by regulated commodity exchanges. Contracts for the sale of agricultural commodities generally do not extend beyond one future crop cycle. The impact of changes in fair value of these instruments is presented in Cost of goods sold.
The Company uses derivative instruments referred to as forward freight agreements ("FFAs") and FFA options to hedge portions of its current and anticipated ocean freight costs. The impact of changes in fair value of these instruments is presented in Cost of goods sold.
The Company uses energy derivative instruments to manage its exposure to volatility in energy costs. Hedges may be entered into for natural gas, electricity, coal and fuel oil, including bunker fuel. The impact of changes in fair value of these instruments is presented in Cost of goods sold.
The Company may also enter into other derivatives, including credit default swaps, carbon emission derivatives and equity derivatives to manage its exposure to credit risk and broader macroeconomic risks, respectively. The impact of changes in fair value of these instruments is presented in Cost of goods sold.
The table below summarizes the volume of economic derivatives as of September 30, 2022 and December 31, 2021. For those contracts traded bilaterally through the OTC markets (e.g., forwards, forward rate agreements ("FRAs"), swaps, and variable interests rate obligations), the gross position is provided. For exchange traded (e.g., futures, FFAs and options) and cleared positions (e.g., energy swaps), the net position is provided.
30
Table of Contents
September 30, December 31,
2022 2021 Unit of
Measure
(US$ in millions) Long (Short) Long (Short)
Interest rate
Swaps $ 75 $ ( 788 ) $ 2,924 $ ( 2,506 ) $ Notional
Futures $ — $ ( 16 ) $ — $ — $ Notional
Currency
Forwards $ 10,794 $ ( 11,145 ) $ 12,961 $ ( 14,065 ) $ Notional
Swaps $ 3,294 $ ( 3,557 ) $ 1,362 $ ( 1,422 ) $ Notional
Futures $ 11 $ — $ — $ ( 8 ) $ Notional
Options $ 81 $ ( 80 ) $ 88 $ ( 106 ) Delta
Agricultural commodities
Forwards 31,678,168 ( 30,332,548 ) 29,329,244 ( 34,810,969 ) Metric Tons
Swaps — ( 2,272,494 ) 33,250 ( 502,652 ) Metric Tons
Futures — ( 1,747,421 ) — ( 7,221,848 ) Metric Tons
Options 11,547 ( 350,333 ) 218,106 ( 116,370 ) Metric Tons
Ocean freight
FFA — ( 11,512 ) — ( 6,713 ) Hire Days
FFA options 77 — 548 — Hire Days
Natural gas
Swaps 895,261 — 1,764,455 — MMBtus
Futures — ( 4,163,882 ) 5,147,500 — MMBtus
Energy - other
Swaps 350,257 ( 122,226 ) 741,307 ( 426,476 ) Metric Tons
Electricity
Swaps 536,325 ( 169,356 ) 670,973 ( 256,949 ) Mwh
Energy - CO2
Futures 349,000 — — — Metric Tons
Other
Swaps and futures $ 23 $ ( 45 ) $ 20 $ ( 585 ) $ Notional

The Effect of Derivative Instruments and Hedge Accounting on the Condensed Consolidated Statements of Income
The tables below summarize the net effect of derivative instruments and hedge accounting on the condensed consolidated statements of income for the three and nine months ended September 30, 2022 and 2021.
31
Table of Contents
Gain (Loss) Recognized in
Income on Derivative Instruments
Three Months Ended September 30,
(US$ in millions) 2022 2021
Income statement classification Type of derivative
Net sales
Hedge accounting Foreign currency $ — $ 1
Cost of goods sold
Hedge accounting Foreign currency $ 3 $ —
Economic hedges Foreign currency $ 59 $ ( 207 )
Commodities $ 303 242
Other (1)
$ ( 3 ) ( 84 )
Total Cost of goods sold $ 362 $ ( 49 )
Selling, general & administrative
Hedge Accounting Foreign exchange $ ( 1 ) $ —
Interest expense
Hedge accounting Interest rate $ ( 8 ) $ 8
Foreign exchange gains (losses)
Hedge accounting Foreign currency $ 2 $ ( 3 )
Economic hedges Foreign currency 14 68
Total Foreign exchange gains (losses) $ 16 $ 65
Other income (expense)
Economic hedges Interest Rate $ 1 $ —
Other comprehensive income (loss)
Gains and losses on derivatives used as fair value hedges of foreign currency risk included in other comprehensive income (loss) during the period $ ( 2 ) $ 1
Gains and losses on derivatives used as cash flow hedges of foreign currency risk included in other comprehensive income (loss) during the period $ 38 $ ( 5 )
Gains and losses on derivatives used as net investment hedges included in other comprehensive income (loss) during the period
$ ( 4 ) $ 52
Amounts released from accumulated other comprehensive income (loss) during the period
Cash flow hedge of foreign currency risk $ ( 18 ) $ ( 1 )
(1) Other includes results from freight, energy and other derivatives.







32
Table of Contents



Gain (Loss) Recognized in
Income on Derivative Instruments
Nine months ended September 30,
(US$ in millions) 2022 2021
Income statement classification Type of derivative
Net sales
Hedge accounting Foreign currency $ 7 $ 2
Cost of goods sold
Hedge accounting Foreign currency $ 3 $ —
Economic hedges Foreign currency $ 482 $ ( 23 )
Commodities ( 318 ) ( 1,494 )
Other (1)
90 175
Total Cost of goods sold $ 257 $ ( 1,342 )
Selling, general & administrative
Hedge accounting Foreign exchange $ ( 1 ) —
Interest expense
Hedge accounting Interest rate $ ( 12 ) $ 21
Economic hedges Interest rate 1 —
Total Interest expense $ ( 11 ) $ 21
Foreign exchange gains (losses)
Hedge accounting Foreign currency $ ( 35 ) $ ( 20 )
Economic hedges Foreign currency 130 1
Total Foreign exchange gains (losses) $ 95 $ ( 19 )
Other income (expense)
Economic hedges Interest rate $ 2 $ 1
Other comprehensive income (loss)
Gains and losses on derivatives used as fair value hedges of foreign currency risk included in other comprehensive income (loss) during the period $ — $ ( 1 )
Gains and losses on derivatives used as cash flow hedges of foreign currency risk included in other comprehensive income (loss) during the period $ 72 $ ( 2 )
Gains and losses on derivatives used as net investment hedges included in other comprehensive income (loss) during the period
$ ( 110 ) $ ( 6 )
Amounts released from accumulated other comprehensive income (loss) during the period
Cash flow hedge of foreign currency risk $ ( 25 ) $ ( 3 )
(1) Other includes results from freight, energy and other derivatives.

33
Table of Contents


14. DEBT
Bunge’s $ 600 million commercial paper program is supported by an identical amount of committed back-up bank credit lines (the "Liquidity Facility") provide d by banks that are rated at least A-1 by Standard & Poor’s Financial Services and P-1 by Moody’s Investors Service. The cost of borrowing under the Liquidity Facility would typically be higher than the cost of issuing under Bunge’s commercial paper program. At September 30, 2022, and December 31, 2021, there were $ 215 million and no borrowings outstanding under the commercial paper program and no borrowings under the Liquidity Facility, respectively. The Liquidity Facility is Bunge's only revolving credit facility that requires lenders to maintain minimum credit ratings. The Liquidity Facility is set to expire on July 16, 2026.
Bunge had no borrowings outstanding at September 30, 2022, under the unsecured $ 1.1 billion 364 -day Revolving Credit Agreement (the "$ 1.1 Billion Credit Agreement"), with a group of lenders, entered into on July 15, 2022, and maturing on July 14, 2023. Bunge may from time-to-time request one or more of the existing or new lenders to increase the total participations under the $ 1.1 Billion Credit Agreement by an aggregate amount up to $ 250 million pursuant to an accordion provision. Borrowings will bear interest at the SOFR plus a credit spread adjustment and applicable margin, as defined in the $ 1.1 Billion Credit Agreement. The $ 1.1 Billion Credit Agreement replaces the previous unsecured $ 1 billion 364 -day Revolving Credit Agreement (the "$ 1 Billion Credit Agreement") that matured on July 15, 2022.
Bunge had no borrowings outstanding at September 30, 2022, and December 31, 2021, under the unsecured committed $ 1.35 billion 5 -year Revolving Credit Agreement (the "$ 1.35 Billion Credit Agreement") with a group of lenders, maturing July 16, 2026. Bunge may, from time to time, request one or more of the existing or new lenders to increase the total commitments under the $ 1.35 Billion Credit Agreement by an aggregate amount up to $ 200 million pursuant to an accordion provision. Borrowings will bear interest at LIBOR plus an applicable margin, as defined in the $ 1.35 Billion Credit Agreement.
Bunge had no borrowings outstanding at September 30, 2022, and December 31, 2021, under the unsecured $ 865 million Revolving Credit Agreement (the "$ 865 Million 2026 Facility") with a group of lenders, set to mature on October 29, 2026. Borrowings will bear interest at SOFR plus a credit spread adjustment and applicable margin, as defined in the $ 865 Million 2026 Facility.
Bunge had no borrowings outstanding at September 30, 2022, and December 31, 2021, under the unsecured $ 1.75 billion Revolving Credit Facility ("$ 1.75 Billion Revolving Credit Facility"), set to mature on December 16, 2024. The interest rate under the $ 1.75 Billion Revolving Credit Facility is tied to certain sustainability criteria, including, but not limited to, recently established science-based targets that define Bunge's climate goals within its operations and a commitment to a deforestation-free supply chain in 2025. Bunge may from time to time, with the consent of the agent, request one or more of the existing lenders or new lenders to increase the total commitments by an amount not to exceed $ 250 million pursuant to an accordion provision. Borrowings under the $ 1.75 Billion Revolving Credit Facility will bear interest at LIBOR plus a margin, which will vary from 0.30 % to 1.30 %, based on the senior long-term unsecured debt ratings provided by Moody’s Investors Services Inc. and S&P Global Ratings. Bunge will also pay a fee that will vary from 0.10 % to 0.40 % based on its utilization of the Revolving Credit Facility.
At September 30, 2022, Bunge had $ 6,700 million unused and available committed borrowing capacity under committed revolving credit facilities and the commercial paper program, totaling $ 5,665 million, in addition to $ 1,250 million in committed unsecured delayed draw term loans, as discussed below. At December 31, 2021, Bunge had $ 5,815 million unused and available committed borrowing capacity under committed revolving credit facilities and the commercial paper program, totaling $ 5,565 million, in addition to $ 250 million in committed unsecured delayed draw term loans, as discussed below.
In addition to committed facilities, from time to time, Bunge Limited and/or its financing subsidiaries enter into uncommitted bilateral short-term credit lines as necessary based on financing requirements. At September 30, 2022, and December 31, 2021, there w ere $ 125 million in borrowings an d no b orrowings, respectively, outstanding under these bilateral short-term credit lines. Loans under such credit lines are non-callable by the respective lenders. In addition, Bunge's operating compani es had $ 987 million a nd $ 673 million in short-term borrowings outstanding under local bank lines of credit at September 30, 2022, and December 31, 2021 , respectively, to support working capital requirements.
34
Table of Contents
The fair value of Bunge’s long-term debt is based on interest rates currently available on comparable maturities to companies with credit standing similar to that of Bunge. The carrying amounts and fair value of long-term debt are as follows:
September 30, 2022 December 31, 2021
(US$ in millions) Carrying
Value 		Fair Value
(Level 2) 		Carrying
Value 		Fair Value
(Level 2)
Long-term debt, including current portion $ 3,770 $ 3,800 $ 5,291 $ 5,489
On February 23, 2022, Bunge issued a notice of redemption for all of the issued and outstanding 4.35 % unsecured senior notes (the " 4.35 % Senior Notes") due March 15, 2024. The redemption for the 4.35 % Senior Notes occurred on March 10, 2022. In connection with the redemption, during the nine months ended September 30, 2022, the Company recorded a $ 47 million charge within Interest expense, of which $ 31 million related to a "make-whole" provision based on the sum of the present values of the remaining scheduled payments of principal and interest on the 4.35 % Senior Notes, plus accrued and unpaid interest as of the March 10, 2022, redemption date, and $ 16 million related to the reclassification of unrealized mark-to-market losses on terminated and de-designated interest rate hedges.
On August 23, 2022, Bunge issued a notice of redemption for all of the issued and outstanding 3.00 % senior notes (the " 3.00 % Senior Notes") due September 25, 2022. The redemption for the 3.00 % Senior Notes occurred on September 7, 2022. In connection with the redemption, during the three and nine months ended September 30, 2022, the Company recorded a $ 405 million payment for redemption of the notes, at par, plus accrued and unpaid interest.
On July 26, 2022, and later amended on October 7, 2022, Bunge entered into an unsecured $ 750 million delayed draw term loan (the "$ 750 Million Delayed Draw Term Loan") with a group of lenders giving Bunge the option to draw the loan by January 25, 2023. The $ 750 Million Delayed Draw Term Loan will bear interest at SOFR plus a credit spread adjustment and applicable margin, as defined in the $ 750 Million Delayed Draw Term Loan agreement. The $ 750 Million Delayed Draw Term Loan matures on October 24, 2025.
On August 5, 2022, Bunge entered into an unsecured $ 250 million delayed draw term loan (the "$ 250 Million February 2023 Delayed Draw Term Loan") with a group of lenders that is required to be drawn by February 2, 2023. The $ 250 Million February 2023 Delayed Draw Term Loan will bear interest at SOFR plus a credit spread adjustment and applicable margin, as defined in the $ 250 Million February 2023 Delayed Draw Term Loan agreement. The $ 250 Million February 2023 Delayed Draw Term Loan matures on August 5, 2027.
On October 29, 2021, Bunge entered into an unsecured $ 250 million delayed draw term loan (the "$ 250 Million October 2022 Delayed Draw Term Loan") with a group of lenders that is required to be drawn by October 27, 2022. The $ 250 Million October 2022 Delayed Draw Term Loan will bear interest at SOFR plus a credit spread adjustment and applicable margin, as defined in the $ 250 Million October 2022 Delayed Draw Term Loan agreement. The $ 250 Million October 2022 Delayed Draw Term Loan matures on October 29, 2028, and was drawn on October 21, 2022.


15. RELATED PARTY TRANSACTIONS
Bunge purchases agricultural commodity products from certain of its unconsolidated investees and other related parties. Such related party purchases comprised approximately 6 % or less of total Cost of goods sold for the three and nine months ended September 30, 2022, and 2021. Bunge also sells agricultural commodity products to certain of its unconsolidated investees and other related parties. Such related party sales comprised approximately 2 % or less of total Net sales for the three and nine months ended September 30, 2022, and 2021.
In addition, Bunge receives services from and provides services to its unconsolidated investees and other related parties, including tolling, port handling, administrative support, and other services. For the three and nine months ended September 30, 2022, and 2021, such services were not material to the Company's consolidated results.
At September 30, 2022, and December 31, 2021, receivables related to the above related party transactions comprised approximately 1 % or less of total Trade accounts receivable. At September 30, 2022, and December 31, 2021, payables related to the above related party transactions comprised approximately 5 % or less of total Trade accounts payable.
Bunge believes all transaction values to be similar to those that would be conducted with third parties.

35
Table of Contents
16. COMMITMENTS AND CONTINGENCIES
Bunge is party to claims and lawsuits, primarily non-income tax and labor claims in South America, arising in the normal course of business. Bunge is also involved from time to time in various contract, antitrust, environmental litigation and remediation, and other litigation, claims, government investigations, and legal proceedings. The ability to predict the ultimate outcome of such matters involves judgments, estimates and inherent uncertainties. Bunge records liabilities related to legal matters when the exposure item becomes probable and can be reasonably estimated. Bunge management does not expect these matters to have a material adverse effect on Bunge’s financial condition, results of operations, or liquidity. However, these matters are subject to inherent uncertainties and there exists the remote possibility that a liability arising from these matters could have a material adverse impact in the period in which the uncertainties are resolved should the liability substantially exceed the amount of provisions included in the condensed consolidated balance sheets. Information regarding the claims appears in Bunge’s Report on Form 10-K for the year ended December 31, 2021. Included in Other non-current liabilities as of September 30, 2022, and December 31, 2021, are the following amounts related to these matters:
(US$ in millions) September 30,
2022 		December 31,
2021
Non-income tax claims $ 18 $ 15
Labor claims 73 72
Civil and other claims 99 95
Total $ 190 $ 182
Non-income tax claims
Brazil Indirect Taxes - These tax claims relate to ongoing claims against Bunge’s Brazilian subsidiaries, primarily value-added tax claims (ICMS, ISS, IPI and PIS/COFINS).
As of September 30, 2022, the Brazilian federal and state authorities have concluded examinations of the ICMS and PIS/COFINS tax returns and have issued outstanding claims. The Company continues to evaluate the merits of each of these claims and will recognize them when loss is considered probable. The outstanding claims comprise the following:
(US$ in millions) Years Examined September 30, 2022 December 31, 2021
ICMS 1990 to Present $ 198 $ 222
PIS/COFINS 2002 to Present $ 335 $ 228
36
Table of Contents
Labor claims
The labor claims are principally against Bunge’s Brazilian subsidiaries. The labor claims primarily relate to dismissals, severance, health and safety, salary adjustments, and supplementary retirement benefits.
Civil and other claims
The civil and other claims relate to various disputes with third parties, including suppliers and customers.
During the first quarter of 2017, Bunge received a notice from the Brazilian Administrative Council for Economic Defense ("CADE") initiating an administrative proceeding against its Brazilian subsidiary and two of its employees, certain of its former employees, and several other companies in the Brazilian wheat milling industry, and others for alleged anticompetitive activities in the north and northeast of Brazil. While a co-defendant obtained an injunction to stay the proceeding in 2019, on October 24, 2022, a Brazilian appellate court reversed that injunction and the proceeding has resumed before the Brazilian CADE.
Guarantees
Bunge has issued or was a party to the following guarantees at September 30, 2022:
(US$ in millions) Maximum
Potential
Future
Payments
Unconsolidated affiliates guarantee (1)
$ 241
Residual value guarantee (2)
301
Other guarantees 5
Total $ 547
(1)    Bunge has issued guarantees to certain financial institutions related to debt of certain of its unconsolidated affiliates. The terms of the guarantees are equal to the terms of the related financings, which have maturity dates through 2034. There are no recourse provisions or collateral that would enable Bunge to recover any amounts paid under these guarantees. In addition, certain Bunge subsidiaries have guaranteed the obligations of certain of their unconsolidated affiliates and in connection therewith have secured their guarantee obligation s through a pledge to the financial institutions of certain of their unconsolidated affiliates' shares plus loans receivable from the unconsolidated affiliates in the event that the guaranteed obligations are enforced. Based on amounts drawn under such debt facilities at September 30, 2022, Bunge's potential liability was $ 228 million, and it has recorded a $ 3 million obligation related to these guarantees within Other non-current liabilities.
(2)    Bunge has issued guarantees to certain financial institutions that are party to certain operating lease arrangements for railcars, barges, and buildings. These guarantees provide for a minimum residual value to be received by the lessor at the conclusion of the lease term. These leases expire at various dates from 2022 through 2029. At September 30, 2022, no obligation has been recorded related to these guarantees. Any obligation recorded would be recognized in Current operating lease obligations or Non-current operating lease obligations.
Bunge Limited has provided a guarantee to the Director of the Illinois Department of Agriculture as Trustee for Bunge North America, Inc. ("BNA"), an indirect wholly-owned subsidiary, which guarantees all amounts due and owing by BNA to grain producers and/or depositors in the State of Illinois who have delivered commodities to BNA’s Illinois facilities.

17. OTHER NON-CURRENT LIABILITIES
(US$ in millions) September 30,
2022 		December 31,
2021
Labor, legal, and other provisions $ 196 $ 187
Pension and post-retirement obligations (1)
207 227
Uncertain income tax positions (2)
65 73
Unrealized losses on derivative contracts, at fair value (3)
351 49
Other 99 122
Total $ 918 $ 658

(1) On February 28, 2022, the Company, together with plan participants and related employee unions, agreed to the transition of one of the Company's international defined benefit pension plans to a multi-employer pension plan.
37
Table of Contents
Following the transition, the Company accounts for the multi-employer plan similar to a defined contribution plan, resulting in full settlement of the related defined benefit plan obligations.
In connection with the settlement, during the nine months ended September 30, 2022, the Company recorded a $ 41 million pretax gain within Other income (expense) - net in its condensed consolidated statements of income, comprising a $ 4 million settlement of the related defined benefit plan obligations as well as the reclassification of $ 37 million in unamortized actuarial gains from Accumulated other comprehensive income (loss). Of this pretax gain, $ 12 million was attributable to Redeemable non-controlling interests.
(2) See Note 10- Income Taxes.
(3) See Note 12 - Fair Value Measurements.

18. REDEEMABLE NONCONTROLLING INTEREST
In connection with the acquisition of a 70 % ownership interest in Bunge Loders Croklaan Group B.V. ("Loders"), the Company entered into a put/call arrangement with the Loders minority shareholder through which it may be required or elect to purchase the additional 30 % ownership interest in Loders within a specified time frame.
Since the acquisition of the 70 % ownership in Loders, the Company classified these redeemable equity securities outside of permanent stockholders’ equity as the equity securities are redeemable at the option of the holder. The carrying amount of Redeemable noncontrolling interest was the greater of: (i) the initial carrying amount, increased or decreased for the noncontrolling interest's share of net income or loss, equity capital contributions and distributions or (ii) the redemption value. Any resulting increases in the redemption amount, in excess of the initial carrying amount, increased or decreased for the noncontrolling interest's share of net income or loss, equity capital contributions and distributions, were affected via a charge against Retained earnings. Additionally, any such charges to Retained earnings would affect Net income (loss) available to Bunge common shareholders as part of Bunge's calculation of earnings per common share.
On August 5, 2022, Bunge and the Loders minority shareholder completed a transaction in which Bunge acquired an additional 10 % interest in Loders in exchange for approximately $ 102 million in cash, and the existing put/call arrangement over Loders' noncontrolling equity interest was terminated. Bunge's ownership interest in Loders following the transaction increased from 70 % to 80 %. As Loders' remaining $ 235 million noncontrolling interest is no longer redeemable at the option of the holder, it was reclassified from Redeemable noncontrolling interest to Noncontrolling interests within Bunge's condensed consolidated balance sheet and condensed consolidated statement of changes in equity at a value representing the noncontrolling interest's proportionate share in the carrying value of Loders' net assets at the transaction date.

19. EQUITY
Cumulative Convertible Perpetual Preference Shares — On March 18, 2022, Bunge announced all issued and outstanding shares of its 4.875 % Cumulative Convertible Perpetual Preference Shares ("convertible preference shares") would automatically convert into common shares of the Company, par value $ 0.01 per share, effective March 23, 2022 (the "Conversion Date"). On March 18, 2022, the closing price of the common shares of the Company on the New York Stock Exchange ("NYSE") was $ 104.91 , marking the 20 th trading day in the previous 30 trading days that the closing price of the common shares of the Company exceeded 130 % of the conversion price, triggering the Company's right under the certificate of designation for the convertible preference shares, at its option, to mandatorily convert the convertible preference shares. The conversion price adjusted from $ 78.1322 , per Note 24 - Equity included in the Company's 2021 Annual Report on Form 10-K, to $ 77.8482 on February 16, 2022.
Each convertible preference share automatically converted into 1.2846 common shares of the Company on the Conversion Date and cash was paid in lieu of fractional common shares of the Company. There were 6,898,268 convertible preference shares issued and outstanding prior to the conversion, which resulted in the issuance of 8,861,515 new common shares of the Company. Additionally, in the first quarter of 2022, prior to the conversion, 1,415 convertible preference shares were voluntarily converted by preference shareholders into 1,816 common shares. As a result of the conversions, no convertible preference shares were issued or outstanding as of September 30, 2022, and all rights of the former holders of the convertible preference shares terminated, as of March 23, 2022.
38
Table of Contents
Dividends on the convertible preference shares ceased to accrue on the Conversion Date. Accordingly, holders of the convertible preference shares were not entitled to receive the $ 1.21875 per share dividend declared by the Company in respect of the convertible preference shares on February 23, 2022, and payable to holders of record on May 15, 2022. Following the conversion, holders of the convertible preference shares as of the Conversion Date were entitled to receive the $ 0.525 per share dividend declared by the Company with respect to the common shares on February 23, 2022, but only to the extent such holder remained a holder of record of common shares of the Company on May 19, 2022.
Share repurchase program — During October 2021, Bunge's Board of Directors approved a new program for the repurchase of up to $ 500 million of Bunge's issued and outstanding common shares. The program has no expiration date. Under this program, 2,109,115 common shares were repurchased for $ 200 million during the three and nine month periods ended September 30, 2022. As of September 30, 2022, $ 300 million remains outstanding for repurchases under the program.
During the three and nine month periods ended September 30, 2021, Bunge repurchased 1,298,384 common shares for $ 100 million, thereby completing a previous $ 500 million share repurchase program, established May 2015.
Dividends on common shares — On August 11, 2022, Bunge announced that the Company's Board of Directors had declared a dividend of $ 0.625 per common share, payable on December 2, 2022, to shareholders of record on November 18, 2022. During the nine months ended September 30, 2022, the Company's Board of Directors declared total dividends on common shares of $ 1.775 per common share.
Accumulated other comprehensive income (loss) attributable to Bunge — The following table summarizes the balances of related after-tax components of Accumulated other comprehensive income (loss) attributable to Bunge:
(US$ in millions) Foreign Exchange
Translation
Adjustment 		Deferred
Gains (Losses)
on Hedging
Activities 		Pension and Other
Postretirement
Liability
Adjustments 		Accumulated
Other
Comprehensive
Income (Loss)
Balance, July 1, 2022 $ ( 5,962 ) $ ( 331 ) $ ( 143 ) $ ( 6,436 )
Other comprehensive income (loss) before reclassifications ( 333 ) 32 — ( 301 )
Acquisition of redeemable noncontrolling interest ( 15 ) — — ( 15 )
Amount reclassified from accumulated other comprehensive income (loss) 158 ( 18 ) 1 141
Balance, September 30, 2022 $ ( 6,152 ) $ ( 317 ) $ ( 142 ) $ ( 6,611 )
(US$ in millions) Foreign Exchange
Translation
Adjustment 		Deferred
Gains (Losses)
on Hedging
Activities 		Pension and Other
Postretirement
Liability
Adjustments 		Accumulated
Other
Comprehensive
Income (Loss)
Balance, July 1, 2021 $ ( 5,771 ) $ ( 311 ) $ ( 176 ) $ ( 6,258 )
Other comprehensive income (loss) before reclassifications ( 222 ) 43 2 ( 177 )
Amount reclassified from accumulated other comprehensive income (loss) — ( 1 ) — ( 1 )
Balance, September 30, 2021 $ ( 5,993 ) $ ( 269 ) $ ( 174 ) $ ( 6,436 )
(US$ in millions) Foreign Exchange
Translation
Adjustment 		Deferred
Gains (Losses)
on Hedging
Activities 		Pension and Other
Postretirement
Liability
Adjustments 		Accumulated
Other
Comprehensive
Income (Loss)
Balance, January 1, 2022 $ ( 6,093 ) $ ( 254 ) $ ( 124 ) $ ( 6,471 )
Other comprehensive income (loss) before reclassifications ( 202 ) ( 38 ) — ( 240 )
Acquisition of redeemable noncontrolling interest ( 15 ) — — ( 15 )
Amount reclassified from accumulated other comprehensive income (loss) (1)
158 ( 25 ) ( 18 ) 115
Balance, September 30, 2022 $ ( 6,152 ) $ ( 317 ) $ ( 142 ) $ ( 6,611 )
39
Table of Contents
(1) On February 28, 2022, the Company, together with plan participants and related employee unions, agreed to the transition of one of the Company's international defined benefit pension plans to a multi-employer pension plan. Following the transition, the Company accounts for the multi-employer plan similar to a defined contribution plan, resulting in full settlement of the related defined benefit plan obligations.
In connection with the settlement, during the nine months ended September 30, 2022, the Company reclassified $ 27 million (net of $ 10 million tax expense) in unamortized actuarial gains from Accumulated other comprehensive income (loss), of which $ 19 million was attributable to Bunge (net of $ 7 million in tax expense), and $ 8 million was attributable to redeemable non-controlling interest (net of $ 3 million in tax expense).

(US$ in millions) Foreign Exchange
Translation
Adjustment 		Deferred
Gains (Losses)
on Hedging
Activities 		Pension and Other
Postretirement
Liability
Adjustments 		Accumulated
Other
Comprehensive
Income (Loss)
Balance, January 1, 2021 $ ( 5,857 ) $ ( 215 ) $ ( 174 ) $ ( 6,246 )
Other comprehensive income (loss) before reclassifications ( 136 ) ( 51 ) — ( 187 )
Amount reclassified from accumulated other comprehensive income (loss) — ( 3 ) — ( 3 )
Balance, September 30, 2021 $ ( 5,993 ) $ ( 269 ) $ ( 174 ) $ ( 6,436 )

20. EARNINGS PER COMMON SHARE
The following table sets forth the computation of basic and diluted earnings per common share.
Three Months Ended
September 30, 		Nine Months Ended
September 30,
(US$ in millions, except for share data) 2022 2021 2022 2021
Net income (loss) $ 383 $ 649 $ 1,304 $ 1,935
Net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests ( 3 ) 4 ( 30 ) ( 88 )
Net income (loss) attributable to Bunge $ 380 $ 653 $ 1,274 $ 1,847
Convertible preference share dividends (1)
— ( 8 ) — ( 25 )
Net income (loss) available to Bunge common shareholders - Basic $ 380 $ 645 $ 1,274 $ 1,822
Add back convertible preference share dividends — 8 — 25
Net income (loss) available to Bunge common shareholders - Diluted $ 380 $ 653 $ 1,274 $ 1,847
Weighted-average number of common shares outstanding:
Basic 150,560,803 141,433,651 148,321,921 141,108,272
Effect of dilutive shares:
—stock options and awards (2)
1,859,490 2,308,535 2,562,862 2,422,293
—convertible preference shares (1)
— 8,796,406 2,629,703 8,796,406
Diluted 152,420,293 152,538,592 153,514,486 152,326,971
Earnings per common share:
Net income (loss) attributable to Bunge common shareholders—basic $ 2.52 $ 4.56 $ 8.59 $ 12.91
Net income (loss) attributable to Bunge common shareholders—diluted $ 2.49 $ 4.28 $ 8.30 $ 12.12
(1) Effective March 23, 2022, (the "Conversion Date"), in accordance with the terms of the certificate of designation governing the convertible preference shares, all of the Company's issued and outstanding convertible preference shares were automatically converted into 1.2846 common shares of the Company, par value $ 0.01 per share. As a result of
40
Table of Contents
this conversion, dividends on the convertible preference shares ceased to accrue on the Conversion Date. Accordingly, holders of the convertible preference shares were not entitled to receive the $ 1.21875 per share dividend declared by the Company in respect of the convertible preference shares on February 23, 2022, and payable to holders of record on May 15, 2022, and no convertible preference shares were issued or outstanding as of September 30, 2022. Refer to Note 19 - Equity for further information.
(2) The weighted-average common shares outstanding-diluted exclude approximately zero and 2 million stock options and contingently issuable restricted stock units, which were not dilutive and not included in the computation of earnings per share for the three months ended September 30, 2022, and 2021, respectively.
The weighted-average common shares outstanding-diluted exclude approximately zero and 2 million stock options and contingently issuable restricted stock units, which were not dilutive and not included in the computation of earnings per share for the nine months ended September 30, 2022, and 2021, respectively.

21. SEGMENT INFORMATION
The Company's operations are organized, managed, and classified into four reportable segments - Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy, based upon their similar economic characteristics, products and services offered, production processes, types and classes of customer, and distribution methods. The Company’s remaining operations are not reportable segments, as defined by the applicable accounting standard, and are classified as Corporate and Other.
The Agribusiness reportable segment is characterized by both inputs and outputs being agricultural commodities and thus high volume and low margin. The Refined and Specialty Oils reportable segment involves the processing, production, and marketing of products derived from vegetable oils. The Milling reportable segment involves the processing, production, and marketing of products derived primarily from wheat and corn. The Sugar and Bioenergy reportable segment primarily comprises the net earnings in the Company’s 50 % interest in BP Bunge Bioenergia, a joint venture with BP p.l.c. ("BP").
Corporate and Other includes salaries and overhead for corporate functions that are not allocated to the Company’s individual reporting segments because the operating performance of each reporting segment is evaluated by the Company's chief operating decision maker exclusive of these items, as well as certain other activities, including Bunge Ventures, as well as the Company's captive insurance activities, securitization program, and certain income tax assets and liabilities.
Transfers between segments are generally valued at market. Segment revenues generated from these transfers are shown in the following table as “Inter-segment revenues.”
Three Months Ended September 30, 2022
(US$ in millions)
Agribusiness Refined and Specialty Oils Milling Sugar and
Bioenergy 		Corporate and Other Eliminations Total
Net sales to external customers $ 11,741 $ 4,302 $ 631 $ 74 $ 11 $ — $ 16,759
Inter–segment revenues 2,520 54 13 — — ( 2,587 ) —
Cost of goods sold ( 11,109 ) ( 4,070 ) ( 586 ) ( 72 ) ( 34 ) — ( 15,871 )
Gross profit 632 232 45 2 ( 23 ) — 888
Selling, general and administrative expenses ( 135 ) ( 86 ) ( 26 ) — ( 90 ) — ( 337 )
Foreign exchange gains (losses) ( 35 ) ( 6 ) — — ( 11 ) — ( 52 )
EBIT attributable to noncontrolling interests (1)
3 ( 3 ) ( 1 ) — — — ( 1 )
Other income (expense) - net 6 ( 9 ) 1 2 40 — 40
Income (loss) from affiliates 10 — — 20 — — 30
Total Segment EBIT (2)
481 128 19 24 ( 84 ) — 568
Total assets 17,193 4,190 1,058 360 1,991 — 24,792
41
Table of Contents
Three Months Ended September 30, 2021
(US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and
Bioenergy 		Corporate and Other Eliminations Total
Net sales to external customers $ 9,868 $ 3,648 $ 530 $ 69 $ 2 $ — $ 14,117
Inter–segment revenues 2,200 86 6 — — ( 2,292 ) —
Cost of goods sold ( 9,277 ) ( 3,430 ) ( 460 ) ( 67 ) ( 21 ) — ( 13,255 )
Gross profit 591 218 70 2 ( 19 ) — 862
Selling, general and administrative expenses ( 118 ) ( 83 ) ( 25 ) — ( 101 ) — ( 327 )
Foreign exchange gains (losses) ( 30 ) ( 1 ) ( 2 ) — ( 3 ) — ( 36 )
EBIT attributable to noncontrolling interests (1)
5 ( 2 ) — — 2 — 5
Other income (expense) - net 181 ( 2 ) — — 41 — 220
Income (loss) from affiliates 10 — — 51 ( 1 ) — 60
Total Segment EBIT (2)
639 130 43 53 ( 81 ) — 784
Total assets 16,177 4,091 1,352 207 2,282 — 24,109
Nine Months Ended September 30, 2022
(US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and
Bioenergy 		Corporate and Other Eliminations Total
Net sales to external customers $ 35,719 $ 12,723 $ 1,911 $ 195 $ 24 $ — $ 50,572
Inter–segment revenues 7,899 252 480 — — ( 8,631 ) —
Cost of goods sold ( 33,907 ) ( 11,904 ) ( 1,669 ) ( 189 ) ( 39 ) — ( 47,708 )
Gross profit 1,812 819 242 6 ( 15 ) — 2,864
Selling, general and administrative expenses ( 375 ) ( 262 ) ( 78 ) ( 1 ) ( 263 ) — ( 979 )
Foreign exchange gains (losses) ( 119 ) ( 14 ) 2 — ( 19 ) — ( 150 )
EBIT attributable to noncontrolling interests (1)
( 14 ) ( 7 ) ( 1 ) — ( 11 ) — ( 33 )
Other income (expense) - net ( 71 ) ( 17 ) 2 2 71 — ( 13 )
Income (loss) from affiliates 41 — ( 1 ) 56 ( 1 ) — 95
Total Segment EBIT (2)
1,274 519 166 63 ( 238 ) — 1,784
Total assets 17,193 4,190 1,058 360 1,991 — 24,792
Nine Months Ended September 30, 2021
(US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and
Bioenergy 		Corporate and Other Eliminations Total
Net sales to external customers $ 31,312 $ 9,572 $ 1,392 $ 190 $ 3 $ — $ 42,469
Inter–segment revenues 5,711 313 114 — — ( 6,138 ) —
Cost of goods sold ( 29,425 ) ( 8,924 ) ( 1,231 ) ( 187 ) ( 28 ) — ( 39,795 )
Gross profit 1,887 648 161 3 ( 25 ) — 2,674
Selling, general and administrative expenses ( 313 ) ( 259 ) ( 73 ) ( 1 ) ( 250 ) — ( 896 )
Foreign exchange gains (losses) ( 1 ) 1 ( 2 ) — ( 9 ) — ( 11 )
EBIT attributable to noncontrolling interests (1)
( 6 ) ( 85 ) ( 1 ) — 2 — ( 90 )
Other income (expense) - net 227 236 — 1 55 — 519
Income (loss) from affiliates 44 — — 89 — — 133
Total Segment EBIT (2)
1,838 541 85 92 ( 227 ) — 2,329
Total assets 16,177 4,091 1,352 207 2,282 — 24,109
42
Table of Contents
(1) Include noncontrolling interests' share of interest and tax with EBIT attributable to noncontrolling interests in order to reconcile to consolidated Net (income) loss attributable to noncontrolling interests and redeemable noncontrolling interests.
(2) Total segment earnings before interest and taxes ("EBIT") is an operating performance measure used by Bunge’s management to evaluate segment operating activities. Bunge’s management believes Total Segment EBIT is a useful measure of operating profitability, since the measure allows for an evaluation of the performance of its segments without regard to its financing methods or capital structure. In addition, Total Segment EBIT is a financial measure that is widely used by analysts and investors in Bunge’s industry. Total Segment EBIT is a non-GAAP financial measure and is not intended to replace Net income (loss) attributable to Bunge, the most directly comparable U.S. GAAP financial measure. Further, Total Segment EBIT is not a measure of consolidated operating results under U.S. GAAP and should not be considered as an alternative to Net income (loss) or any other measure of consolidated operating results under U.S. GAAP. See the reconciliation of Total Segment EBIT to Net income (loss) attributable to Bunge in the table below.
A reconciliation of Net income (loss) attributable to Bunge to Total Segment EBIT follows:
Three Months Ended
September 30, 		Nine Months Ended
September 30,
(US$ in millions) 2022 2021 2022 2021
Net income (loss) attributable to Bunge $ 380 $ 653 $ 1,274 $ 1,847
Interest income ( 30 ) ( 19 ) ( 50 ) ( 34 )
Interest expense 103 57 306 184
Income tax expense (benefit) 113 92 257 334
Noncontrolling interests' share of interest and tax 2 1 ( 3 ) ( 2 )
Total Segment EBIT from continuing operations $ 568 $ 784 $ 1,784 $ 2,329
The Company’s Net sales comprise sales from commodity contracts accounted for under ASC 815, Derivatives and Hedging (ASC 815) and sales of other products and services accounted for under ASC 606, Revenue from Contracts with Customers (ASC 606). The following tables provide a disaggregation of Net sales to external customers between sales from contracts with customers and sales from other arrangements:
Three Months Ended September 30, 2022
(US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and
Bioenergy 		Corporate and Other Total
Sales from other arrangements $ 10,900 $ 333 $ 26 $ 72 $ — $ 11,331
Sales from contracts with customers 841 3,969 605 2 11 5,428
Net sales to external customers $ 11,741 $ 4,302 $ 631 $ 74 $ 11 $ 16,759
Three Months Ended September 30, 2021
(US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and
Bioenergy 		Corporate and Other Total
Sales from other arrangements $ 9,081 $ 296 $ — $ 67 $ — $ 9,444
Sales from contracts with customers 787 3,352 530 2 2 4,673
Net sales to external customers $ 9,868 $ 3,648 $ 530 $ 69 $ 2 $ 14,117
43
Table of Contents
Nine Months Ended September 30, 2022
(US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and
Bioenergy 		Corporate and Other Total
Sales from other arrangements $ 33,396 $ 963 $ 135 $ 191 $ — $ 34,685
Sales from contracts with customers 2,323 11,760 1,776 4 24 15,887
Net sales to external customers $ 35,719 $ 12,723 $ 1,911 $ 195 $ 24 $ 50,572
Nine Months Ended September 30, 2021
(US$ in millions) Agribusiness Refined and Specialty Oils Milling Sugar and
Bioenergy 		Corporate and Other Total
Sales from other arrangements $ 29,568 $ 725 $ — $ 186 $ — $ 30,479
Sales from contracts with customers 1,744 8,847 1,392 4 3 11,990
Net sales to external customers $ 31,312 $ 9,572 $ 1,392 $ 190 $ 3 $ 42,469

44
Table of Contents
Cautionary Statement Regarding Forward Looking Statements
This report contains both historical and forward looking statements. All statements, other than statements of historical fact are, or may be deemed to be, forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (Exchange Act). These forward looking statements are not based on historical facts, but rather reflect our current expectations and projections about our future results, performance, prospects and opportunities. We have tried to identify these forward looking statements by using words including “may,” “will,” “should,” “could,” “expect,” “anticipate,” “believe,” “plan,” “intend,” “estimate,” “continue” and similar expressions. These forward looking statements are subject to a number of risks, uncertainties, assumptions and other factors that could cause our actual results, performance, prospects or opportunities to differ materially from those expressed in, or implied by, these forward looking statements. These factors include the risks, uncertainties, trends and other factors described in our Form 10-K, Form 10-Q, and Form 8-K reports (including all amendments to those reports) and include: the impact on our employees, operations, and facilities from the war in Ukraine and the resulting economic and other sanctions imposed on Russia, including the impact on Bunge resulting from the continuation and/or escalation of the war and sanctions against Russia; the ongoing impacts of the COVID-19 pandemic and other pandemic outbreaks; the effect of weather conditions and the impact of crop and animal disease on our business; the impact of global and regional economic, agricultural, financial and commodities market, political, social and health conditions; changes in governmental policies and laws affecting our business, including agricultural and trade policies, financial markets regulation and environmental, tax and biofuels regulation; the impact of seasonality; the impact of government policies and regulations; the outcome of pending regulatory and legal proceedings; our ability to complete, integrate and benefit from acquisitions, divestitures, joint ventures and strategic alliances; the impact of industry conditions, including fluctuations in supply, demand and prices for agricultural commodities and other raw materials and products that we sell and use in our business, fluctuations in energy and freight costs and competitive developments in our industries; the effectiveness of our capital allocation plans, funding needs and financing sources; the effectiveness of our risk management strategies; operational risks, including industrial accidents, natural disasters and cybersecurity incidents; changes in foreign exchange policy or rates; the impact of our dependence on third parties; our ability to attract and retain executive management and key personnel; and other factors affecting our business generally.
The forward looking statements included in this report are made only as of the date of this report, and except as otherwise required by federal securities law, we do not have any obligation to publicly update or revise any forward looking statements to reflect subsequent events or circumstances.
You should refer to “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on February 24, 2022, and “Part II — Item 1A. Risk Factors” in this Quarterly Report on Form 10-Q for a more detailed discussion of these factors.
45
Table of Contents


ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Third Quarter 2022 Overview
You should refer to "Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations - Factors Affecting Operating Results" in our Annual Report on Form 10-K for the year ended December 31, 2021, for a discussion of key factors affecting operating results in each of our business segments. In addition, you should refer to "Item 9A, Controls and Procedures" in our Annual Report on Form 10-K for the year ended December 31, 2021, and to "Item 4, Controls and Procedures" in this Quarterly Report on Form 10-Q for the period ended September 30, 2022, for a discussion of our internal controls over financial reporting.
Non-U.S. GAAP Financial Measures
Total segment earnings before interest and taxes ("EBIT") is an operating performance measure used by Bunge’s management to evaluate segment operating activities. Bunge also uses Core Segment EBIT, Non-core Segment EBIT and Total Segment EBIT to evaluate the operating performance of Bunge’s Core reportable segments, Non-core reportable segments, and Total reportable segments together with our Corporate and Other activities. Core Segment EBIT is the aggregate of the earnings before interest and taxes of each of Bunge’s Agribusiness, Refined and Specialty Oils, and Milling segments. Non-core Segment EBIT is the earnings before interest and taxes of Bunge’s Sugar & Bioenergy segment. Total Segment EBIT is the aggregate of the earnings before interest and taxes of Bunge’s Core and Non-core reportable segments, together with its corporate and other activities. Bunge’s management believes Core Segment EBIT, Non-core Segment EBIT and Total Segment EBIT are useful measures of operating profitability since the measures allow for an evaluation of the performance of its segments without regard to financing methods or capital structure. In addition, EBIT is a financial measure that is widely used by analysts and investors in Bunge’s industry. Total Segment EBIT is a non-U.S. GAAP financial measure and is not intended to replace Net income (loss) attributable to Bunge, the most directly comparable U.S. GAAP financial measure. Further, Total Segment EBIT excludes EBIT attributable to noncontrolling interests and is not a measure of consolidated operating results under U.S. GAAP and should not be considered as an alternative to Net income (loss) or any other measure of consolidated operating results under U.S. GAAP. See the reconciliation of Net income (loss) attributable to Bunge to Total Segment EBIT below.
Cash provided by (used for) operating activities, adjusted is calculated by including the Proceeds from beneficial interests in securitized trade receivables with Cash provided by (used for) operating activities. Cash provided by (used for) operating activities, adjusted is a non-GAAP financial measure and is not intended to replace Cash provided by (used for) operating activities, the most directly comparable U.S. GAAP financial measure. Our management believes presentation of this measure allows investors to view our cash generating performance using the same measure that management uses in evaluating financial and business performance and trends.
Executive Summary
Net Income (Loss) Attributable to Bunge - For the three months ended September 30, 2022, Net income attributable to Bunge was $380 million, a decrease of $273 million compared to $653 million for the three months ended September 30, 2021. For the nine months ended September 30, 2022, Net income attributable to Bunge was $1,274 million, a decrease of $573 million, compared to $1,847 million for the nine months ended September 30, 2021. The decreases for the three and nine months ended September 30, 2022, were due to lower Segment EBIT in our Core segments, Non-core segment, and Corporate and Other activities, as further discussed in the Segment Overview & Results of Operations section below.
Earnings Per Common Share - Diluted - For the three months ended September 30, 2022, Net income attributable to Bunge common shareholders, diluted, was $2.49 per share, a decrease of $1.79 per share, compared to income of $4.28 per share for the three months ended September 30, 2021. For the nine months ended September 30, 2022, Net income attributable to Bunge common shareholders, diluted, was $8.30 per share, a decrease of $3.82 per share, compared to income of $12.12 per share for the nine months ended September 30, 2021.
EBIT - For the three months ended September 30, 2022, Total Segment EBIT was $568 million, a decrease of $216 million compared to Total Segment EBIT of $784 million for the three months ended September 30, 2021. For the nine months ended September 30, 2022, Total Segment EBIT was $1,784 million, a decrease of $545 million compared to Total Segment EBIT of $2,329 million for the nine months ended September 30, 2021. The decreases in Total Segment EBIT for the three and nine months ended September 30, 2022, were due to lower Segment EBIT in our Core segments, Non-core
46
Table of Contents
segment, and Corporate and Other activities, as further discussed in the Segment Overview & Results of Operations section below.
Income Tax (Expense) Benefit - Income tax expense was $113 million for the three months ended September 30, 2022 compared to income tax expense of $92 million for the three months ended September 30, 2021. The increase was primarily due to unfavorable tax impacts on North American dispositions and expected European dispositions. Income tax expense was $257 million for the nine months ended September 30, 2022 compared to $334 million for the nine months ended September 30, 2021. The decrease was primarily due to lower pretax income.
Liquidity and Capital Resources – At September 30, 2022, working capital, which equals Total current assets less Total current liabilities, was $6,628 million, a decrease of $147 million, compared to working capital of $6,775 million at September 30, 2021, and a decrease of $508 million, compared to working capital of $7,136 million at December 31, 2021. The decreases in working capital at September 30, 2022, compared to September 30, 2021, and December 31, 2021, were primarily due to lower net assets held for sale following the completion of the sale of our Mexican wheat milling business, as well as an increase in the current portion of long-term debt due to the reclassification from long-term debt of the current portion of our 1.85% Senior Notes, due 2023.
Segment Overview & Results of Operations
Our operations are organized, managed and classified into four reportable segments based upon their similar economic characteristics, nature of products and services offered, production processes, types and classes of customer, and distribution methods. We further organize these reportable segments into Core operations and Non-core operations. Core operations comprise our Agribusiness, Refined and Specialty Oils, and Milling segments. Non-core operations comprise our Sugar & Bioenergy segment, which itself primarily comprises the Company’s 50% interest in the net earnings of BP Bunge Bioenergia, a joint venture with BP p.l.c. ("BP").
Our remaining operations are not reportable segments, as defined by the applicable accounting standard, and are classified as Corporate and Other. Corporate and Other includes salaries and overhead for corporate functions that are not allocated to our individual reportable segments because the operating performance of each reportable segment is evaluated by the Company's chief operating decision maker exclusive of these items, as well as certain other activities including Bunge Ventures, the Company's captive insurance activities and securitization program, as well as certain income tax assets and liabilities.
Effective January 1, 2022, we changed our methodology for reporting volumetric data for our reportable segments to simplify and more closely align our volume reporting with our primary income-generating activities. The primary change comprises the elimination of grain and oilseed volumes originated from our suppliers. Volumes are now reported as follows:
• In our Agribusiness segment, reported Processing volumes comprise oilseed volumes crushed (processed) during a period, which approximate sales volumes to third parties during the same period. Reported Merchandising volumes represent sales volumes to third party customers.
• Refined and Specialty Oils segment volumes represent sales volumes to third party customers.
• Milling segment volumes represent feedstock ground (processed) during a period, again approximating sales volumes during the same period.
• No volumes are reported for our Sugar and Bioenergy segment, which primarily comprises the Company's net earnings from its 50% interest in BP Bunge Bioenergia, or our Corporate and Other activities, which have no material revenue-generating activities.
Certain reclassifications of prior period volumes have been made to conform to current presentation.

47
Table of Contents
A reconciliation of Net income (loss) attributable to Bunge to Total Segment EBIT follows:
Three Months Ended
September 30, 		Nine Months Ended
September 30,
(US$ in millions) 2022 2021 2022 2021
Net income (loss) attributable to Bunge $ 380 $ 653 $ 1,274 $ 1,847
Interest income (30) (19) (50) (34)
Interest expense 103 57 306 184
Income tax expense (benefit) 113 92 257 334
Noncontrolling interests' share of interest and tax 2 1 (3) (2)
Total Segment EBIT $ 568 $ 784 $ 1,784 $ 2,329
Agribusiness Segment EBIT 481 639 1,274 1,838
Refined and Specialty Oils Segment EBIT 128 130 519 541
Milling Segment EBIT 19 43 166 85
Core Segment EBIT 628 812 1,959 2,464
Corporate and Other EBIT (84) (81) (238) (227)
Sugar and Bioenergy Segment EBIT 24 53 63 92
Non Core Segment EBIT 24 53 63 92
Total Segment EBIT $ 568 $ 784 $ 1,784 $ 2,329

Core Segments

Agribusiness Segment
Three Months Ended
September 30, 		Nine Months Ended
September 30,
(US$ in millions, except volumes) 2022 2021 2022 2021
Volumes (in thousand metric tons) 19,622 19,534 59,182 62,827
Net sales $ 11,741 $ 9,868 $ 35,719 $ 31,312
Cost of goods sold (11,109) (9,277) (33,907) (29,425)
Gross profit 632 591 1,812 1,887
Selling, general and administrative expense (135) (118) (375) (313)
Foreign exchange gains (losses) (35) (30) (119) (1)
EBIT attributable to noncontrolling interests 3 5 (14) (6)
Other income (expense) – net 6 181 (71) 227
Income (loss) from affiliates 10 10 41 44
Total Agribusiness Segment EBIT $ 481 $ 639 $ 1,274 $ 1,838

Three Months Ended September 30, 2022 Compared to Three Months Ended September 30, 2021
Agribusiness segment Net sales increased $1,873 million, or 19%, to $11,741 million for the three months ended September 30, 2022, compared to $9,868 million for the three months ended September 30, 2021. The net increase was primarily due to the following:
• In Processing, Net sales increased $1,371 million, primarily due to higher average sales prices in all regions, higher volumes in our North American soybean and softseed processing, and South American soybean processing
48
Table of Contents
businesses, partially offset by lower volumes in our European soybean and softseed processing businesses. The higher average sales prices result from higher global commodity prices following the onset of the Ukraine-Russia war, which exacerbated an already tight commodity supply environment. The higher volumes in our North and South American stem from continued strong oil and meal demand. The lower volumes in our European softseed processing business stems from reduced activity at our Ukrainian facilities as a result of the Ukraine-Russia war.

• In Merchandising, Net sales increased $502 million, primarily due to higher average sales prices in our global corn, wheat and oils businesses, resulting from higher global commodity prices following the onset of the Ukraine-Russia war, which exacerbated an already tight commodity supply environment. The above increases were partially offset by lower overall sales volumes, again due to the Ukraine-Russia war.
Cost of goods sold increased $1,832 million, or 20%, to $11,109 million for the three months ended September 30, 2022, compared to $9,277 million for the three months ended September 30, 2021. The net increase was primarily due to the following:
• In Processing, Cost of goods sold increased $1,186 million, primarily due to higher average commodity prices, as noted in Net sales above, increased industrial input costs, in particular energy, due to inflationary pressures, as well as a non-recurring impairment charge of $21 million related to the classification of our Russian oilseed processing business as held-for-sale in the current period, partially offset by more favorable mark-to-market results.
• In Merchandising, Cost of goods sold increased $646 million, primarily due to the higher average commodity prices, as noted in Net sales above, as well as less favorable mark-to-market results.
Gross profit increased $41 million, or 7%, to $632 million for the three months ended September 30, 2022, compared to $591 million for the three months ended September 30, 2021. The net increase was primarily due to the following:
• In Processing, an increase of $185 million was due to higher Net sales in excess of higher Cost of goods sold, primarily driven by more favorable mark-to-market results, as described above.
• In Merchandising, a decrease of $144 million was due to higher Cost of goods sold in excess of higher Net sales, primarily driven by less favorable mark-to-market results, as described above.
Selling, general and administrative ("SG&A") expenses increased $17 million, or 14%, to $135 million for the three months ended September 30, 2022, compared to $118 million for the three months ended September 30, 2021. The increase was primarily driven by increased bad debt expense in the current period .
Other income (expense) - net decreased $175 million, to income of $6 million for the three months ended September 30, 2022, compared to income of $181 million for the three months ended September 30, 2021. The decrease was primarily due to a $7 million mark-to-market loss on marketable securities and other short-term investments with exposures to Ukraine, following the onset of the Ukraine-Russia war, a $158 million prior period gain on sale of a portfolio of interior grain elevators in the United States.
Segment EBIT decreased $158 million, or 25%, to $481 million for the three months ended September 30, 2022, compared to $639 million for the three months ended September 30, 2021. The net decrease was primarily due to the following:
• In Processing, an increase of $46 million was primarily due to higher Gross profit, partially offset by higher SG&A, and lower Other income (expense) - net, as described above.
• In Merchandising, a decrease of $204 million was primarily due to lower Gross profit, higher SG&A, and lower Other income (expense) - net, as described above.

49
Table of Contents

Nine Months Ended September 30, 2022 Compared to Nine Months Ended September 30, 2021
Agribusiness segment Net sales increased by $4,407 million, or 14%, to $35,719 million for the nine months ended September 30, 2022, compared to $31,312 million for the nine months ended September 30, 2021. The net increase was primarily due to the following:
• In Processing, Net sales increased $3,039 million, primarily due to higher average sales prices in our soybean processing businesses in all regions, and in our European softseed processing businesses. These price increases primarily resulted from higher global commodity prices following the onset of the Ukraine-Russia war, which exacerbated an already tight commodity supply environment. Additionally, higher sales volumes in North and South America were driven by strong oil and meal demand. The above increases were partially offset by lower sales volumes in our European softseed processing businesses, due to reduced activity at our Ukrainian facilities as a result of the Ukraine-Russia war.
• In Merchandising, Net sales increased $1,368 million, primarily due to higher average sales prices in our global wheat, corn, and oil businesses, as a result of higher global commodity prices following the onset of the Ukraine-Russia war, which exacerbated an already tight commodity supply environment. Additional sales increases were driven by strong execution and higher prices in our ocean freight business. The above increases were partially offset by lower sales volumes in our global corn, wheat, and oil businesses, as a result of the Ukraine-Russia war, and the completion of the sale of a portfolio of grain elevators in the interior of the United States during the third quarter of 2021.
Cost of goods sold increased by $4,482 million, or 15%, to $33,907 million for the nine months ended September 30, 2022, compared to $29,425 million for the nine months ended September 30, 2021. The net increase was primarily due to the following:
• In Processing, Cost of goods sold increased $3,188 million, primarily due to higher average commodity prices, as noted in Net sales above, increased industrial input costs, in particular energy, due to inflationary pressures, unfavorable mark-to-market results, as well as $52 million in charges for losses sustained in relation to the Ukraine-Russia war, and a $21 million non-recurring impairment charge related to the classification of our Russian business as held-for-sale in the current period.
• In Merchandising, Cost of goods sold increased $1,294 million, primarily due to the higher average commodity prices, as noted in Net sales above, as well as $28 million in charges for losses sustained in relation to the Ukraine-Russia war, partially offset by more favorable mark-to-market results, and lower volumes due to the completion of the sale of a portfolio of grain elevators in the interior of the United States during the third quarter of 2021.
Gross profit decreased by $75 million, or 4%, to $1,812 million for the nine months ended September 30, 2022, compared to $1,887 million for the nine months ended September 30, 2021. The net decrease was primarily due to the following:
• In Processing, a decrease of $149 million was due to higher Cost of goods sold in excess of higher Net sales, primarily driven by higher industrial input costs, in particular energy, due to inflationary pressures, unfavorable mark-to-market results, as well as certain non-recurring charges, as described above.
• In Merchandising, an increase of $74 million was due to higher Net sales in excess of higher Cost of goods sold, primarily driven by strong execution and higher prices in our ocean freight business and more favorable mark-to-market results.
SG&A increased by $62 million, or 20%, to $375 million for the nine months ended September 30, 2022, compared to $313 million for the nine months ended September 30, 2021. The increase was primarily driven by increased variable incentive costs and increased bad debt expense in the current period .
Foreign exchange results decreased $118 million to a loss of $119 million for the nine months ended September 30, 2022, compared to a loss of $1 million for the nine months ended September 30, 2021. Foreign exchange results were primarily driven by losses on U.S. dollar denominated loans payable in non-U.S. functional currency operations during the second and third quarter, due to a strengthening U.S. dollar.
Other income (expense) - net decreased by $298 million, or 131%, to expense of $71 million for the nine months ended September 30, 2022, compared to income of $227 million for the nine months ended September 30, 2021. The
50
Table of Contents
decrease was primarily due to a $76 million mark-to-market loss on marketable securities and other short-term investments with exposures to Ukraine, following the onset of the Ukraine-Russia war, as well as a $158 million prior year gain on sale of a portfolio of interior grain elevators in the United States.
Segment EBIT decreased by $564 million, or 31%, to $1,274 million for the nine months ended September 30, 2022, compared to $1,838 million for the nine months ended September 30, 2021. The net decrease was primarily due to the following:
• In Processing, a decrease of $457 million was primarily due to lower Gross profit, higher SG&A, lower Foreign exchange results, and lower Other income (expense) - net, as described above.
• In Merchandising, a decrease of $107 million was primarily due to higher SG&A, lower Foreign exchange results, and lower Other income (expense) - net, which more than offset higher Gross profit, as described above.

Refined and Specialty Oils Segment
Three Months Ended
September 30, 		Nine Months Ended
September 30,
(US$ in millions, except volumes) 2022 2021 2022 2021
Volumes (in thousand metric tons) 2,316 2,383 6,941 6,802
Net sales $ 4,302 $ 3,648 $ 12,723 $ 9,572
Cost of goods sold (4,070) (3,430) (11,904) (8,924)
Gross profit 232 218 819 648
Selling, general and administrative expense (86) (83) (262) (259)
Foreign exchange gains (losses) (6) (1) (14) 1
EBIT attributable to noncontrolling interests (3) (2) (7) (85)
Other income (expense) – net (9) (2) (17) 236
Income (loss) from affiliates — — — —
Total Refined and Specialty Oils Segment EBIT $ 128 $ 130 $ 519 $ 541

Three Months Ended September 30, 2022 Compared to Three Months Ended September 30, 2021
Refined and Specialty Oils segment Net sales increased $654 million, or 18%, to $4,302 million for the three months ended September 30, 2022, compared to $3,648 million for the three months ended September 30, 2021. The increase was primarily due to higher average sales prices in all regions, driven by strong food services demand as well as strong oil demand for use as renewable feedstock.
Cost of goods sold increased $640 million, or 19%, to $4,070 million for the three months ended September 30, 2022, compared to $3,430 million for the three months ended September 30, 2021. The increase was primarily due to higher average commodity prices in all regions, as described for Net sales above, a non-recurring impairment charge of $55 million related to the classification of our Russian oilseed and processing business as held-for-sale in the current period, accelerated depreciation in relation to our Wormerveer facility located in the Netherlands, which we announced during the fourth quarter of 2021 would be closing in 2025, and increased industrial input costs, in particular energy, during the current year.
Gross profit for the three months ended September 30, 2022, increased $14 million, or 6%, to $232 million, compared to $218 million for the three months ended September 30, 2021. The increase was due to increased Net sales in excess of increased Cost of goods sold, primarily driven by strong food services demand and strong oil demand for use as renewable feedstock, partially offset by the non-recurring impairment charge, accelerated depreciation, and higher industrial input costs, described above.
Segment EBIT decreased $2 million, or 2%, to $128 million for the three months ended September 30, 2022, compared to $130 million for the three months ended September 30, 2021. The decrease was primarily due to higher SG&A expenses and lower Foreign exchange results, partially offset by higher gross profit, as described above.

51
Table of Contents
Nine Months Ended September 30, 2022 Compared to Nine Months Ended September 30, 2021
Refined and Specialty Oils segment Net sales increased $3,151 million, or 33%, to $12,723 million for the nine months ended September 30, 2022, compared to $9,572 million for the nine months ended September 30, 2021, primarily due to higher average sales prices in all regions, driven by strong oil demand for use as renewable feedstock as well as strong food services demand.
Cost of goods sold increased by $2,980 million, or 33%, to $11,904 million for the nine months ended September 30, 2022, compared to $8,924 million for the nine months ended September 30, 2021. The increase in Cost of goods sold was primarily due to higher average commodity prices in all regions, as described for Net sales above, a non-recurring impairment charge of $55 million related to the classification of our Russian oilseed and processing business as held-for-sale in the current period, unfavorable mark-to-market results, accelerated depreciation in relation to our Wormerveer facility located in the Netherlands, which we announced during the fourth quarter of 2021 would be closing in 2025, and increased industrial input costs, in particular energy, during the current year.
Gross profit increased by $171 million, or 26%, to $819 million for the nine months ended September 30, 2022, compared to $648 million for the nine months ended September 30, 2021. The increase was due to increased Net sales in excess of increased Cost of goods sold, primarily driven by strong oil demand for use as renewable feedstock, and in food services, as described above.
EBIT attributable to noncontrolling interests, an expense when subsidiaries with noncontrolling interests generate earnings before interest and tax, versus income when subsidiaries with noncontrolling interests generate loss before interest and tax, decreased by $78 million, to an expense of $7 million in the nine months ended September 30, 2022, compared to an expense of $85 million in the nine months ended September 30, 2021. The decrease was primarily due to the large noncontrolling interest share of a gain on the sale of our Rotterdam oils refinery in the prior year.
Other income (expense), net decreased $253 million to expense of $17 million for the nine months ended September 30, 2022, compared to income of $236 million for the nine months ended September 30, 2021. The prior year income primarily related to a $219 million gain on the sale of our Rotterdam oils refinery located in the Netherlands, as well as a $19 million gain on the sale of a Mexican oils packaging facility.
Segment EBIT decreased by $22 million, or 4%, to $519 million for the nine months ended September 30, 2022, compared to $541 million for the nine months ended September 30, 2021. The decrease was due to non-recurring prior year gains on sales of our oils facilities in the Netherlands and Mexico, as noted in Other income (expense) - net above, partially offset by higher Gross profit and lower EBIT attributable to noncontrolling interests, as described above.


52
Table of Contents
Milling Segment

Three Months Ended
September 30, 		Nine Months Ended
September 30,
(US$ in millions, except volumes) 2022 2021 2022 2021
Volumes (in thousand metric tons) 1,234 1,190 3,537 3,351
Net sales $ 631 $ 530 $ 1,911 $ 1,392
Cost of goods sold (586) (460) (1,669) (1,231)
Gross profit 45 70 242 161
Selling, general and administrative expense (26) (25) (78) (73)
Foreign exchange gains (losses) — (2) 2 (2)
EBIT attributable to noncontrolling interests (1) — (1) (1)
Other income (expense) – net 1 — 2 —
Income (loss) from affiliates — — (1) —
Total Milling Segment EBIT $ 19 $ 43 $ 166 $ 85

Three Months Ended September 30, 2022 Compared to Three Months Ended September 30, 2021

Milling segment Net sales increased $101 million, or 19%, to $631 million for the three months ended September 30, 2022, compared to $530 million for the three months ended September 30, 2021. The increase was primarily due to higher sales volumes and prices in our South American wheat milling business and in our North American corn milling business, due to an increase in global commodity prices following the onset of the Ukraine-Russia war, which exacerbated an already tight commodity supply environment.
Cost of goods sold increased $126 million, or 27%, to $586 million for the three months ended September 30, 2022, compared to $460 million for the three months ended September 30, 2021. The increase was primarily due to increased average commodity prices, as described for Net sales above, as well as increased industrial input costs, in particular energy, and less favorable mark-to-market results.
Gross profit decreased $25 million, or 36%, to $45 million for the three months ended September 30, 2022, compared to $70 million for the three months ended September 30, 2021. The decrease was primarily due to higher raw material cost increases and less favorable mark-to-market results, which more than offset higher sales volumes and prices in our South American wheat milling and North American corn milling businesses, as described above.
Segment EBIT decreased $24 million, or 56%, to $19 million for the three months ended September 30, 2022, compared to $43 million for the three months ended September 30, 2021. The decrease was primarily due to lower gross profit as described above.

Nine Months Ended September 30, 2022 Compared to Nine Months Ended September 30, 2021
Milling segment Net sales increased by $519 million, or 37%, to $1,911 million for the nine months ended September 30, 2022, compared to $1,392 million for the nine months ended September 30, 2021. The increase was primarily due to higher sales volumes and prices in our South American wheat milling and North American corn milling businesses, due to an increase in global commodity prices following the onset of the Ukraine-Russia war, which exacerbated an already tight commodity supply environment, partially offset by lower volumes in our North American wheat milling business.
Cost of goods sold increased by $438 million, or 36%, to $1,669 million for the nine months ended September 30, 2022, compared to $1,231 million for the nine months ended September 30, 2021. The increase was primarily due to increased average commodity prices, as described for Net sales above, as well as increased industrial input costs, in particular energy, and unfavorable mark-to-market results.
Gross profit increased by $81 million, or 50%, to $242 million for the nine months ended September 30, 2022, compared to $161 million for the nine months ended September 30, 2021. The increase was primarily due to higher sales
53
Table of Contents
volumes and prices, in excess of related raw material cost increases, especially in our South American wheat milling business, as described above.
SG&A expenses increased by $5 million, or 7%, to $78 million for the nine months ended September 30, 2022, compared to $73 million for the nine months ended September 30, 2021. The increase was due to higher variable incentive costs, as well as higher costs in South America as a result of appreciation in the Brazilian real versus the U.S. dollar during the first half of the year.
Segment EBIT increased by $81 million, or 95%, to $166 million for the nine months ended September 30, 2022, compared to $85 million for the nine months ended September 30, 2021. The increase was primarily due to higher gross profit, as described above.

Corporate and Other
Three Months Ended
September 30, 		Nine Months Ended
September 30,
(US$ in millions, except volumes) 2022 2021 2022 2021
Net sales $ 11 $ 2 $ 24 $ 3
Cost of goods sold (34) (21) (39) (28)
Gross profit (23) (19) (15) (25)
Selling, general and administrative expense (90) (101) (263) (250)
Foreign exchange gains (losses) (11) (3) (19) (9)
EBIT attributable to noncontrolling interests — 2 (11) 2
Other income (expense) – net 40 41 71 55
Income (loss) from affiliates — (1) (1) —
Total Corporate and Other EBIT $ (84) $ (81) $ (238) $ (227)

Three Months Ended September 30, 2022 Compared to Three Months Ended September 30, 2021
Corporate and Other EBIT decreased by $3 million, or 4%, to a loss of $84 million for the three months ended September 30, 2022, compared to a loss of $81 million for the three months ended September 30, 2021. The decrease was primarily driven by lower overall unrealized mark-to-market gains compared to the prior year in two of Bunge Ventures' (our venture capital unit) investments, and a non-recurring impairment charge of $11 million related to the classification of our Russian business as held-for-sale, partially offset by lower variable incentive costs.

Nine Months Ended September 30, 2022 Compared to Nine Months Ended September 30, 2021
Segment EBIT decreased by $11 million, or 5%, to a loss of $238 million for the nine months ended September 30, 2022, compared to a loss of $227 million for the nine months ended September 30, 2021. The decrease was primarily driven by increased expenses associated with growth initiatives, a non-recurring impairment charge of $11 million related to the classification of our Russian business as held-for-sale, and net unrealized mark-to-market losses related to one of our venture capital unit's investments. The decrease was partially offset by a $29 million gain, at Bunge's 70% share at the time, related to the settlement of one of the Company's international defined benefit pension plans in the first quarter of 2022.

54
Table of Contents

Non-core Segment

Sugar and Bioenergy Segment
Three Months Ended
September 30, 		Nine Months Ended
September 30,
(US$ in millions, except volumes) 2022 2021 2022 2021
Net sales $ 74 $ 69 $ 195 $ 190
Cost of goods sold (72) (67) (189) (187)
Gross profit 2 2 6 3
Selling, general and administrative expense — — (1) (1)
Foreign exchange gains (losses) — — — —
EBIT attributable to noncontrolling interests — — — —
Other income (expense) – net 2 — 2 1
Income (loss) from affiliates 20 51 56 89
Total Sugar and Bioenergy Segment EBIT $ 24 $ 53 $ 63 $ 92

Three Months Ended September 30, 2022 Compared to Three Months Ended September 30, 2021
Segment EBIT decreased $29 million, or 55%, to $24 million for the three months ended September 30, 2022, compared to $53 million for the three months ended September 30, 2021. The decrease was due to less favorable results from our investment in BP Bunge Bioenergia, resulting from foreign exchange losses on U.S. dollar denominated debt of the joint venture, due to depreciation in the Brazilian real during the current quarter, as well as lower ethanol sales volumes.
Nine Months Ended September 30, 2022 Compared to Nine Months Ended September 30, 2021
Segment EBIT decreased by $29 million, or 32%, to $63 million for the nine months ended September 30, 2022, compared to $92 million for the nine months ended September 30, 2021. The decrease was due to less favorable results from our investment in BP Bunge Bioenergia, resulting from foreign exchange losses and lower ethanol sales volumes.

Interest - A summary of consolidated interest income and expense follows:
Three Months Ended
September 30, 		Nine Months Ended
September 30,
(US$ in millions) 2022 2021 2022 2021
Interest income $ 30 $ 19 $ 50 $ 34
Interest expense (103) (57) (306) (184)

Interest income was $30 million for the three months ended September 30, 2022, compared to $19 million for the three months ended September 30, 2021. Interest expense increased by $46 million, to $103 million for the three months ended September 30, 2022, compared to $57 million for the three months ended September 30, 2021. The increase in net interest expense was due to higher variable interest rates in the current period.
Interest income was $50 million for the nine months ended September 30, 2022, compared to $34 million for the nine months ended September 30, 2021. Interest expense increased by $122 million, to $306 million for the nine months ended September 30, 2022, compared to $184 million for the nine months ended September 30, 2021. The increase in net interest expense was due to higher variable interest rates in the current period, as well as a $47 million charge in connection with the early redemption of all our issued and outstanding 4.35% Senior Notes during the current period. The $47 million charge comprised a $31 million "make-whole" provision based on the sum of the present values of the remaining scheduled payments of principal and interest on the 4.35% Senior Notes, plus accrued and unpaid interest as of the March 10, 2022 redemption date, as well as $16 million related to the recognition of unrealized mark-to market losses on terminated and de-designated interest rate hedges.

Liquidity and Capital Resources
55
Table of Contents
Our main financial objectives are to prudently manage financial risks, ensure consistent access to liquidity and minimize cost of capital in order to efficiently finance our business and maintain balance sheet strength. We generally finance our ongoing operations with cash flows generated from operations, issuances of commercial paper, borrowings under various bilateral and syndicated revolving credit facilities, term loans, and proceeds from the issuance of senior notes. Acquisitions and long-lived assets are generally financed with a combination of equity and long-term debt.
Working Capital
As of
US$ in millions, except current ratio September 30, 2022 September 30, 2021 December 31, 2021
Cash and cash equivalents $ 956 $ 1,033 $ 902
Trade accounts receivable, net 2,336 2,431 2,112
Inventories 8,112 8,014 8,431
Other current assets (1)
5,791 5,056 5,015
Total current assets $ 17,195 $ 16,534 $ 16,460
Short-term debt $ 1,327 $ 1,151 $ 673
Current portion of long-term debt 773 510 504
Trade accounts payable 4,455 3,944 4,250
Current operating lease obligations 436 332 350
Other current liabilities (2)
3,576 3,822 3,547
Total current liabilities $ 10,567 $ 9,759 $ 9,324
Working capital (3)
$ 6,628 $ 6,775 $ 7,136
Current ratio (4)
1.63 1.69 1.77
(1) Comprises Assets held for sale and Other current assets.
(2) Comprises Liabilities held for sale and Other current liabilities.
(3) Working capital is Total current assets less Total current liabilities.
(4) Current ratio represents Total current assets divided by Total current liabilities.
Working capital was $6,628 million at September 30, 2022, a decrease of $508 million from working capital of $7,136 million at December 31, 2021, and a decrease of $147 million from working capital of $6,775 million at September 30, 2021.
Cash and Cash Equivalents - Cash and cash equivalents were $956 million at September 30, 2022, an increase of $54 million from $902 million at December 31, 2021, and a decrease of $77 million from $1,033 million at September 30, 2021. Cash balances are managed in accordance with our investment policy, the objectives of which are to preserve the principal value of our cash assets, maintain a high degree of liquidity, and deliver competitive returns subject to prevailing market conditions. Cash balances are typically invested in short-term deposits with highly-rated financial institutions and in U.S. government securities. Please refer to the Cash Flows section of this report, below, for details regarding the primary factors giving rise to the change in Cash and cash equivalents during the nine months ended September 30, 2022.
Trade accounts receivable, net - Trade accounts receivable, net were $2,336 million at September 30, 2022, an increase of $224 million from $2,112 million at December 31, 2021, and a decrease of $95 million from $2,431 million at September 30, 2021. The increase from December 31, 2021, was primarily due to increased Net sales in the current period driven by factors described in the Segment Overview & Results of Operations above, partially offset by an increase in the aggregate size of the Trade Receivables Securitization Program, as noted in Note 5 - Trade Accounts Receivable and Trade Receivable Securitization Program, that occurred during the first quarter of 2022 . The decrease from September 30, 2021, was primarily due to the increase in the aggregate size of the Trade Receivables Securitization Program described above .
Inventories - Inventories were $8,112 million at September 30, 2022, a decrease of $319 million from $8,431 million at December 31, 2021, and an increase of $98 million from $8,014 million at September 30, 2021. The decrease from December 31, 2021, is due to slightly lower average prices as of September 30, 2022, partially offset by higher volumes, while the increase from September 30, 2021, relates to higher average commodity prices than for the comparative period.
RMI comprise agricultural commodity inventories, such as soybeans, soybean meal, soybean oil, corn, and wheat that are readily convertible to cash because of their commodity characteristics, widely available markets and international
56
Table of Contents
pricing mechanisms. Total RMI reported at fair value was $6,443 million, $6,869 million, and $6,505 at September 30, 2022, December 31, 2021, and September 30, 2021, respectively (see Note 6 - Inventories to our condensed consolidated financial statements).
Other current assets - Other current assets were $5,791 million at September 30, 2022, an increase of $776 million from $5,015 million at December 31, 2021, and an increase of $735 million from $5,056 million at September 30, 2021. The increase from December 31, 2021, was primarily due to significantly higher unrealized gains on derivative contracts, higher margin deposits, higher prepaid expenses as a result of an Argentinian Export Program offered temporarily in September 2022 (see Note 1 - Basis of Presentation, Principles of Consolidation, And Significant Accounting Policies to our condensed consolidated financial statements for details), and an increase in the deferred purchase price receivable due to increased trade accounts receivable transfers under our securitization program. These increases were partially offset by a decrease in marketable securities and other short-term investments, due to a decrease in investments with Ukrainian exposures following the onset of the Ukraine-Russia war, as well as a decrease in assets held for sale due to the completion of the sale of our Mexico wheat milling business. The increase from September 30, 2021, was primarily due to higher unrealized gains on derivative contracts, higher prepaid expenses as a result of the Argentinian Export Program offered temporarily in September 2022, an increase in the deferred purchase price receivable due to increased trade accounts receivable transfers under our securitization program, and higher assets held for sale following the announcement of the sale of our Russian business during in the third quarter of 2022. These increases were partially offset by lower marketable securities and other short-term investments due to a decrease in investments with Ukrainian exposures following the onset of the Ukraine-Russia war.
Short-term debt - Short-term debt, including the current portion of long-term debt, was $2,100 million at September 30, 2022, an increase of $923 million from $1,177 million at December 31, 2021, and an increase of $439 million from $1,661 million at September 30, 2021. The higher short-term debt levels at September 30, 2022, compared to December 31, 2021, and September 30, 2021, are due to higher working ca pital funding requirements, as well as an increase in the current portion of long-term debt associated with our 1.85% Senior Notes, due 2023 .
Trade accounts payable - Trade accounts payable were $4,455 million at September 30, 2022, an increase of $205 million from $4,250 million at December 31, 2021, and an increase of $511 million from $3,944 million at September 30, 2021. The increases from December 31, 2021, and September 30, 2021, were primarily due to higher average inventory prices during the current period.
Other current liabilities - Other current liabilities were $3,576 million at September 30, 2022, an increase of $29 million from $3,547 million at December 31, 2021, and a decrease of $246 million from $3,822 million at September 30, 2021. The increase from December 31, 2021, was primarily due to higher unrealized losses on derivative contracts during the current period, partially offset by a decrease in liabilities held for sale due to the completion of the Mexico wheat milling disposition. The decrease from September 30, 2021, was primarily due to lower unrealized losses on derivative contracts and lower income taxes payable due to lower pretax income compared to the prior year.
Debt
Financing Arrangements and Outstanding Indebtedness - We conduct most of our financing activities through a centralized financing structure that provides the Company with efficient access to debt and capital markets. This structure includes a master trust, the primary assets of which comprise intercompany loans made to Bunge Limited and its subsidiaries. Certain of Bunge Limited’s 100% owned finance subsidiaries, including Bunge Limited Finance Corp., Bunge Finance Europe B.V., and Bunge Asset Funding Corp., fund the master trust with short and long-term debt obtained from third parties, including through our commercial paper program and certain credit facilities, as well as the issuance of senior notes. Borrowings by these finance subsidiaries carry full, unconditional guarantees by Bunge Limited.
Revolving Credit Facilities - At September 30, 2022, we had $6,700 million unused and available committed borrowing capacity, comprising committed revolving credit facilities and a commercial paper program, totaling $5,665 million, as well as committed unsecured $1,250 million delayed draw term loans. The following table summarizes these facilities as of the periods presented:
57
Table of Contents
(US$ in millions) Total Committed
Capacity 		Borrowings Outstanding
Commercial Paper Program and Revolving Credit Facilities (1)
Maturities September 30,
2022 		September 30,
2022 		December 31,
2021
Commercial paper 2026 $ 600 $ 215 $ —
Revolving credit facilities
$1.1 Billion 364-day Revolving Credit Agreement (2)
2023 1,100 — —
$1.75 Billion 2024 Revolving Credit Facility 2024 1,750 — —
$1.35 Billion 5-year Revolving Credit Agreement 2026 1,350 — —
$865 Million 2026 Revolving Credit Facility 2026 865 — —
Total revolving credit facilities $ 5,065 $ — $ —
Total (3)
$ 5,665 $ 215 $ —
(1) See Note 14- Debt for further information on these programs.
(2) On July 15, 2022, we entered into an unsecured $1.1 billion 364-day Revolving Credit Agreement (the "$1.1 Billion Credit Agreement"), with a group of lenders maturing on July 14, 2023 (see Note 14- Debt ) . The $1.1 Billion Credit Agreement replaces the Company's previous $1 Billion 364-day Revolving Credit Agreement.
(3) Total committed capacity for our commercial paper program revolving credit facilities excludes the committed capacity of a $250 million delayed draw term loan entered into on October 29, 2021, and which is required to be drawn by October 27, 2022. This delayed draw term loan was drawn on October 21, 2022. Total committed capacity also excludes the committed capacity of an additional $250 million delayed draw term loan entered into on August 5, 2022, and which is required to be drawn by February 2, 2023. Finally, total committed capacity excludes a $750 million delayed draw term loan entered into on July 26, 2022, which gives us the option to draw under the loan by January 25, 2023. The delayed draw term loans will bear interest when drawn at SOFR plus a credit spread adjustment and applicable margin (see Note 14- Debt) .
Short and long-term debt - Our short and long-term debt decreased by $867 million to $5,097 million at September 30, 2022, from $5,964 million at December 31, 2021, primarily due to lower working capital funding requirements, mostly comprising RMI. For the nine months ended September 30, 2022, our average short and long-term debt outstanding was approximately $6,240 million, compared to approximately $7,455 million for the nine months ended September 30, 2021. Our long-term debt balance, including the current portion of long-term debt, was $3,770 million at September 30, 2022, a decrease of $1,521 million, compared to $5,291 million at December 31, 2021. The decrease was primarily due to the early redemption during the current period of all of our issued and outstanding 4.35% Senior Notes due 2024, and the redemption during the current period of all of our issued and outstanding 3.00% Senior Notes due 2022.
The following table summarizes our short-term debt at September 30, 2022.
(US$ in millions)
Outstanding
Balance at
September 30, 2022
Weighted Average
Interest Rate at
September 30, 2022
Highest Balance
Outstanding During
Quarter Ended September 30, 2022
Average Balance
During Quarter Ended
September 30, 2022
Weighted Average
Interest Rate
During Quarter Ended September 30, 2022
Bank borrowings (1)
$ 1,112 10.15 % $ 2,154 $ 1,477 12.63 %
Commercial paper 215 3.20 % 215 69 3.04 %
Total $ 1,327 $ 2,369 $ 1,546
(1) Includes $334 million of local currency bank borrowings in certain Central and Eastern European, South American, and Asia-Pacific countries at a weighted average interest rate of 25.33% as of September 30, 2022.
From time to time, through our financing subsidiaries, we enter into bilateral short-term credit lines as necessary based on our financing requirements. At September 30, 2022, there were $125 million borrowings outstanding under these bilateral short-term credit lines. In addition, Bunge's operating companies had $987 million and $673 million in short-term borrowings outstanding from local bank lines of credit at September 30, 2022, and December 31, 2021, respectively, to support working capital requirements.
58
Table of Contents

The following table summarizes our short and long-term indebtedness:
(US$ in millions) September 30,
2022 		December 31,
2021
Short-term debt: (1)
Short-term debt $ 1,327 $ 673
Current portion of long-term debt 773 504
Total short-term debt 2,100 1,177
Long-term debt:
Term loan due 2024 - three-month TONAR plus 0.75% (Tranche A) (2)
213 267
Term loan due 2024 - three-month LIBOR plus 1.30% (Tranche B) 90 89
3.00% Senior Notes due 2022 (4)
— 399
1.85% Senior Notes due 2023 - Euro
780 906
4.35% Senior Notes due 2024 (3)
— 598
1.63% Senior Notes due 2025 597 596
3.25% Senior Notes due 2026 697 697
3.75% Senior Notes due 2027 597 596
2.75% Senior Notes due 2031 990 989
Other (194) 154
Subtotal 3,770 5,291
Less: Current portion of long-term debt (773) (504)
Total long-term debt (5)
2,997 4,787
Total debt $ 5,097 $ 5,964
(1) Includes secured debt of $29 million and $43 million at September 30, 2022, and December 31, 2021, respectively.
(2) Effective January 1, 2022, the three-month Yen LIBOR rate was discontinued and replaced by the Tokyo Overnight Average Rate ("TONAR" or "TONA").
(3) On February 23, 2022, Bunge issued a notice of redemption for all of the issued and outstanding 4.35% Senior Notes due March 15, 2024. The redemption of the 4.35% Senior Notes occurred on March 10, 2022. In connection with the redemption, during the nine months ended September 30, 2022, the Company recorded a $47 million charge within Interest expense, of which $31 million related to a "make-whole" provision based on the sum of the present values of the remaining scheduled payments of principal and interest on the 4.35% Senior Notes, plus accrued and unpaid interest as of the March 10, 2022 redemption date, and $16 million related to the recognition of unrealized mark-to-market losses on terminated and de-designated interest rate hedges.
(4) On August 23, 2022, Bunge issued a notice of redemption for all of the issued and outstanding 3.00% Senior Notes due September 25, 2022. The redemption of the 3.00% Senior Notes occurred on September 7, 2022. In connection with the redemption, during the three and nine months ended September 30, 2022, the Company recorded a $405 million payment for redemption of the notes, at par, plus accrued and unpaid interest.
(5) Includes secured debt of $47 million and $50 million at September 30, 2022, and December 31, 2021, respectively.

59
Table of Contents

Credit Ratings — Bunge’s debt ratings and outlook by major credit rating agencies at September 30, 2022, were as follows:
Short-term
Debt (1)
Long-term
Debt 		Outlook
Standard & Poor’s A-1 BBB Positive
Moody’s P-1 Baa2 Stable
Fitch
BBB Stable
(1) Short-term debt rating applies only to Bunge Asset Funding Corp., the issuer under our commercial paper program.

Our debt agreements do not have any credit rating downgrade triggers that would accelerate maturity of our debt. However, credit rating downgrades would increase borrowing costs under our syndicated credit facilities and, depending on their severity, could impede our ability to obtain credit facilities or access the capital markets in the future on competitive terms. A significant increase in our borrowing costs could impair our ability to compete effectively in our business relative to competitors with higher credit ratings.
Our credit facilities and certain senior notes require us to comply with specified financial covenants including minimum net worth, minimum current ratio, a maximum debt to capitalization ratio and limitations on secured indebtedness. We were in compliance with these covenants as of September 30, 2022.

Equity
Total equity is set forth in the following table:
(US$ in millions) September 30,
2022 		December 31, 2021
Equity:
Convertible perpetual preference shares $ — $ 690
Common shares 1 1
Additional paid-in capital 6,655 5,590
Retained earnings 9,980 8,979
Accumulated other comprehensive income (loss) (6,611) (6,471)
Treasury shares, at cost; 2022 - 18,835,812 shares, and 2021 - 16,726,697 shares (1,320) (1,120)
Total Bunge shareholders’ equity 8,705 7,669
Noncontrolling interest 666 156
Total equity $ 9,371 $ 7,825
Total Bunge shareholders’ equity was $8,705 million at September 30, 2022, compared to $7,669 million at December 31, 2021, an increase of $1,036 million. The increase was primarily due to $1,274 million of Net income attributable to Bunge, $234 million in Additional paid-in capital on formation of a joint venture, Bunge Chevron Ag Renewables LLC, $47 million of stock-based compensation expense, $45 million in Additional paid in capital on the acquisition of an additional 10% ownership interest in our subsidiary, Bunge Loders Croklaan Group B.V., and $44 million from the issuance of common shares under our share based compensation programs, partially offset by $268 million of declared dividends to common shareholders, $200 million of common share repurchases, and $140 million of Other comprehensive income, as described in Note 19 - Equity .
60
Table of Contents
Cumulative Convertible Perpetual Preference Shares — On March 18, 2022, we announced all issued and outstanding shares of our 4.875% Cumulative Convertible Perpetual Preference Shares ("convertible preference shares") would automatically convert into common shares of the Company, par value $0.01 per share, effective March 23, 2022 (the "Conversion Date"). On March 18, 2022, the closing price of the common shares of the Company on the NYSE was $104.91, marking the 20th trading day in the previous 30 trading days that the closing price of the common shares of the Company exceeded 130% of the conversion price, triggering our right under the certificate of designation for the convertible preference shares, at our option, to mandatorily convert the convertible preference shares. The conversion price adjusted from $78.1322, per Note 24 - Equity included in the Company's 2021 Annual Report on Form 10-K, to $77.8482 on February 16, 2022.
Each convertible preference share automatically converted into 1.2846 common shares of the Company on the Conversion Date and cash was paid in lieu of fractional common shares of the Company. There were 6,898,268 convertible preference shares issued and outstanding prior to the conversion, which resulted in the issuance of 8,861,515 new common shares of the Company. Additionally, during the first quarter of 2022, prior to the conversion, 1,415 convertible preference shares were voluntarily converted by preference shareholders into 1,816 common shares. As a result of the conversions, no convertible preference shares are issued or outstanding, and all rights of the former holders of the convertible preference shares terminated as of March 23, 2022.
Share repurchase program - During October 2021, our Board of Directors approved a new program for the repurchase of up to $500 million of our issued and outstanding common shares. The program has no expiration date. Under this program, 2,109,115 common shares were repurchased for $200 million during the three and nine month periods ended September 30, 2022. As of September 30, 2022, $300 million remains outstanding for repurchases under the program.
During the three and nine month periods ended September 30, 2021, Bunge repurchased 1,298,384 common shares for $100 million, thereby completing a previous $500 million share repurchase program, established May 2015.

Cash Flows
Nine Months Ended
September 30,
US$ in millions 2022 2021
Cash provided by (used for) operating activities $ (5,031) $ (1,642)
Cash provided by (used for) investing activities 5,113 3,562
Cash provided by (used for) financing activities (102) (1,166)
Effect of exchange rate changes on cash and cash equivalents, restricted cash, and cash held for sale 112 (79)
Net increase (decrease) in cash and cash equivalents, restricted cash, and cash held for sale $ 92 $ 675
Our cash flows from operations vary depending on, among other items, the market prices and timing of purchases and sales of our inventories. Generally, during periods when commodity prices are rising, our Agribusiness operations require increased use of cash to support working capital to acquire inventories and fund daily settlement requirements on exchange traded futures that we use to minimize price risk related to purchases and sales of our inventories.
During the nine months ended September 30, 2022, our cash and cash equivalents, restricted cash, and cash held for sale increased by $92 million, compared to an increase of $675 million during the nine months ended September 30, 2021.
Operating : Cash used for operating activities was $5,031 million for the nine months ended September 30, 2022, an increase of $3,389 million, compared to $1,642 million for the nine months ended September 30, 2021. The increase was primarily due to lower net income, and higher working capital and increased beneficial interest in securitized trade receivables, driven by higher average commodity prices, during the nine months ended September 30, 2022.
61
Table of Contents
Nine Months Ended
September 30,
US$ in millions 2022 2021
Cash provided by (used for) operating activities $ (5,031) $ (1,642)
Net proceeds from beneficial interest in securitized trade receivables 5,176 3,255
Cash provided by (used for) operating activities, adjusted $ 145 $ 1,613

Cash provided by (used for) operating activities, adjusted for net proceeds from beneficial interests in securitized trade receivables, was cash provided of $145 million for the nine months ended September 30, 2022, compared to cash provided of $1,613 million for the nine months ended September 30, 2021. The decrease was primarily due to lower net income and higher working capital adjusted for net proceeds from beneficial interest in securitized trade receivables, driven by higher average commodity prices, during the nine months ended September 30, 2022.
Certain of our non-U.S. operating subsidiaries are primarily funded with U.S. dollar-denominated debt, while currency risk is hedged with U.S. dollar-denominated assets. The functional currency of our operating subsidiaries is generally the local currency. The financial statements of our subsidiaries are calculated in the functional currency, and when the local currency is the functional currency, translated into U.S. dollars. U.S. dollar-denominated loans are remeasured into their respective functional currencies at exchange rates at the applicable balance sheet date. Also, certain of our U.S. dollar functional operating subsidiaries outside the U.S. are partially funded with local currency borrowings, while the currency risk is hedged with local currency denominated assets. Local currency loans in U.S. dollar functional currency subsidiaries outside the U.S. are remeasured into U.S. dollars at the exchange rate on the applicable balance sheet date. The resulting gain or loss is included in our condensed consolidated statements of income as Foreign exchange (losses) gains. For the nine months ended September 30, 2022, we recorded a foreign currency gain on our debt of $96 million, and for the nine months ended September 30, 2021, we recorded a foreign currency loss on our debt of $7 million, which were included as adjustments to reconcile net income to cash used for operating activities in the line item "foreign exchange (gain) loss on net debt" in our condensed consolidated statements of cash flows. These adjustments are required as the gains an d losses are non-cash items that arise from financing activities and therefore will have no impact on cash flows from operations.
Investing: Cash provided by investing activities was $5,113 million for the nine months ended September 30, 2022, an increase of $1,551 million, compared to cash provided by investing activities of $3,562 million for the nine months ended September 30, 2021. The increase was primarily due to higher net proceeds from beneficial interests in securitized trade receivables, driven by higher average commodity prices, partially offset by lower proceeds received on the sale of our Mexican wheat milling business during the nine months ended September 30, 2022, compared to proceeds received from the sales of our oils facilities in the Netherlands and Mexico during the nine months ended September 30, 2021.
Financing : Cash used for financing activities was $102 million for the nine months ended September 30, 2022, a decrease of $1,064 million, compared to cash used for financing activities of $1,166 million for the nine months ended September 30, 2021. During the nine months ended September 30, 2022, we made net cash repayments of short and long-term debt of $147 million, paid $256 million in dividend payments to common shareholders, repurchased $200 million of common shares, and paid $102 million to acquire an additional 10% ownership interest from redeemable noncontrolling interest holders in our subsidiary, Bunge Loders Croklaan Group B.V. These cash outflows were partially offset by $521 million in cash received from the sale of a noncontrolling interest on formation of a joint venture, Bunge Chevron Ag Renewables LLC, as described in Note 1 - Basis of Presentation, Principles of Consolidation, And Significant Accounting Policies, and $30 million in proceeds from the exercise of options for common shares. During the nine months ended September 30, 2021, we made net cash repayments of short and long-term debt of $643 million, paid $147 million to acquire the noncontrolling equity interests of our Polish subsidiary, Z.T. Kruszwica S.A., paid $240 million in dividends to our common and preferred shareholders, paid $75 million in dividends to noncontrolling interest shareholders, and repurchased $100 million of common shares, partially offset by $72 million in cash received from the exercise of options for common shares.

Off-Balance Sheet Arrangements

Please refer to Note 16 - Commitments and Contingencies to our condensed consolidated financial statements for details concerning our off-balance sheet arrangements that have or are reasonably likely to have a material current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

62
Table of Contents
Dividends
We paid a regular quarterly cash dividend of $0.625 per share on September 2, 2022, to common shareholders of record on August 19, 2022. On August 11, 2022, Bunge announced that the Company's Board of Directors had declared a dividend of $0.625 per common share, payable on December 2, 2022, to shareholders of record on November 18, 2022.



Critical Accounting Policies and Estimates
Critical accounting policies are defined as those policies that are significant to our financial condition and results of operations and require management to exercise significant judgment. For a complete discussion of our accounting policies, see Note 1 to our Annual Report on Form 10-K for the year ended December 31, 2021, filed with the Securities and Exchange Commission on February 24, 2022. For recent accounting pronouncements refer to Note 1 - Basis of Presentation, Principles of Consolidation, And Significant Accounting Policies , to the condensed consolidated financial statements in this Quarterly Report on Form 10-Q. For accounting considerations in connection with the Ukraine-Russia war, refer to Note 2 - Ukraine-Russia War to the condensed consolidated financial statements in this Quarterly Report on Form 10-Q.

63
Table of Contents
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Risk Management
As a result of our global activities, we are exposed to changes in, among other things, agricultural commodity prices, transportation costs, foreign currency exchange rates, interest rates, energy costs, and inflationary pressures, which may affect our results of operations and financial position. We actively monitor and manage these various market risks associated with our business activities. Our risk management decisions take place in various locations, but exposure limits are centrally set and monitored, operating under a global governance framework. Additionally, our Board of Directors' Enterprise Risk Management Committee oversees our global market risk governance framework, including risk management policies and limits.
We use derivative instruments for the purpose of managing the exposures associated with commodity prices, transportation costs, foreign currency exchange rates, interest rates, energy costs, and for positioning our overall portfolio relative to expected market movements in accordance with established policies and procedures. We enter into derivative instruments, primarily with commodity exchanges in the case of commodity futures and options, major financial institutions, or approved exchange clearing shipping companies in the case of ocean freight. While these derivative instruments are subject to fluctuations in value, for hedged exposures those fluctuations are generally offset by the changes in fair value of the underlying exposures. The derivative instruments that we use for hedging purposes are intended to reduce the volatility of our results of operations. However, they can occasionally result in earnings volatility, which may be material. See Note 13 - Derivative Instruments And Hedging Activities to the condensed consolidated financial statements in this Quarterly Report on Form 10-Q for a more detailed discussion of our use of derivative instruments.
Credit and Counterparty Risk
Through our normal business activities, we are subject to significant credit and counterparty risks that arise through commercial sales and purchases, including forward commitments to buy or sell, and through various other over-the-counter ("OTC") derivative instruments that we use to manage risks inherent in our business activities. We define credit and counterparty risk as a potential financial loss due to the failure of a counterparty to honor its obligations. The exposure is measured based upon several factors, including unpaid accounts receivable from counterparties, as well as unrealized gains from forward purchase or sales contracts and OTC derivative instruments. Credit and counterparty risk also includes sovereign credit risk. We actively monitor credit and counterparty risk through regular reviews of exposures and credit analysis by regional credit teams, as well as a review by global and corporate committees that monitor counterparty performance. We record provisions for counterparty losses from time to time as a result of our credit and counterparty analysis.
During periods of tight conditions in global credit markets, downturns in regional or global economic conditions, and/or significant price volatility, credit and counterparty risks are heightened. This increased risk is monitored through, among other things, exposure reporting, increased communication with key counterparties, management reviews, and a specific focus on counterparties or groups of counterparties that we may determine as high risk. We have reduced exposures and associated position limits in certain cases, and also decreased our use of non-exchange cleared derivative instruments.
Commodities Risk
We operate in many areas of the food industry, from agricultural raw materials to the production and sale of branded food products. As a result, we purchase and produce various materials, many of which are agricultural commodities, including: soybeans, soybean oil, soybean meal, palm oil (from crude to various degrees of refined products), softseeds (including sunflower seed, rapeseed and canola) and related oil and meal derived from them, wheat, barley, shea nut, and corn. Agricultural commodities are subject to price fluctuations due to a number of unpredictable factors, including inflationary pressures, that may create price risk. As described above, we are also subject to the risk of counterparty non-performance under forward purchase and sales contracts. From time to time, we have experienced instances of counterparty non-performance as a result of significant declines in counterparty profitability under these contracts due to movements in commodity prices between the time the contracts were entered into and the contractual forward delivery period.
We enter into various derivative contracts with the primary objective of managing our exposure to adverse price movements in the agricultural commodities used and produced in our business operations. We have established policies that limit the amount of unhedged fixed price agricultural commodity positions permissible for our operating companies, which are generally a combination of volumetric, drawdown, and value-at-risk ("VaR") limits. We measure and review our commodity positions on a daily basis. We also employ stress-testing techniques in order to quantify our exposures to price and liquidity risks under non-normal or event driven market conditions.
Our daily net agricultural commodity position consists of inventory, forward purchase and sales contracts, and OTC and exchange-traded derivative instruments, including those used to hedge portions of our production requirements. The fair value
64
Table of Contents
of that position is a summation of the fair values of each agricultural commodity, calculated by valuing all of our commodity positions for the period at quoted market prices, where available, or by utilizing a close proxy. VaR is calculated on the net position and monitored at the 95% confidence interval. In addition, scenario analysis and stress testing are performed. For example, one measure of market risk is estimated as the potential loss in fair value resulting from a hypothetical 10% adverse change in prices. The results of this analysis, which may differ from actual results, are as follows:
Nine Months Ended
September 30, 2022 		Year Ended
December 31, 2021
(US$ in millions) Value Market
Risk 		Value Market
Risk
Highest daily aggregated position value $ 1,809 $ (181) $ 1,706 $ (171)
Lowest daily aggregated position value $ (416) $ 42 $ (3) $ —

Ocean Freight Risk
Ocean freight represents a significant portion of our operating costs. The market price for ocean freight varies depending on the supply and demand for ocean vessels, global economic conditions, inflationary pressure, and other factors. We enter into time charter agreements for time on ocean freight vessels based on forecasted requirements for the purpose of transporting agricultural commodities. Our time charter agreements generally have terms ranging from two months to approximately three years. We use financial derivatives, generally freight forward agreements, to hedge portions of our ocean freight costs. The ocean freight derivatives are included in Other current assets and Other current liabilities on the consolidated balance sheets at fair value.
Energy Risk
We purchase various energy commodities such as electricity, natural gas and bunker fuel, which are used to operate our manufacturing facilities and ocean freight vessels. These energy commodities are subject to price risk, including inflationary pressures. We use financial derivatives, including exchange traded and OTC swaps and options for various purposes, to manage our exposure to volatility in energy costs and market prices. These energy derivatives are included in Other current assets and Other current liabilities on the consolidated balance sheets at fair value.
Currency Risk
Our global operations require active participation in foreign exchange markets. Our primary foreign currency exposures are the Brazilian real , Canadian dollar , Euro, and Chinese yuan/renminbi . To reduce the risk arising from foreign exchange rate fluctuations, we enter into derivative instruments, such as foreign currency forward contracts, swaps and options. The changes in market value of such contracts have a high correlation to the price changes in the related currency exposures. The potential loss in fair value of such net currency positions resulting from a hypothetical 10% adverse change in foreign currency exchange rates as of September 30, 2022, was not material.
When determining our exposure, we exclude intercompany loans that are deemed to be permanently invested. Repayments of permanently invested intercompany loans are neither planned nor anticipated in the foreseeable future and are therefore treated analogous to equity for accounting purposes. As a result, the foreign exchange gains and losses on these borrowings are excluded from the determination of Net income (loss) and recorded as a component of Accumulated other comprehensive income (loss) in the condensed consolidated balance sheets. Included in Other comprehensive income (loss) are foreign exchange losses of $61 million for the nine months ended September 30, 2022, and foreign exchange losses of $74 million for the year ended December 31, 2021, related to permanently invested intercompany loans.
Interest Rate Risk
We have debt in fixed and floating rate instruments. We are exposed to market risk due to changes in interest rates, including inflationary pressures. We may enter into interest rate swap agreements to manage our interest rate exposure related to our debt portfolio.
The aggregate fair value of our short and long-term debt, based on market yields at September 30, 2022, was $5,126 million, with a carrying value of $5,097 million. There was no significant change in our interest rate risk as of September 30, 2022.
65
Table of Contents
A hypothetical 100 basis point increase in the interest yields on our debt at September 30, 2022, would result in a decrease of approximately $10 million in the fair value of our debt. Similarly, a decrease of 100 basis points in the interest yields on our debt at September 30, 2022, would cause an increase of approximately $2 million in the fair value of our debt.
A hypothetical 100 basis point change in LIBOR would result in a change of approximately $55 million in interest expense on our variable rate debt at September 30, 2022. Some of our variable rate debt is denominated in currencies other than in U.S. dollars and is indexed to non-U.S. dollar-based interest rate indices, such as ESTR and TONAR, and certain benchmark rates in local markets. As such, the hypothetical 100 basis point change in interest rate ignores the potential impact of any currency movements. See Part I, “Item 1A. Risk Factors” in our 2021 Annual Report on Form 10-K for a discussion of certain risks related to LIBOR.
Inflation Risk
Inflationary factors generally affect us by increasing our labor and overhead costs, as well as costs associated with certain risks identified above, which may adversely affect our results of operations and financial position. We have historically been able to recover the impacts of inflation through sales price increases, however we cannot reasonably estimate our ability to successfully recover any impact of inflation through price increases in the future. Our inability to do so could harm our results of operations and financial position. For details relating to the impact of inflationary pressures in Turkey, see Note 1 - Basis of Presentation, Principles of Consolidation, And Significant Accounting Policies to the condensed consolidated financial statements in this Quarterly Report on Form 10-Q.
Derivative Instruments
Foreign Exchange Derivatives —We use a combination of foreign exchange forward, swap, futures and options contracts in certain of our operations to mitigate the risk of exchange rate fluctuations in connection with certain commercial and balance sheet exposures. The foreign exchange forward swap and option contracts may be designated as cash flow hedges or fair value hedges. We may also use net investment hedges to partially offset the translation adjustments arising from the remeasurement of our investment in certain of our foreign subsidiaries.
We assess, both at the inception of the hedge and on an ongoing basis, whether the derivatives that are used in hedge transactions are highly effective in offsetting changes in the hedged items.
Interest Rate Derivatives —We may enter into interest rate swap agreements for the purpose of managing certain of our interest rate exposures. Interest rate swaps used by us as hedging instruments are recorded at fair value in the consolidated balance sheets with changes in fair value recorded contemporaneously in earnings. Certain of these agreements may be designated as fair value hedges. In such instances, the carrying amount of the associated hedged debt is also adjusted through earnings for changes in fair value arising from changes in benchmark interest rates. We may also enter into interest rate basis swap agreements that do not qualify as hedges for accounting purposes. The impact of changes in fair value of interest rate swap agreements is primarily presented in Interest expense.
Commodity Derivatives —We primarily use derivative instruments to manage our exposure to movements associated with agricultural commodity prices. We generally use exchange-traded futures and options contracts to minimize the effects of changes in the prices of agricultural commodities held as inventories or subject to forward purchase and sales contracts, but may also enter into OTC commodity transactions, including swaps, which are settled in cash at maturity or termination based on exchange-quoted futures prices. Changes in fair values of exchange-traded futures contracts, representing the unrealized gains and/or losses on these instruments, are settled daily, generally through our 100% owned futures clearing subsidiary. Forward purchase and sales contracts are primarily settled through delivery of agricultural commodities. While we consider these exchange-traded futures and forward purchase and sales contracts to be effective economic hedges, we do not designate or account for the majority of our commodity contracts as hedges. Changes in fair values of these contracts and related RMI are included in Cost of goods sold in the consolidated statements of income. The forward contracts require performance of both us and the contract counterparty in future periods. Contracts to purchase agricultural commodities generally relate to current or future crop years for delivery periods quoted by regulated commodity exchanges. Contracts for the sale of agricultural commodities generally do not extend beyond one future crop cycle.
Ocean Freight Derivatives —We use derivative instruments referred to as freight forward agreements, or FFAs, and FFA options to hedge portions of our current and anticipated ocean freight costs. Changes in the fair values of ocean freight derivatives are recorded in Cost of goods sold.
Energy Derivatives —We use derivative instruments for various purposes, including to manage our exposure to volatility in energy costs and our exposure to market prices related to the sale of biofuels. Our operations use substantial amounts of energy, including natural gas, coal, and fuel oil, including bunker fuel. Changes in the fair values of energy derivatives are recorded in Cost of goods sold.
66
Table of Contents
Other Derivatives —We may also enter into other derivatives, including credit default swaps and equity derivatives, to manage our exposure to credit risk and broader macroeconomic risks, respectively. The impact of changes in fair value of these instruments is presented in Cost of goods sold.
For more information, see Note 13 - Derivative Instruments And Hedging Activities to the condensed consolidated financial statements in this Quarterly Report on Form 10-Q.

ITEM 4. CONTROLS AND PROCEDURES
Disclosure Controls and Procedures - Disclosure controls and procedures are the controls and other procedures that are designed to provide reasonable assurance that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including the principal executive and principal financial officer, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.
As of September 30, 2022, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as that term is defined in Exchange Act Rules 13a-15(e) and 15d-15(e), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of the end of the period covered by this Quarterly Report on Form 10-Q.
Internal Control Over Financial Reporting - There have been no changes in the Company’s internal control over financial reporting during the quarter ended September 30, 2022, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. However, we continue to migrate certain processes from across our operations to shared business service models in order to consolidate back-office functions while standardizing our processes and financial systems globally. These initiatives are not in response to any identified deficiency or weakness in our internal controls over financial reporting. We plan to continue these initiatives in phases over the next several years and, accordingly, we have and will continue to align and streamline the design and operation of our internal controls over financial reporting, as necessary, to accommodate modifications to our business processes and accounting procedures. Specifically, during the nine months ended September 30, 2022, we began migrating certain of our financial reporting systems in Argentina to our South American Enterprise Resource Planning (ERP) system, a process that is expected to take several months, and which may result in changes to our internal controls over financial reporting relating to our Argentinian operations.
Additionally, management performed an evaluation of the impacts of the Ukraine-Russia War (discussed further in Note 2 – Ukraine-Russia War to our financial statements included as part of this Form 10-Q) on our internal controls over financial reporting. In doing so management noted that, as a result of the war, we are currently unable to perform certain of our Ukrainian internal controls over financial reporting, primarily relating to on-site physical inspections of certain of our operating facilities, due to safety concerns, particularly in areas of active conflict. Additionally, some of our Ukrainian employees have been forced to relocate to other countries or safer locations elsewhere within Ukraine. In response, management has implemented compensating controls, including using third party contractors to carry out visual inspections of the physical condition of our assets held at Ukrainian facilities, as well as certain other internal controls over financial reporting capable of being performed on a remote basis. To date, our Russian offices and facilities have remained open and operating with no changes to related internal controls over financial reporting.
67
Table of Contents
PART II.
INFORMATION
ITEM 1. LEGAL PROCEEDINGS
From time to time, we are involved in litigation and other claims, investigations and proceedings incidental to our business. While the outcome of these matters cannot be predicted with certainty, we believe the outcome of these proceedings, net of established reserves, will not have a material adverse effect on our consolidated financial position, results of operations or liquidity.
For a discussion of cert ain legal an d tax matters see Note 16 - Commitments and Contingencies to our condensed consolidated financial statements included as part of this Quarterly Report on Form 10-Q. Additionally, we are a party to a large number of labor, civil and other claims, primarily relating to our Brazilian operations. We have reserved an aggregate of $73 million and $99 million, for labor and civil claims, respectively, as of September 30, 2022. The labor claims primarily relate to dismissals, severance, health and safety, salary adjustments and supplementary retirement benefits. The civil claims relate to various legal proceedings and disputes, including disputes with suppliers and customers .

ITEM 1A.    RISK FACTORS
In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our 2021 Annual Report on Form 10-K, which could materially affect our business, financial condition or future results. The risks described in our Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results. Following are material updates to the risk factors previously disclosed in our 2021 Annual Report on Form 10-K:
The ongoing war between Russia and Ukraine may adversely affect our business, financial condition or results of operations.
We maintain operations in Ukraine and Russia. On February 24, 2022, Russia initiated a military offensive in Ukraine. Ukraine forms part of a key international grain originating region and is also the world’s largest supplier of sunflower seed and sunflower oil; commodities that cannot be completely replaced from other origins. Bunge's Ukrainian operations comprise two oilseed crushing facilities, located in Mykolaiv and Dnipropetrovsk, a grain export terminal in the Mykolaiv commercial seaport, numerous grain elevators, and an office in Kiev. The Company also operates a corn milling facility in Ukraine via a joint venture. Assets and operations located in regions affected by the war could be at an increased risk of property damage, inventory loss, business disruption, and expropriation. As of the date of this memo, no material damage has been noted at any of Bunge's Ukrainian facilities, including its Mykolaiv port facility that sustained minor shelling damage earlier in the year. However, due to safety concerns, it is not always possible to conduct onsite physical inspections of all of the Company's Ukrainian facilities to understand the full extent of the impact of the war. As of September 30, 2022, we had total assets and total liabilities of $293 million and $180 million, respectively, in Ukraine.
The Company’s Ukrainian operations employ over 1,000 employees. While as of the date of this report some of the Company’s Ukrainian employees have been forced to relocate to other countries or elsewhere within Ukraine, our workforce remains largely intact and we are resuming idled operations when and where possible. The ongoing war could cause harm to our employees and otherwise impair their ability to work for extended periods of time, which could have a material adverse effect on our operations. Disruption to telecommunications systems, banks, and other critical infrastructure necessary to conduct business in Ukraine could also severely impair our Ukrainian operations.
The scope, intensity, duration and outcome of the ongoing war is uncertain and the continuation or escalation of the war may have a material adverse effect on Bunge’s assets, operations and financial condition.
Additionally, in response to the war, the United States, other North Atlantic Treaty Organization ("NATO") member states, as well as non-member states, have announced targeted economic sanctions on Russia, certain Russian citizens, and Russian enterprises. Any continuation or escalation of the war may trigger a series of additional economic and other sanctions. On September 16, 2022, Bunge signed an agreement to sell its remaining Russian operations, primarily comprising an oilseed crushing and refining facility in Voronezh, southwest Russia, to Karen Vanetsyan. Please refer to Note 3 - Acquisitions and Dispositions to our condensed consolidated financial statements included as part of this Quarterly Report on Form 10-Q for further details regarding the transaction. Until the sale is complete we continue to operate our Russian oilseed crushing and refining facility, doing so in compliance with all legal requirements imposed following the start of the war, hence remain exposed to the risks associated with operating in Russia as the conflict in Ukraine continues. The economic and other sanctions imposed, or that may be imposed, against Russia may result in an adverse effect on our remaining Russian operations until the date the sale is completed.
68
Table of Contents

The risk of cybersecurity incidents has increased in connection with the ongoing war, driven by justifications such as retaliation for the sanctions imposed in conjunction with the war, or in response to certain companies' continued operations in Russia. For example, the war has been accompanied by cyberattacks against the Ukrainian government and other countries in the region. It is possible that these attacks could have collateral effects on additional critical infrastructure and financial institutions globally, which could adversely affect our operations and could increase the frequency and severity of cyber-based attacks against our information technology systems. While we have taken actions to mitigate such potential risks, the proliferation of malware from the war into systems unrelated to the war, or cyberattacks against U.S. companies in retaliation for U.S. sanctions against Russia, or U.S. support of Ukraine, could also adversely affect our operations.
Although we insure ourselves against many types of risks, including certain of the risks associated with the ongoing war, our level of insurance may not cover all losses we could incur. The potential impact of our insurance being unable to adequately insure against the possible exposure we could experience as a result of the war could have a material adverse effect on our business, results of operations and financial condition.
Risks associated with the Ukraine-Russia war (the "war") are overseen at the Board of Directors level by the Enterprise Risk Management Committee ("ERMC"), which has responsibility for supervising the quality and integrity of our risk management practices, and at the executive level as part of our enterprise risk management ("ERM") framework, overseen by our Chief Risk Officer, who reports to our CEO, with input from relevant teams and functions.
To the extent the current war adversely affects our business, it may also have the effect of heightening many other risks disclosed in Part I, “Item 1A. Risk Factors” in our 2021 Annual Report on Form 10-K, any of which could materially and adversely affect our business and results of operations. However, due to the continually evolving nature of the war, the potential impact that the war could have on such risk factors, and others that cannot yet be identified, remains uncertain.
Even if the war moderates, or a resolution between Ukraine and Russia is reached, we expect that we will continue to experience ongoing financial and operational impacts resulting from the war for the foreseeable future as Ukraine rebuilds its economy and infrastructure.
Adverse weather conditions, including as a result of climate change, may adversely affect the availability, quality and price of agricultural commodities and agricultural commodity products, as well as our operations, supply chains, and operating results.
Adverse weather conditions have historically caused volatility in the agricultural commodity industry and consequently in our operating results by causing crop failures or significantly reduced harvests, which may affect the supply and pricing of the agricultural commodities that we sell and use in our business, reduce demand for our fertilizer products and negatively affect the creditworthiness of agricultural producers who do business with us.
Severe adverse weather conditions, such as hurricanes, severe storms, may also result in extensive property damage, extended business interruption, personal injuries and other loss and damage to us. Our operations also rely on dependable and efficient transportation services, including via ocean vessel, river barges, rail, and truck. A disruption in transportation services as a result of weather conditions, for example low river levels following periods of drought, or otherwise, may also significantly adversely impact our operations and related supply chains.
Additionally, the potential physical impacts of climate change are uncertain and may vary by region. These potential effects could include changes in rainfall patterns, water shortages, changing sea levels, changing storm patterns and intensities, shifts in agricultural production areas, changing temperature levels, and climatic volatility. The frequency and severity of the effects of climate change or weather patterns have been increasing and could adversely impact our business operations, the location, costs and competitiveness of global agricultural commodity production and related storage and processing facilities, as well as the supply and demand for agricultural commodities, and may result in incidents of stranded physical assets. These effects could be material to our results of operations, liquidity or capital resources.

69
Table of Contents

ITEM 2.    UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Issuer Purchases of Equity Securities
The following table is a summary of purchases of equity securities during the third quarter of 2022 by Bunge and any of its affiliated purchasers, pursuant to SEC rules.
Period Total Number of Shares (or Units) Purchased Average Price Paid per Share (or Unit)
Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs (1)
Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs (1)
July 1, 2022 - July 31, 2022 — $ — — $ 500,000,000
August 1, 2022 - August 31, 2022 2,109,115 $ 94.83 2,109,115 $ 300,000,071
September 1, 2022 - September 30, 2022 — $ — — $ 300,000,071
Total 2,109,115 $ — 2,109,115
(1) Program was established in October 2021 for the repurchase of up to $500 million issued and outstanding common shares. The program has no expiration date.
ITEM 3.    DEFAULTS UPON SENIOR SECURITIES
None.

ITEM 4.    MINE SAFETY DISCLOSURES
Not applicable.

ITEM 5.    OTHER INFORMATION
None.

ITEM 6. EXHIBITS
(a) The exhibits in the accompanying Exhibit Index on page E-1 are filed or furnished as part of this Quarterly Report.

70
Table of Contents
EXHIBIT INDEX
Revolving Credit Agreement, among Bunge Limited Finance Corp., as borrower, Sumitomo Mitsui Banking Corporation, as syndication agent, BNP Paribas, Citibank, N.A., Natixis, New York Branch, and U.S. Bank National Association, as co-documentation agents, Coöperatieve Rabobank U.A., New York Branch, as administrative agent, and certain lenders party thereto, dated July 15, 2022 (the “Rabobank Credit Agreement”) (incorporated by reference from the Registrant’s Form 8-K filed July 18, 2022)
Guaranty by Bunge Limited pursuant to the Rabobank Credit Agreement, dated July 15, 2022 (incorporated by reference from the Registrant’s Form 8-K filed July 18, 2022)
Term Loan Agreement among Bunge Limited Finance Corp., as borrower, Sumitomo Mitsui Banking Corporation, Bank of America, N.A., BNP Paribas, Citibank, N.A., Coöperatieve Rabobank U.A., New York Branch, ING Bank, N.V., JPMorgan Chase Bank, N.A., Mizuho Bank, Ltd., PNC Bank, National Association, Royal Bank of Canada, The Toronto-Dominion Bank, New York Branch, Truist Bank, U.S. Bank National Association and Wells Fargo Bank, National Association, as syndication agents, JPMorgan Chase Bank, N.A., as administrative agent, and certain lenders party thereto, dated July 26, 2022 (the “Term Loan Agreement”) (incorporated by reference from the Registrant’s Form 8-K filed July 26, 2022)
Guaranty by Bunge Limited pursuant to the Term Loan Agreement, dated July 26, 2022 (incorporated by reference from the Registrant’s Form 8-K filed July 26, 2022)
Credit Agreement among Bunge Limited Finance Corp., as borrower, CoBank, ACB, as administrative agent and lead arranger, and certain lenders party thereto from time to time, dated August 5, 2022 (the “CoBank Credit Agreement”) (incorporated by reference from the Registrant’s Form 8-K filed August 9, 2022)
Guaranty by Bunge Limited pursuant to the CoBank Credit Agreement, dated August 5, 2022 (incorporated by reference from the Registrant’s Form 8-K filed August 9, 2022)
*
Subsidiary Issuers of Guaranteed Securities
* Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002
* Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002
** Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002
** Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002
101 SCH XBRL Taxonomy Extension Schema Document
101 CAL XBRL Taxonomy Extension Calculation Linkbase Document
101 LAB XBRL Taxonomy Extension Labels Linkbase Document
101 PRE XBRL Taxonomy Extension Presentation Linkbase Document
101 DEF XBRL Taxonomy Extension Definition Linkbase Document
101 INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
* Filed herewith.
** Furnished herewith.

E-1

71
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
BUNGE LIMITED
Date: October 26, 2022 By: /s/ John W. Neppl
John W. Neppl
Executive Vice President, Chief Financial Officer
/s/ J. Matt Simmons, Jr.
J. Matt Simmons, Jr.
Controller and Principal Accounting Officer
72
TABLE OF CONTENTS
Part I Financial InformationprintItem 1. Financial StatementsprintNote 9 - Variable Interest EntitiesprintNote 12 - Fair Value MeasurementsprintNote 3 - Acquisitions and DispositionsprintNote 13 - Derivative Instruments and Hedging ActivitiesprintNote 7 - Other Current AssetsprintNote 5 - Trade Accounts Receivable and Trade Receivable Securitization ProgramprintNote 1 - Basis Of Presentation, Principles Of Consolidation, and Significant Accounting Policies,printNote 11 - Investments in AffiliatesprintNote 4 - Trade Structured Finance ProgramprintNote 8- Other Non-current AssetsprintNote 14- DebtprintNote 15 - Fair Value Measurements,printNote 10- Income TaxesprintNote 24 - EquityprintNote 19 - EquityprintItem 2. Management S Discussion and Analysis Of Financial Condition and Results Of OperationsprintNote 5 - Trade Accounts Receivable and Trade Receivable Securitization Program,printNote 6 - InventoriesprintNote 1 - Basis Of Presentation, Principles Of Consolidation, and Significant Accounting PoliciesprintNote 14- Debt)printNote 16 - Commitments and ContingenciesprintNote 2 - Ukraine-russia WarprintItem 3. Quantitative and Qualitative Disclosures About Market RiskprintItem 4. Controls and ProceduresprintNote 2 Ukraine-russia WarprintPart IIprintItem 1. Legal ProceedingsprintItem 1A. Risk FactorsprintItem 2. Unregistered Sales Of Equity Securities and Use Of ProceedsprintItem 3. Defaults Upon Senior SecuritiesprintItem 4. Mine Safety DisclosuresprintItem 5. Other InformationprintItem 6. Exhibitsprint

Exhibits

10.1 Revolving Credit Agreement, among Bunge Limited Finance Corp., as borrower, Sumitomo Mitsui Banking Corporation, as syndication agent, BNP Paribas, Citibank, N.A., Natixis, New York Branch, and U.S. Bank National Association, as co-documentation agents, Coperatieve Rabobank U.A., New York Branch, as administrative agent, and certain lenders party thereto, dated July 15, 2022 (the Rabobank Credit Agreement) (incorporated by reference from the Registrants Form 8-K filed July 18, 2022) 10.2 Guaranty by Bunge Limited pursuant to the Rabobank Credit Agreement, dated July 15, 2022 (incorporated by reference from the Registrants Form 8-K filed July 18, 2022) 10.3 Term Loan Agreement among Bunge Limited Finance Corp., as borrower, Sumitomo Mitsui Banking Corporation, Bank of America, N.A., BNP Paribas, Citibank, N.A., Coperatieve Rabobank U.A., New York Branch, ING Bank, N.V., JPMorgan Chase Bank, N.A., Mizuho Bank, Ltd., PNC Bank, National Association, Royal Bank of Canada, The Toronto-Dominion Bank, New York Branch, Truist Bank, U.S. Bank National Association and Wells Fargo Bank, National Association, as syndication agents, JPMorgan Chase Bank, N.A., as administrative agent, and certain lenders party thereto, dated July 26, 2022 (the Term Loan Agreement) (incorporated by reference from the Registrants Form 8-K filed July 26, 2022) 10.4 Guaranty by Bunge Limited pursuant to the Term Loan Agreement, dated July 26, 2022 (incorporated by reference from the Registrants Form 8-K filed July 26, 2022) 10.5 Credit Agreement among Bunge Limited Finance Corp., as borrower, CoBank, ACB, as administrative agent and lead arranger, and certain lenders party thereto from time to time, dated August 5, 2022 (the CoBank Credit Agreement) (incorporated by reference from the Registrants Form 8-K filed August 9, 2022) 10.6 Guaranty by Bunge Limited pursuant to the CoBank Credit Agreement, dated August 5, 2022 (incorporated by reference from the Registrants Form 8-K filed August 9, 2022) 22.1 * Subsidiary Issuers of Guaranteed Securities 31.1 * Certification of Chief Executive Officer pursuant to Rule13a-14(a)/15d-14(a)of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section302 of the Sarbanes Oxley Act of 2002 31.2 * Certification of Chief Financial Officer pursuant to Rule13a-14(a)/15d-14(a)of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section302 of the Sarbanes Oxley Act of 2002 32.1 ** Certification of Chief Executive Officer pursuant to 18U.S.C. 1350, as adopted pursuant to Section906 of the Sarbanes Oxley Act of 2002 32.2 ** Certification of Chief Financial Officer pursuant to 18U.S.C. 1350, as adopted pursuant to Section906 of the Sarbanes Oxley Act of 2002